Murine respirovirus (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Murine respirovirus" in English language version.

refsWebsite

Global rank English rank

529nih.gov

4^th place

363doi.org

2^nd place

92semanticscholar.org

11^th place

8^th place

34harvard.edu

18^th place

17^th place

10worldcat.org

5^th place

9proteinatlas.org

low place

8uniprot.org

5,673^rd place

6,418^th place

7genome.jp

low place

2handle.net

102^nd place

76^th place

2atcc.org

low place

1ictvonline.org

5,233^rd place

low place

1expasy.org

7,021^st place

7,383^rd place

1sciencedirect.com

149^th place

178^th place

1missouri.edu

3,342^nd place

3,036^th place

1ratguide.com

low place

1unige.ch

6,897^th place

6,705^th place

1britannica.com

40^th place

58^th place

1iastate.edu

2,548^th place

1,587^th place

1stanford.edu

179^th place

183^rd place

1d2vxd53ymoe6ju.cloudfront.net

low place

1psu.edu

207^th place

136^th place

1nature.com

234^th place

397^th place

1springer.com

274^th place

309^th place

1youtube.com

9^th place

13^th place

1ghostarchive.org

32^nd place

21^st place

1patents.google.com

1,182^nd place

725^th place

1aacrjournals.org

8,869^th place

8,487^th place

1aai.org

low place

1osaka-u.ac.jp

low place

1thermofisher.com

low place

1virology.ws

low place

aacrjournals.org

cancerres.aacrjournals.org

Westrick MA, Lee WM, Macher BA (December 1983). "Isolation and characterization of gangliosides from chronic myelogenous leukemia cells". Cancer Research. 43 (12 Pt 1): 5890–5894. PMID 6580065.

aai.org

journals.aai.org

Ohishi K, Ishikura A, Nishida S, Abo H, Nakatsukasa H, Kawashima H (2024-06-01). "Sialyl Lewis X Defines an Activated and Functional Regulatory T Cell Subpopulation in Mice". The Journal of Immunology. 212 (11): 1627–1638. doi:10.4049/jimmunol.2300349. ISSN 0022-1767. PMID 38639586.

atcc.org

"Sendai virus (ATCC VR-105)". American Type Culture Collection (ATCC).
"RT4". ATCC. Retrieved 20 August 2021.

britannica.com

"Sendai virus | infectious agent". Encyclopedia Britannica. Retrieved 2019-08-26.

d2vxd53ymoe6ju.cloudfront.net

"Recombinant Sendai Viral Vectors" (PDF). Occupational and Environmental Health and Safety. University of Utah.

doi.org

Samal SK (2008). "Paramyxoviruses of Animals". Encyclopedia of Virology. Elsevier. pp. 40–47. doi:10.1016/b978-012374410-4.00460-x. ISBN 9780123744104. S2CID 81060576.
Faísca P, Desmecht D (February 2007). "Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date". Research in Veterinary Science. 82 (1): 115–125. doi:10.1016/j.rvsc.2006.03.009. PMID 16759680.
Saga K, Kaneda Y (2015). "Oncolytic Sendai virus-based virotherapy for cancer: recent advances". Oncolytic Virotherapy. 4: 141–7. doi:10.2147/OV.S66419. PMC 4918391. PMID 27512677.
Matveeva OV, Kochneva GV, Netesov SV, Onikienko SB, Chumakov PM (April 2015). "Mechanisms of Oncolysis by Paramyxovirus Sendai". Acta Naturae. 7 (2): 6–16. doi:10.32607/20758251-2015-7-2-6-16. PMC 4463408. PMID 26085940. Material was copied from this source, which is available under a Creative Commons Attribution License.
Ilyinskaya GV, Mukhina EV, Soboleva AV, Matveeva OV, Chumakov PM (2018). "Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)". Frontiers in Veterinary Science. 5: 116. doi:10.3389/fvets.2018.00116. PMC 5995045. PMID 29915788.
Köhler G, Milstein C (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. PMID 1172191. S2CID 4161444.
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009). "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 85 (8): 348–62. Bibcode:2009PJAB...85..348F. doi:10.2183/pjab.85.348. PMC 3621571. PMID 19838014.
Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. (August 2011). "Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors". Proceedings of the National Academy of Sciences of the United States of America. 108 (34): 14234–9. Bibcode:2011PNAS..10814234B. doi:10.1073/pnas.1103509108. PMC 3161531. PMID 21821793.
Russell CJ, Hurwitz JL (2015-12-09). "Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses". Expert Review of Vaccines. 15 (2): 189–200. doi:10.1586/14760584.2016.1114418. PMC 4957581. PMID 26648515.
Russell CJ, Hurwitz JL (May 2021). "Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses". Viruses. 13 (6): 1023. doi:10.3390/v13061023. PMC 8230104. PMID 34072332.
Hu Z, Jiang W, Gu L, Qiao D, Shu T, Lowrie DB, et al. (December 2019). "Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines". Journal of Molecular Medicine. 97 (12): 1685–1694. doi:10.1007/s00109-019-01844-3. PMID 31786669. S2CID 208359634.
Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, et al. (February 2021). "Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults". Human Vaccines & Immunotherapeutics. 17 (2): 554–559. doi:10.1080/21645515.2020.1779517. PMC 7899675. PMID 32750273.
Seki S, Matano T (2016). "Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses". Expert Review of Vaccines. 15 (1): 119–127. doi:10.1586/14760584.2016.1105747. PMID 26512881. S2CID 27197590.
Nyombayire J, Anzala O, Gazzard B, Karita E, Bergin P, Hayes P, et al. (January 2017). "First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens". The Journal of Infectious Diseases. 215 (1): 95–104. doi:10.1093/infdis/jiw500. PMC 5225252. PMID 28077588.
Morimoto S, Saeki K, Takeshita M, Hirano K, Shirakawa M, Yamada Y, et al. (January 2023). "Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model". Genes to Cells. 28 (1): 29–41. doi:10.1111/gtc.12992. PMID 36401755. S2CID 253671438.
MacLachlan NJ, Dubovi EJ, eds. (2017). "Chapter 17 - Paramyxoviridae and Pneumoviridae". Fenner's Veterinary Virology (Fifth ed.). Academic Press. pp. 327–356. doi:10.1016/B978-0-12-800946-8.00017-9. ISBN 9780128009468. S2CID 214757272.
Flecknell PA, Parry R, Needham JR, Ridley RM, Baker HF, Bowes P (April 1983). "Respiratory disease associated with parainfluenza Type I (Sendai) virus in a colony of marmosets (Callithrix jacchus)". Laboratory Animals. 17 (2): 111–113. doi:10.1258/002367783780959448. PMID 6306336. S2CID 7413539.
Nicklas W, Bleich A, Mähler M (2012-01-01). "Chapter 3.2 - Viral Infections of Laboratory Mice". In Hedrich HJ (ed.). The Laboratory Mouse (Second ed.). Academic Press. pp. 427–480. doi:10.1016/B978-0-12-382008-2.00019-2. ISBN 9780123820082. PMC 7150319.
López CB, Yount JS, Hermesh T, Moran TM (May 2006). "Sendai virus infection induces efficient adaptive immunity independently of type I interferons". Journal of Virology. 80 (9): 4538–4545. doi:10.1128/JVI.80.9.4538-4545.2006. PMC 1472017. PMID 16611914.
Faisca P, Anh DB, Desmecht DJ (November 2005). "Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains". American Journal of Physiology. Lung Cellular and Molecular Physiology. 289 (5): L777 – L787. doi:10.1152/ajplung.00240.2005. PMID 16006482.
Burke CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, et al. (July 2011). "Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy". PLOS Pathogens. 7 (7): e1002134. doi:10.1371/journal.ppat.1002134. PMC 3131265. PMID 21750677.
Parker JC, Whiteman MD, Richter CB (January 1978). "Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents". Infection and Immunity. 19 (1): 123–30. doi:10.1128/IAI.19.1.123-130.1978. PMC 414057. PMID 203530.
Simon AY, Moritoh K, Torigoe D, Asano A, Sasaki N, Agui T (December 2009). "Multigenic control of resistance to Sendai virus infection in mice". Infection, Genetics and Evolution. 9 (6): 1253–9. Bibcode:2009InfGE...9.1253S. doi:10.1016/j.meegid.2009.08.011. hdl:2115/42554. PMID 19733691.
Sangster M, Smith FS, Coleclough C, Hurwitz JL (September 1995). "Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection". Virology. 212 (1): 13–9. doi:10.1006/viro.1995.1448. PMID 7676623.
Stone AE, Giguere S, Castleman WL (November 2003). "IL-12 reduces the severity of Sendai virus-induced bronchiolar inflammation and remodeling". Cytokine. 24 (3): 103–13. doi:10.1016/j.cyto.2003.07.005. PMID 14581004.
Lock LF (2007). "Mouse and Human Pluripotent Stem Cells". In Fox JG, Barthold S, Davisson M, Newcomer CE, Quimby FW, Smith A (eds.). The Mouse in Biomedical Research (2nd ed.). Amsterdam: Academic Press. pp. 281–309. doi:10.1016/B978-012369454-6/50039-X.
Kiyotani K, Sakaguchi T, Kato A, Nagai Y, Yoshida T (March 2007). "Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice". Virology. 359 (1): 82–91. doi:10.1016/j.virol.2006.08.053. PMID 17027894.
Irie T, Nagata N, Igarashi T, Okamoto I, Sakaguchi T (May 2010). "Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses". PLOS ONE. 5 (5): e10719. Bibcode:2010PLoSO...510719I. doi:10.1371/journal.pone.0010719. PMC 2873429. PMID 20502666.
Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y (April 2001). "Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis". Journal of Virology. 75 (8): 3802–10. doi:10.1128/JVI.75.8.3802-3810.2001. PMC 114871. PMID 11264369.
Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE, et al. (September 2022). "IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation". Proceedings of the National Academy of Sciences of the United States of America. 119 (37): e2121385119. Bibcode:2022PNAS..11921385P. doi:10.1073/pnas.2121385119. PMC 9478676. PMID 36067309.
Koyama AH, Irie H, Kato A, Nagai Y, Adachi A (April 2003). "Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins". Microbes and Infection. 5 (5): 373–8. doi:10.1016/S1286-4579(03)00043-1. PMID 12737992.
Yamaguchi M, Kitagawa Y, Zhou M, Itoh M, Gotoh B (January 2014). "An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction". FEBS Letters. 588 (1): 28–34. Bibcode:2014FEBSL.588...28Y. doi:10.1016/j.febslet.2013.11.015. PMID 24269682. S2CID 24831300.
Kitagawa Y, Yamaguchi M, Kohno M, Sakai M, Itoh M, Gotoh B (2020). "Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling". FEBS Letters. 594 (5): 864–877. doi:10.1002/1873-3468.13670. PMID 31705658. S2CID 207944272.
Irie T, Yoshida A, Sakaguchi T (2013-08-09). "Clustered basic amino acids of the small sendai virus C protein Y1 are critical to its RAN GTPase-mediated nuclear localization". PLOS ONE. 8 (8): e73740. Bibcode:2013PLoSO...873740I. doi:10.1371/journal.pone.0073740. PMC 3739745. PMID 23951363.
Oda K, Matoba Y, Irie T, Kawabata R, Fukushi M, Sugiyama M, et al. (November 2015). "Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein". Journal of Virology. 89 (22): 11487–99. doi:10.1128/JVI.01887-15. PMC 4645678. PMID 26339056.
Oda K, Oda T, Matoba Y, Sato M, Irie T, Sakaguchi T (December 2017). "Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling". The Journal of Biological Chemistry. 292 (48): 19752–19766. doi:10.1074/jbc.m117.786285. PMC 5712616. PMID 28978648.
Odkhuu E, Komatsu T, Naiki Y, Koide N, Yokochi T (November 2014). "Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling". International Immunopharmacology. 23 (1): 267–72. doi:10.1016/j.intimp.2014.09.012. PMID 25242386.
Odkhuu E, Komatsu T, Koide N, Naiki Y, Takeuchi K, Tanaka Y, et al. (October 2018). "Sendai virus C protein limits NO production in infected RAW264.7 macrophages". Innate Immunity. 24 (7): 430–438. doi:10.1177/1753425918796619. PMC 6830875. PMID 30189760.
MacMicking J, Xie QW, Nathan C (1997). "Nitric oxide and macrophage function". Annual Review of Immunology. 15 (1): 323–50. doi:10.1146/annurev.immunol.15.1.323. PMID 9143691.
Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B (October 2008). "Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA". Journal of Virology. 82 (20): 10102–10. doi:10.1128/JVI.00599-08. PMC 2566265. PMID 18684815.
Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, et al. (December 2004). "The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter". Proceedings of the National Academy of Sciences of the United States of America. 101 (49): 17264–9. Bibcode:2004PNAS..10117264A. doi:10.1073/pnas.0407639101. PMC 535396. PMID 15563593.
Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, et al. (March 2007). "mda-5, but not RIG-I, is a common target for paramyxovirus V proteins". Virology. 359 (1): 190–200. doi:10.1016/j.virol.2006.09.023. PMID 17049367.
Sánchez-Aparicio MT, Feinman LJ, García-Sastre A, Shaw ML (March 2018). "Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling". Journal of Virology. 92 (6). doi:10.1128/JVI.01960-17. PMC 5827389. PMID 29321315.
Morita N, Tanaka Y, Odkhuu E, Naiki Y, Komatsu T, Koide N (February 2020). "Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages". Microbes and Infection. 22 (8): 322–330. doi:10.1016/j.micinf.2020.01.005. PMID 32032681. S2CID 211064429.
Komatsu T, Tanaka Y, Kitagawa Y, Koide N, Naiki Y, Morita N, et al. (October 2018). "Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly". Journal of Virology. 92 (19): e00842–18. doi:10.1128/JVI.00842-18. PMC 6146803. PMID 30021903.
Rochat S, Komada H, Kolakofsky D (July 1992). "Loss of V protein expression in human parainfluenza virus type 1 is not a recent event". Virus Research. 24 (2): 137–44. doi:10.1016/0168-1702(92)90002-q. PMID 1326826.
Odkhuu E, Komatsu T, Koide N, Naiki Y, Takeuchi K, Tanaka Y, et al. (October 2018). "Sendai virus C protein limits NO production in infected RAW264.7 macrophages". Innate Immunity. 24 (7): 430–438. doi:10.1177/1753425918796619. PMC 6830875. PMID 30189760.
Qiao D, Janke BH, Elankumaran S (August 2009). "Molecular characterization of glycoprotein genes and phylogenetic analysis of two swine paramyxoviruses isolated from United States". Virus Genes. 39 (1): 53–65. doi:10.1007/s11262-009-0353-2. PMID 19337823. S2CID 7100230.
Qiao D, Janke BH, Elankumaran S (January 2010). "Complete genome sequence and pathogenicity of two swine parainfluenzavirus 3 isolates from pigs in the United States". Journal of Virology. 84 (2): 686–94. doi:10.1128/JVI.00847-09. PMC 2798373. PMID 19906928.
Lau SK, Woo PC, Wu Y, Wong AY, Wong BH, Lau CC, et al. (October 2013). "Identification and characterization of a novel paramyxovirus, porcine parainfluenza virus 1, from deceased pigs". The Journal of General Virology. 94 (Pt 10): 2184–90. doi:10.1099/vir.0.052985-0. PMID 23918408.
Palinski RM, Chen Z, Henningson JN, Lang Y, Rowland RR, Fang Y, et al. (February 2016). "Widespread detection and characterization of porcine parainfluenza virus 1 in pigs in the USA". The Journal of General Virology. 97 (2): 281–286. doi:10.1099/jgv.0.000343. PMID 26581410.
Slobod KS, Shenep JL, Luján-Zilbermann J, Allison K, Brown B, Scroggs RA, et al. (August 2004). "Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults". Vaccine. 22 (23–24): 3182–6. doi:10.1016/j.vaccine.2004.01.053. PMID 15297072.
Skiadopoulos MH, Surman SR, Riggs JM, Elkins WR, St Claire M, Nishio M, et al. (May 2002). "Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees". Virology. 297 (1): 153–60. doi:10.1006/viro.2002.1416. PMID 12083845.
Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, et al. (March 2015). "Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children". Clinical and Vaccine Immunology. 22 (3): 298–303. doi:10.1128/CVI.00618-14. PMC 4340902. PMID 25552633.
Hara H, Hara H, Hironaka T, Inoue M, Iida A, Shu T, et al. (June 2011). "Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors". Human Vaccines. 7 (6): 639–45. doi:10.4161/hv.7.6.15408. PMID 21508675. S2CID 24481304.
Moriya C, Horiba S, Inoue M, Iida A, Hara H, Shu T, et al. (July 2008). "Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques". Biochemical and Biophysical Research Communications. 371 (4): 850–4. doi:10.1016/j.bbrc.2008.04.156. PMID 18466766.
Kuroya M, Ishida N, Shiratori T (June 1953). "Newborn virus pneumonitis (type Sendai). II. The isolation of a new virus". The Tohoku Journal of Experimental Medicine. 58 (1): 62. doi:10.1620/tjem.58.62. PMID 13102529.
Fukumi H, Nishikawa F, Kitayama T (August 1954). "A pneumotropic virus from mice causing hemagglutination". Japanese Journal of Medical Science & Biology. 7 (4): 345–63. doi:10.7883/yoken1952.7.345. PMID 13232830.
Ishida N, Homma M (1978). "Sendai virus". Advances in Virus Research. 23: 349–83. doi:10.1016/S0065-3527(08)60103-7. ISBN 9780120398232. PMID 219669.
Griesenbach U, McLachlan G, Owaki T, Somerton L, Shu T, Baker A, et al. (February 2011). "Validation of recombinant Sendai virus in a non-natural host model". Gene Therapy. 18 (2): 182–8. doi:10.1038/gt.2010.131. PMID 20962870. S2CID 23293412.
Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T (October 2006). "Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment". Virus Research. 121 (1): 23–32. doi:10.1016/j.virusres.2006.03.012. PMID 16677733.
Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, et al. (April 2000). "The IRF-3 transcription factor mediates Sendai virus-induced apoptosis". Journal of Virology. 74 (8): 3781–92. doi:10.1128/jvi.74.8.3781-3792.2000. PMC 111887. PMID 10729153.
Cantell K, Hirvonen S, Kauppinen HL, Myllylä G (1981). "[4] Production of interferon in human leukocytes from normal donors with the use of Sendai virus". Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods in Enzymology. Vol. 78. pp. 29–38. doi:10.1016/0076-6879(81)78094-7. ISBN 9780121819781. PMID 6173603.
Miettinen M, Sareneva T, Julkunen I, Matikainen S (October 2001). "IFNs activate toll-like receptor gene expression in viral infections". Genes and Immunity. 2 (6): 349–55. doi:10.1038/sj.gene.6363791. PMID 11607792. S2CID 5819381.
Lappalainen J, Rintahaka J, Kovanen PT, Matikainen S, Eklund KK (April 2013). "Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells". Clinical and Experimental Immunology. 172 (1): 121–8. doi:10.1111/cei.12042. PMC 3719938. PMID 23480192.
Neerincx A, Lautz K, Menning M, Kremmer E, Zigrino P, Hösel M, et al. (August 2010). "A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses". The Journal of Biological Chemistry. 285 (34): 26223–32. doi:10.1074/jbc.M110.109736. PMC 2924034. PMID 20538593.
Seth RB, Sun L, Ea CK, Chen ZJ (September 2005). "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3". Cell. 122 (5): 669–682. doi:10.1016/j.cell.2005.08.012. PMID 16125763. S2CID 11104354.
Leib D (2010-03-08). "Evaluation for RIG-I detects viral genomic RNA during negative-strand RNA virus infection". Faculty of 1000. doi:10.3410/f.2412956.2047054. S2CID 90712939.
Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, et al. (April 2009). "RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1". The Journal of Biological Chemistry. 284 (16): 10774–10782. doi:10.1074/jbc.M807272200. PMC 2667765. PMID 19224920.
Gitlin L, Benoit L, Song C, Cella M, Gilfillan S, Holtzman MJ, et al. (January 2010). "Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo". PLOS Pathogens. 6 (1): e1000734. doi:10.1371/journal.ppat.1000734. PMC 2809771. PMID 20107606.
Servant MJ, Grandvaux N, tenOever BR, Duguay D, Lin R, Hiscott J (March 2003). "Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA". The Journal of Biological Chemistry. 278 (11): 9441–7. doi:10.1074/jbc.M209851200. PMID 12524442. S2CID 19096582.
Barnes BJ, Moore PA, Pitha PM (June 2001). "Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes". The Journal of Biological Chemistry. 276 (26): 23382–90. doi:10.1074/jbc.M101216200. PMID 11303025. S2CID 26896371.
Hua J, Liao MJ, Rashidbaigi A (July 1996). "Cytokines induced by Sendai virus in human peripheral blood leukocytes". Journal of Leukocyte Biology. 60 (1): 125–8. doi:10.1002/jlb.60.1.125. PMID 8699116. S2CID 28976518.
Costas MA, Mella D, Criscuolo M, Díaz A, Finkielman S, Nahmod VE, et al. (December 1993). "Superinduction of mitogen-stimulated interferon-gamma production and other lymphokines by Sendai virus". Journal of Interferon Research. 13 (6): 407–12. doi:10.1089/jir.1993.13.407. PMID 8151134.
Zidovec S, Mazuran R (February 1999). "Sendai virus induces various cytokines in human peripheral blood leukocytes: different susceptibility of cytokine molecules to low pH". Cytokine. 11 (2): 140–3. doi:10.1006/cyto.1998.0411. PMID 10089135.
Nyman TA, Tölö H, Parkkinen J, Kalkkinen N (January 1998). "Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes". The Biochemical Journal. 329 (Pt 2): 295–302. doi:10.1042/bj3290295. PMC 1219044. PMID 9425112.
Zeng J, Fournier P, Schirrmacher V (May 2002). "Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus". Virology. 297 (1): 19–30. doi:10.1006/viro.2002.1413. PMID 12083832.
Génin P, Lin R, Hiscott J, Civas A (2012). "Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression". PLOS ONE. 7 (6): e38336. Bibcode:2012PLoSO...738336G. doi:10.1371/journal.pone.0038336. PMC 3369917. PMID 22685561.
Mandhana R, Horvath CM (November 2018). "Sendai Virus Infection Induces Expression of Novel RNAs in Human Cells". Scientific Reports. 8 (1): 16815. Bibcode:2018NatSR...816815M. doi:10.1038/s41598-018-35231-8. PMC 6235974. PMID 30429577.
Milone MC, Fitzgerald-Bocarsly P (September 1998). "The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses". Journal of Immunology. 161 (5): 2391–9. doi:10.4049/jimmunol.161.5.2391. PMID 9725235. S2CID 30673547.
Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV (September 1997). "Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria". Scandinavian Journal of Immunology. 46 (3): 235–41. doi:10.1046/j.1365-3083.1997.d01-120.x. PMID 9315110. S2CID 40570647.
Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A (March 2007). "Autophagy-dependent viral recognition by plasmacytoid dendritic cells". Science. 315 (5817): 1398–401. Bibcode:2007Sci...315.1398L. CiteSeerX 10.1.1.657.3208. doi:10.1126/science.1136880. PMID 17272685. S2CID 11549012.
Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, et al. (December 2003). "Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells". Journal of Leukocyte Biology. 74 (6): 1125–38. doi:10.1189/jlb.0603255. PMID 12960254. S2CID 12030752.
Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (March 2000). "CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen". Journal of Immunology. 164 (6): 2978–86. doi:10.4049/jimmunol.164.6.2978. PMID 10706685. S2CID 20588521.
Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, Tschopp J, et al. (February 2010). "Quantitative proteomics reveals subset-specific viral recognition in dendritic cells". Immunity. 32 (2): 279–89. doi:10.1016/j.immuni.2010.01.013. PMID 20171123.
Kiener R, Fleischmann M, Wiegand MA, Lemmermann NA, Schwegler C, Kaufmann C, et al. (August 2018). "Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors". Journal of Virology. 92 (15). doi:10.1128/JVI.00569-18. PMC 6052310. PMID 29769344.
Donnelly RP, Kotenko SV (August 2010). "Interferon-lambda: a new addition to an old family". Journal of Interferon & Cytokine Research. 30 (8): 555–64. doi:10.1089/jir.2010.0078. PMC 2925029. PMID 20712453.
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, et al. (September 2012). "Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells". Journal of Immunology. 189 (6): 2735–45. doi:10.4049/jimmunol.1102038. PMC 3579503. PMID 22891284.
Suzuki H, Kurooka M, Hiroaki Y, Fujiyoshi Y, Kaneda Y (April 2008). "Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner". FEBS Letters. 582 (9): 1325–9. Bibcode:2008FEBSL.582.1325S. doi:10.1016/j.febslet.2008.03.011. PMID 18358837. S2CID 207607018.
Kawaguchi Y, Miyamoto Y, Inoue T, Kaneda Y (May 2009). "Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle". International Journal of Cancer. 124 (10): 2478–87. doi:10.1002/ijc.24234. PMID 19173282. S2CID 33289879.
Lin HY, Davis PJ, Thacore HR (December 1991). "Production of human interferon-beta by Sendai virus and poly(rI).poly(rC): inhibition by neomycin". Journal of Interferon Research. 11 (6): 365–9. doi:10.1089/jir.1991.11.365. PMID 1666117.
Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagnæs-Hansen F, et al. (April 2012). "TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice". The Journal of Clinical Investigation. 122 (4): 1368–76. doi:10.1172/JCI60893. PMC 3314467. PMID 22426207.
Ito Y, Hosaka Y (March 1983). "Component(s) of Sendai virus that can induce interferon in mouse spleen cells". Infection and Immunity. 39 (3): 1019–23. doi:10.1128/IAI.39.3.1019-1023.1983. PMC 348058. PMID 6301988.
Subramanian G, Kuzmanovic T, Zhang Y, Peter CB, Veleeparambil M, Chakravarti R, et al. (January 2018). "A new mechanism of interferon's antiviral action: Induction of autophagy, essential for paramyxovirus replication, is inhibited by the interferon stimulated gene, TDRD7". PLOS Pathogens. 14 (1): e1006877. doi:10.1371/journal.ppat.1006877. PMC 5806901. PMID 29381763.
Wetzel JL, Fensterl V, Sen GC (December 2014). "Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon". Journal of Virology. 88 (23): 13593–601. doi:10.1128/JVI.02201-14. PMC 4248979. PMID 25231314.
Haller O, Kochs G (January 2011). "Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity". Journal of Interferon & Cytokine Research. 31 (1): 79–87. doi:10.1089/jir.2010.0076. PMID 21166595.
Peters K, Chattopadhyay S, Sen GC (April 2008). "IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence". Journal of Virology. 82 (7): 3500–8. doi:10.1128/JVI.02536-07. PMC 2268502. PMID 18216110.
Pirhonen J, Matikainen S, Julkunen I (November 2002). "Regulation of virus-induced IL-12 and IL-23 expression in human macrophages". Journal of Immunology. 169 (10): 5673–5678. doi:10.4049/jimmunol.169.10.5673. PMID 12421946.
Ittah M, Miceli-Richard C, Lebon P, Pallier C, Lepajolec C, Mariette X (2011). "Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type". Journal of Innate Immunity. 3 (2): 200–7. doi:10.1159/000321194. PMID 21051868. S2CID 6699971.
Johansson E, Domeika K, Berg M, Alm GV, Fossum C (February 2003). "Characterisation of porcine monocyte-derived dendritic cells according to their cytokine profile". Veterinary Immunology and Immunopathology. 91 (3–4): 183–97. doi:10.1016/s0165-2427(02)00310-0. PMID 12586481.
Li S, Nishikawa T, Kaneda Y (December 2017). "Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells". Cancer Science. 108 (12): 2333–2341. doi:10.1111/cas.13408. PMC 5715349. PMID 28945328.
Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, et al. (December 2006). "Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA". The Journal of Biological Chemistry. 281 (48): 36560–8. doi:10.1074/jbc.M607594200. PMID 17008311. S2CID 23488241.
Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T, et al. (October 2013). "The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity". Journal of Immunology. 191 (8): 4358–66. doi:10.4049/jimmunol.1301170. PMC 3848201. PMID 24048902.
Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN (April 2013). "The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation". Cell. 153 (2): 348–61. doi:10.1016/j.cell.2013.02.054. PMC 3632354. PMID 23582325.
Ryan LK, Diamond G (June 2017). "Modulation of Human β-Defensin-1 Production by Viruses". Viruses. 9 (6): 153. doi:10.3390/v9060153. PMC 5490828. PMID 28635669.
Ryan LK, Dai J, Yin Z, Megjugorac N, Uhlhorn V, Yim S, et al. (August 2011). "Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity". Journal of Leukocyte Biology. 90 (2): 343–56. doi:10.1189/jlb.0209079. PMC 3133436. PMID 21551252.
Öhman T, Söderholm S, Paidikondala M, Lietzén N, Matikainen S, Nyman TA (June 2015). "Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells". Proteomics. 15 (12): 2087–2097. doi:10.1002/pmic.201400586. PMID 25764225. S2CID 32610482.
Samal SK (2021), Vanniasinkam T, Tikoo SK, Samal SK (eds.), "Paramyxoviruses as Vaccine Vectors", Viral Vectors in Veterinary Vaccine Development, Cham: Springer International Publishing, pp. 113–139, doi:10.1007/978-3-030-51927-8_8, ISBN 978-3-030-51926-1, retrieved 2024-05-26
Nakanishi M, Otsu M (October 2012). "Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine". Current Gene Therapy. 12 (5): 410–6. doi:10.2174/156652312802762518. PMC 3504922. PMID 22920683.
Russell CJ, Hurwitz JL (May 2021). "Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses". Viruses. 13 (6): 1023. doi:10.3390/v13061023. PMC 8230104. PMID 34072332.
Kinoh H, Inoue M, Washizawa K, Yamamoto T, Fujikawa S, Tokusumi Y, et al. (July 2004). "Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases". Gene Therapy. 11 (14): 1137–45. doi:10.1038/sj.gt.3302272. PMID 15085175. S2CID 10376042.
Kinoh H, Inoue M (January 2008). "New cancer therapy using genetically-engineered oncolytic Sendai virus vector". Frontiers in Bioscience. 13 (13): 2327–34. doi:10.2741/2847. PMID 17981715. S2CID 25851804.
Tatsuta K, Tanaka S, Tajiri T, Shibata S, Komaru A, Ueda Y, et al. (February 2009). "Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene". Gene Therapy. 16 (2): 240–51. doi:10.1038/gt.2008.161. PMID 18987675. S2CID 27976395.
Zimmermann M, Armeanu-Ebinger S, Bossow S, Lampe J, Smirnow I, Schenk A, et al. (2014). "Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors". PLOS ONE. 9 (3): e90508. Bibcode:2014PLoSO...990508Z. doi:10.1371/journal.pone.0090508. PMC 3944018. PMID 24598703.
Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, et al. (June 2019). "Oncolytic Sendai virus-induced tumor-specific immunoresponses suppress "simulated metastasis" of squamous cell carcinoma in an immunocompetent mouse model". Head & Neck. 41 (6): 1676–1686. doi:10.1002/hed.25642. PMID 30620422. S2CID 58561289.
Yonemitsu Y, Ueda Y, Kinoh H, Hasegawa M (January 2008). "Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen". Frontiers in Bioscience. 13 (13): 1892–8. doi:10.2741/2809. PMID 17981677.
Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, et al. (August 2019). "Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model". Molecular Cancer Therapeutics. 18 (8): 1430–1438. doi:10.1158/1535-7163.MCT-18-1372. PMID 31171582. S2CID 174812921.
Iwadate Y, Inoue M, Saegusa T, Tokusumi Y, Kinoh H, Hasegawa M, et al. (May 2005). "Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats". Clinical Cancer Research. 11 (10): 3821–7. doi:10.1158/1078-0432.CCR-04-1485. PMID 15897582. S2CID 37657020.
Tanaka M, Shimbo T, Kikuchi Y, Matsuda M, Kaneda Y (April 2010). "Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon". International Journal of Cancer. 126 (8): 1982–1991. doi:10.1002/ijc.24965. PMID 19830690. S2CID 3414189.
Qian M, Tan HM, Yu N, Wang T, Zhang Q (April 2018). "Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells". Biomedical and Environmental Sciences. 31 (4): 280–289. Bibcode:2018BioES..31..280Q. doi:10.3967/bes2018.036. PMID 29773091.
Kurooka M, Kaneda Y (January 2007). "Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells". Cancer Research. 67 (1): 227–36. doi:10.1158/0008-5472.CAN-06-1615. PMID 17210703.
Fujihara A, Kurooka M, Miki T, Kaneda Y (January 2008). "Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation". Cancer Immunology, Immunotherapy. 57 (1): 73–84. doi:10.1007/s00262-007-0351-y. PMC 11030187. PMID 17602226. S2CID 8779015.
Nishikawa T, Tung LY, Kaneda Y (December 2014). "Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice". Molecular Therapy. 22 (12): 2046–55. doi:10.1038/mt.2014.128. PMC 4429689. PMID 25023327.
Zhang Q, Yuan WF, Zhai GQ, Zhu SY, Xue ZF, Zhu HF, et al. (October 2012). "Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression". Biomedical and Environmental Sciences. 25 (5): 509–16. Bibcode:2012BioES..25..509Z. doi:10.3967/0895-3988.2012.05.003. PMID 23122307.
Saga K, Tamai K, Yamazaki T, Kaneda Y (February 2013). "Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production". Clinical Cancer Research. 19 (3): 668–79. doi:10.1158/1078-0432.CCR-12-1947. PMID 23251005. S2CID 14105282.
Wheelock EF, Dingle JH (September 1964). "Observations on the Repeated Administration of Viruses to a Patient With Acute Leukemia. A Preliminary Report". The New England Journal of Medicine. 271 (13): 645–51. doi:10.1056/NEJM196409242711302. PMID 14170843.
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV (July 2019). "Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes". Oncolytic Virotherapy. 8: 9–26. doi:10.2147/ov.s176523. PMC 6636189. PMID 31372363.
Zainutdinov SS, Tikunov AY, Matveeva OV, Netesov SV, Kochneva GV (August 2016). "Complete Genome Sequence of the Oncolytic Sendai virus Strain Moscow". Genome Announcements. 4 (4). doi:10.1128/genomeA.00818-16. PMC 4982289. PMID 27516510.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, et al. (June 2020). "Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study". Cancer Immunology, Immunotherapy. 69 (6): 1131–1140. doi:10.1007/s00262-020-02509-8. PMC 11027698. PMID 32047956. S2CID 211074332.
Matveeva OV, Chumakov PM (November 2018). "Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses". Reviews in Medical Virology. 28 (6): e2008. doi:10.1002/rmv.2008. PMC 6906582. PMID 30209859.
Liang JX, Liang Y, Gao W (May 2016). "Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis". OncoTargets and Therapy. 9: 3113–25. doi:10.2147/ott.s102389. PMC 4888715. PMID 27307752.
Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ (2018-05-11). "Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy". Frontiers in Oncology. 8: 150. doi:10.3389/fonc.2018.00150. PMC 5958677. PMID 29795807.
Fuster MM, Esko JD (July 2005). "The sweet and sour of cancer: glycans as novel therapeutic targets". Nature Reviews. Cancer. 5 (7): 526–542. doi:10.1038/nrc1649. PMID 16069816. S2CID 10330140.
Noguchi M, Sato N, Sugimori H, Mori K, Oshimi K (October 2001). "A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells". Leukemia Research. 25 (10): 847–53. doi:10.1016/s0145-2126(01)00036-4. PMID 11532516.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–73. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Okegawa T (2018). "Detection of Circulating Tumor Cells in Castration-Resistant Prostate Cancer". Hormone Therapy and Castration Resistance of Prostate Cancer. Singapore: Springer. pp. 299–305. doi:10.1007/978-981-10-7013-6_30. ISBN 978-981-10-7012-9.
Hatano K, Miyamoto Y, Nonomura N, Kaneda Y (October 2011). "Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells". International Journal of Cancer. 129 (8): 1838–47. doi:10.1002/ijc.25860. PMID 21165949. S2CID 7765966.
Hamasaki H, Aoyagi M, Kasama T, Handa S, Hirakawa K, Taki T (January 1999). "GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1437 (1): 93–9. doi:10.1016/s1388-1981(98)00003-1. PMID 9931455.
Vukelić Z, Kalanj-Bognar S, Froesch M, Bîndila L, Radić B, Allen M, et al. (May 2007). "Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization". Glycobiology. 17 (5): 504–15. doi:10.1093/glycob/cwm012. PMID 17293353.
Markwell MA, Portner A, Schwartz AL (February 1985). "An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein". Proceedings of the National Academy of Sciences of the United States of America. 82 (4): 978–82. Bibcode:1985PNAS...82..978M. doi:10.1073/pnas.82.4.978. PMC 397176. PMID 2983337.
Bitzer M, Lauer U, Baumann C, Spiegel M, Gregor M, Neubert WJ (July 1997). "Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry". Journal of Virology. 71 (7): 5481–6. doi:10.1128/JVI.71.7.5481-5486.1997. PMC 191789. PMID 9188621.
"Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer". Lung Cancer. 13 (1): 93. August 1995. doi:10.1016/0169-5002(95)90215-5. ISSN 0169-5002.
Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A, Yang PC (January 2005). "Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer". Lung Cancer. 47 (1): 59–67. doi:10.1016/j.lungcan.2004.05.018. PMID 15603855.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–1783. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698. S2CID 17515010.
Ariga T, Bhat S, Kanda T, Yamawaki M, Tai T, Kushi Y, et al. (April 1996). "Expression and localization of Lewis(x) glycolipids and GD1a ganglioside in human glioma cells". Glycoconjugate Journal. 13 (2): 135–145. doi:10.1007/BF00731487. PMID 8737237. S2CID 11831860.
Cuello HA, Ferreira GM, Gulino CA, Toledo AG, Segatori VI, Gabri MR (December 2020). "Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma". Oncotarget. 11 (52): 4822–4835. doi:10.18632/oncotarget.27850. PMC 7779250. PMID 33447350.
Son MJ, Woolard K, Nam DH, Lee J, Fine HA (May 2009). "SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma". Cell Stem Cell. 4 (5): 440–452. doi:10.1016/j.stem.2009.03.003. PMC 7227614. PMID 19427293.
Mao XG, Zhang X, Xue XY, Guo G, Wang P, Zhang W, et al. (December 2009). "Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15". Translational Oncology. 2 (4): 247–257. doi:10.1593/tlo.09136. PMC 2781066. PMID 19956386.
Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J, et al. (February 2010). "CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors". BMC Cancer. 10 (1): 66. doi:10.1186/1471-2407-10-66. PMC 2841664. PMID 20181261.
Ward RJ, Lee L, Graham K, Satkunendran T, Yoshikawa K, Ling E, et al. (June 2009). "Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma". Cancer Research. 69 (11): 4682–4690. doi:10.1158/0008-5472.CAN-09-0342. PMID 19487286.
Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, et al. (February 2009). "Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma". Cancer Cell. 15 (2): 135–147. doi:10.1016/j.ccr.2008.12.016. PMC 2664097. PMID 19185848.
Singh AR, Joshi S, Zulcic M, Alcaraz M, Garlich JR, Morales GA, et al. (2016-03-03). Castresana JS (ed.). "PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma". PLOS ONE. 11 (3): e0150836. Bibcode:2016PLoSO..1150836S. doi:10.1371/journal.pone.0150836. PMC 4777592. PMID 26938241.
Fukuoka K, Narita N, Saijo N (May 1998). "Increased expression of sialyl Lewis(x) antigen is associated with distant metastasis in lung cancer patients: immunohistochemical study on bronchofiberscopic biopsy specimens". Lung Cancer. 20 (2): 109–116. doi:10.1016/s0169-5002(98)00016-6. PMID 9711529.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, et al. (April 1997). "Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis". Diseases of the Colon and Rectum. 40 (4): 420–431. doi:10.1007/bf02258386. PMID 9106690. S2CID 24770173.
Nakagoe T, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, et al. (March 2001). "Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels". Journal of Gastroenterology. 36 (3): 166–172. doi:10.1007/s005350170124. PMID 11291879. S2CID 25161348.
Yamadera M, Shinto E, Tsuda H, Kajiwara Y, Naito Y, Hase K, et al. (January 2018). "Sialyl Lewis^x expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer". Oncology Letters. 15 (1): 221–228. doi:10.3892/ol.2017.7340. PMC 5769389. PMID 29391881.
Trinchera M, Aronica A, Dall'Olio F (February 2017). "Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers". Biology. 6 (1): 16. doi:10.3390/biology6010016. PMC 5372009. PMID 28241499.
Nakagoe T, Fukushima K, Sawai T, Tsuji T, Jibiki M, Nanashima A, et al. (January 2002). "Increased expression of sialyl Lewis(x) antigen as a prognostic factor in patients with stage 0, I, and II gastric cancer". Cancer Letters. 175 (2): 213–221. doi:10.1016/S0304-3835(01)00705-4. PMID 11741750.
Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, et al. (May 2002). "Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer". Journal of Cancer Research and Clinical Oncology. 128 (5): 257–264. doi:10.1007/s00432-002-0334-5. PMID 12029441. S2CID 24553989.
Carrascal MA, Silva M, Ferreira JA, Azevedo R, Ferreira D, Silva AM, et al. (September 2018). "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer". Biochimica et Biophysica Acta (BBA) - General Subjects. 1862 (9): 2069–2080. doi:10.1016/j.bbagen.2018.05.013. PMID 29777742. S2CID 29167912.
Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL (August 2004). "Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin". Cancer Research. 64 (15): 5261–5269. doi:10.1158/0008-5472.CAN-04-0691. PMID 15289332. S2CID 11632075.
Munkley J (March 2017). "Glycosylation is a global target for androgen control in prostate cancer cells". Endocrine-Related Cancer. 24 (3): R49 – R64. doi:10.1530/erc-16-0569. PMID 28159857.
Idikio HA (November 1997). "Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer". Glycoconjugate Journal. 14 (7): 875–877. doi:10.1023/a:1018502424487. PMID 9511995. S2CID 28112794.
Fujii Y, Yoshida M, Chien LJ, Kihara K, Kageyama Y, Yasukochi Y, et al. (2000). "Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium". Urologia Internationalis. 64 (3): 129–133. doi:10.1159/000030512. PMID 10859542. S2CID 23332254.
Liang JX, Liang Y, Gao W (2016). "Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis". OncoTargets and Therapy. 9: 3113–3125. doi:10.2147/OTT.S102389. PMC 4888715. PMID 27307752.
Macher BA, Beckstead JH (1990-01-01). "Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells". Leukemia Research. 14 (2): 119–130. doi:10.1016/0145-2126(90)90040-G. PMID 1690317.
Majdic O, Bettelheim P, Stockinger H, Aberer W, Liszka K, Lutz D, et al. (May 1984). "M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells". International Journal of Cancer. 33 (5): 617–623. doi:10.1002/ijc.2910330511. PMID 6724736. S2CID 20483491.
Noguchi M, Sato N, Sugimori H, Mori K, Oshimi K (October 2001). "A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells". Leukemia Research. 25 (10): 847–853. doi:10.1016/s0145-2126(01)00036-4. PMID 11532516.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–4973. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, et al. (June 2005). "Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70". Cancer Research. 65 (12): 5428–5438. doi:10.1158/0008-5472.CAN-04-4395. PMID 15958592.
Hatano K, Miyamoto Y, Nonomura N, Kaneda Y (October 2011). "Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells". International Journal of Cancer. 129 (8): 1838–1847. doi:10.1002/ijc.25860. PMID 21165949. S2CID 7765966.
Hamasaki H, Aoyagi M, Kasama T, Handa S, Hirakawa K, Taki T (January 1999). "GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1437 (1): 93–99. doi:10.1016/S1388-1981(98)00003-1. PMID 9931455.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–83. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698.
Britten CJ, Bird MI (February 1997). "Chemical modification of an alpha 3-fucosyltransferase; definition of amino acid residues essential for enzyme activity". Biochimica et Biophysica Acta (BBA) - General Subjects. 1334 (1): 57–64. doi:10.1016/s0304-4165(96)00076-1. PMID 9042366.
de Vries T, Knegtel RM, Holmes EH, Macher BA (October 2001). "Fucosyltransferases: structure/function studies". Glycobiology. 11 (10): 119R – 128R. doi:10.1093/glycob/11.10.119r. PMID 11588153.
Shetterly S, Jost F, Watson SR, Knegtel R, Macher BA, Holmes EH (August 2007). "Site-specific fucosylation of sialylated polylactosamines by alpha1,3/4-fucosyltransferases-V and -VI Is defined by amino acids near the N terminus of the catalytic domain". The Journal of Biological Chemistry. 282 (34): 24882–92. doi:10.1074/jbc.m702395200. PMID 17604274. S2CID 27689343.
Trinchera M, Aronica A, Dall'Olio F (February 2017). "Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers". Biology. 6 (1): 16. doi:10.3390/biology6010016. PMC 5372009. PMID 28241499.
Ngamukote S, Yanagisawa M, Ariga T, Ando S, Yu RK (December 2007). "Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains". Journal of Neurochemistry. 103 (6): 2327–41. doi:10.1111/j.1471-4159.2007.04910.x. PMID 17883393. S2CID 21405747.
Xu W, Kozak CA, Desnick RJ (April 1995). "Uroporphyrinogen-III synthase: molecular cloning, nucleotide sequence, expression of a mouse full-length cDNA, and its localization on mouse chromosome 7". Genomics. 26 (3): 556–62. doi:10.1016/0888-7543(95)80175-l. PMID 7607680.
Vandermeersch S, Vanbeselaere J, Delannoy CP, Drolez A, Mysiorek C, Guérardel Y, et al. (April 2015). "Accumulation of GD1α Ganglioside in MDA-MB-231 Breast Cancer Cells Expressing ST6GalNAc V". Molecules. 20 (4): 6913–24. doi:10.3390/molecules20046913. PMC 6272744. PMID 25913930.
Chandrasekaran EV, Xue J, Xia J, Locke RD, Patil SA, Neelamegham S, et al. (November 2011). "Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides". Biochemistry. 50 (44): 9475–87. doi:10.1021/bi200301w. PMC 3206213. PMID 21913655.
Hidalgo IJ, Raub TJ, Borchardt RT (March 1989). "Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability". Gastroenterology. 96 (3): 736–49. doi:10.1016/0016-5085(89)90897-4. PMID 2914637.
Katopodis P, Anikin V, Randeva HS, Spandidos DA, Chatha K, Kyrou I, et al. (August 2020). "Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19". International Journal of Oncology. 57 (2): 533–539. doi:10.3892/ijo.2020.5071. PMC 7307597. PMID 32468052.
Nilsson G, Blom T, Kusche-Gullberg M, Kjellén L, Butterfield JH, Sundström C, et al. (May 1994). "Phenotypic characterization of the human mast-cell line HMC-1". Scandinavian Journal of Immunology. 39 (5): 489–98. doi:10.1111/j.1365-3083.1994.tb03404.x. PMID 8191224. S2CID 28014083.
Martin P, Papayannopoulou T (June 1982). "HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression". Science. 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. doi:10.1126/science.6177045. PMID 6177045.
Xiao H, He M, Xie G, Liu Y, Zhao Y, Ye X, et al. (October 2019). "The release of tryptase from mast cells promote tumor cell metastasis via exosomes". BMC Cancer. 19 (1): 1015. doi:10.1186/s12885-019-6203-2. PMC 6819443. PMID 31664930.
Bedsaul JR, Zaritsky LA, Zoon KC (November 2016). "Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection". Journal of Interferon & Cytokine Research. 36 (11): 652–665. doi:10.1089/jir.2016.0051. PMC 5105340. PMID 27508859.
Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. (April 2017). "Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway". Cell Death and Differentiation. 24 (4): 615–625. doi:10.1038/cdd.2016.153. PMC 5384020. PMID 28060376.
Goto H, Ohta K, Matsumoto Y, Yumine N, Nishio M (September 2016). López S (ed.). "Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference". Journal of Virology. 90 (17): 7640–7646. doi:10.1128/JVI.01087-16. ISSN 0022-538X. PMC 4988132. PMID 27279623.
Miyara M, Chader D, Sage E, Sugiyama D, Nishikawa H, Bouvry D, et al. (2015-06-09). "Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans". Proceedings of the National Academy of Sciences. 112 (23): 7225–7230. doi:10.1073/pnas.1508224112. ISSN 0027-8424. PMC 4466753. PMID 26015572.
Ohishi K, Ishikura A, Nishida S, Abo H, Nakatsukasa H, Kawashima H (2024-06-01). "Sialyl Lewis X Defines an Activated and Functional Regulatory T Cell Subpopulation in Mice". The Journal of Immunology. 212 (11): 1627–1638. doi:10.4049/jimmunol.2300349. ISSN 0022-1767. PMID 38639586.
Ebert O, Shinozaki K, Kournioti C, Park MS, García-Sastre A, Woo SL (May 2004). "Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer". Cancer Research. 64 (9): 3265–70. doi:10.1158/0008-5472.CAN-03-3753. PMID 15126368.
Altomonte J, Marozin S, Schmid RM, Ebert O (February 2010). "Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma". Molecular Therapy. 18 (2): 275–84. doi:10.1038/mt.2009.231. PMC 2839313. PMID 19809404.
Tai JA, Chang CY, Nishikawa T, Kaneda Y (August 2019). "Cancer immunotherapy using the Fusion gene of Sendai virus" (PDF). Cancer Gene Therapy. 27 (6): 498–508. doi:10.1038/s41417-019-0126-6. PMID 31383952. S2CID 199450913.
Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, et al. (May 2001). "Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas". Human Gene Therapy. 12 (7): 811–21. doi:10.1089/104303401750148766. PMID 11339897.
Lin EH, Salon C, Brambilla E, Lavillette D, Szecsi J, Cosset FL, et al. (April 2010). "Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer". Cancer Gene Therapy. 17 (4): 256–65. doi:10.1038/cgt.2009.74. PMID 19893593. S2CID 11203950.
Kursunel MA, Esendagli G (June 2017). "Corrigendum to "The untold story of IFN-γ in cancer biology" [Cytokine Growth Factor Rev. 31 (2016) 73-81]". Cytokine & Growth Factor Reviews. 35: 97. doi:10.1016/j.cytogfr.2017.02.002. PMID 28258821.
Ikeda H, Old LJ, Schreiber RD (April 2002). "The roles of IFN gamma in protection against tumor development and cancer immunoediting". Cytokine & Growth Factor Reviews. 13 (2): 95–109. doi:10.1016/s1359-6101(01)00038-7. PMID 11900986.
Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, et al. (July 2005). "A critical function for type I interferons in cancer immunoediting". Nature Immunology. 6 (7): 722–9. doi:10.1038/ni1213. PMID 15951814. S2CID 20374688.
Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. (December 2007). "Interferons at age 50: past, current and future impact on biomedicine". Nature Reviews. Drug Discovery. 6 (12): 975–90. doi:10.1038/nrd2422. PMC 7097588. PMID 18049472. S2CID 583709.
Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C, et al. (April 2000). "Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach". The American Journal of Pathology. 156 (4): 1381–93. doi:10.1016/S0002-9440(10)65007-9. PMC 1876903. PMID 10751362.
Yogeeswaran G, Salk PL (June 1981). "Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines". Science. 212 (4502): 1514–6. Bibcode:1981Sci...212.1514Y. doi:10.1126/science.7233237. PMID 7233237.
Passaniti A, Hart GW (June 1988). "Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures". The Journal of Biological Chemistry. 263 (16): 7591–603. doi:10.1016/S0021-9258(18)68540-0. PMID 3372501.
Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S (July 1980). "Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line". Proceedings of the National Academy of Sciences of the United States of America. 77 (7): 4336–9. Bibcode:1980PNAS...77.4336P. doi:10.1073/pnas.77.7.4336. PMC 349829. PMID 6933486.
Benedetto A, Elia G, Sala A, Belardelli F (January 1989). "Hyposialylation of high-molecular-weight membrane glycoproteins parallels the loss of metastatic potential in wheat-germ agglutinin-resistant Friend leukemia cells". International Journal of Cancer. 43 (1): 126–33. doi:10.1002/ijc.2910430124. PMID 2910824. S2CID 24704777.
Hsu CC, Lin TW, Chang WW, Wu CY, Lo WH, Wang PH, et al. (February 2005). "Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids". Gynecologic Oncology. 96 (2): 415–22. doi:10.1016/j.ygyno.2004.10.010. PMID 15661230.
Chang WW, Yu CY, Lin TW, Wang PH, Tsai YC (March 2006). "Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells". Biochemical and Biophysical Research Communications. 341 (2): 614–9. doi:10.1016/j.bbrc.2005.12.216. PMID 16427612.
Chiang CH, Wang CH, Chang HC, More SV, Li WS, Hung WC (May 2010). "A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling". Journal of Cellular Physiology. 223 (2): 492–9. doi:10.1002/jcp.22068. PMID 20112294. S2CID 24218458.
Cohen M, Elkabets M, Perlmutter M, Porgador A, Voronov E, Apte RN, et al. (November 2010). "Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting". Journal of Immunology. 185 (10): 5869–78. doi:10.4049/jimmunol.1001635. PMID 20956342. S2CID 45698975.
Bossart KN, Fusco DL, Broder CC (2013). "Paramyxovirus Entry". Viral Entry into Host Cells. Advances in Experimental Medicine and Biology. Vol. 790. New York, NY: Springer. pp. 95–127. doi:10.1007/978-1-4614-7651-1_6. ISBN 978-1-4614-7650-4. PMC 8782154. PMID 23884588.
Powell LD, Whiteheart SW, Hart GW (July 1987). "Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction". Journal of Immunology. 139 (1): 262–70. doi:10.4049/jimmunol.139.1.262. PMID 2953814. S2CID 25762755.
Tyagarajan K, Forte JG, Townsend RR (January 1996). "Exoglycosidase purity and linkage specificity: assessment using oligosaccharide substrates and high-pH anion-exchange chromatography with pulsed amperometric detection". Glycobiology. 6 (1): 83–93. doi:10.1093/glycob/6.1.83. PMID 8991514.
Drzeniek R, Gauhe A (February 1970). "Differences in substrate specificity of myxovirus neuraminidases". Biochemical and Biophysical Research Communications. 38 (4): 651–6. doi:10.1016/0006-291x(70)90630-3. PMID 5443707.
Brostrom MA, Bruening G, Bankowski RA (December 1971). "Comparison of neuraminidases of paramyxoviruses with immunologically dissimilar hemagglutinins". Virology. 46 (3): 856–65. doi:10.1016/0042-6822(71)90086-9. PMID 4332979.
Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, et al. (August 2009). "Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase". Journal of Virology. 83 (16): 8108–21. doi:10.1128/JVI.00211-09. PMC 2715740. PMID 19515783.
Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O (September 2001). "Recognition of viral hemagglutinins by NKp44 but not by NKp30". European Journal of Immunology. 31 (9): 2680–9. doi:10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A. PMID 11536166. S2CID 22437769.
Ueda Y, Hasegawa M, Yonemitsu Y (2009). "Sendai Virus for Cancer Immunotherapy". Viral Applications of Green Fluorescent Protein. Methods in Molecular Biology. Vol. 515. Totowa, NJ: Humana Press. pp. 299–308. doi:10.1007/978-1-59745-559-6_21. ISBN 978-1-934115-87-9. PMID 19378123.
Harada Y, Yonemitsu Y (June 2011). "Dramatic improvement of DC-based immunotherapy against various malignancies". Frontiers in Bioscience. 16 (6): 2233–2242. doi:10.2741/3850. PMID 21622173. S2CID 30195748.
Shibata S, Okano S, Yonemitsu Y, Onimaru M, Sata S, Nagata-Takeshita H, et al. (September 2006). "Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene". Journal of Immunology. 177 (6): 3564–3576. doi:10.4049/jimmunol.177.6.3564. PMID 16951315. S2CID 20134438.
Okano S, Yonemitsu Y, Shirabe K, Kakeji Y, Maehara Y, Harada M, et al. (February 2011). "Provision of continuous maturation signaling to dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virus". Journal of Immunology. 186 (3): 1828–1839. doi:10.4049/jimmunol.0901641. PMID 21187441. S2CID 36653582.
Sugiyama M, Kakeji Y, Tsujitani S, Harada Y, Onimaru M, Yoshida K, et al. (March 2011). "Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites". Molecular Cancer Therapeutics. 10 (3): 540–549. doi:10.1158/1535-7163.MCT-10-0479. hdl:2324/25486. PMID 21209070. S2CID 37616710.
Yoneyama Y, Ueda Y, Akutsu Y, Matsunaga A, Shimada H, Kato T, et al. (March 2007). "Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells". Biochemical and Biophysical Research Communications. 355 (1): 129–135. doi:10.1016/j.bbrc.2007.01.132. PMID 17292867.
Komaru A, Ueda Y, Furuya A, Tanaka S, Yoshida K, Kato T, et al. (October 2009). "Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus". Journal of Immunology. 183 (7): 4211–4219. doi:10.4049/jimmunol.0803845. PMID 19734206. S2CID 39194525.
Kato T, Ueda Y, Kinoh H, Yoneyama Y, Matsunaga A, Komaru A, et al. (November 2010). "RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer". Neoplasia. 12 (11): 906–914. doi:10.1593/neo.10732. PMC 2978913. PMID 21076616.
Edgar LJ, Thompson AJ, Vartabedian VF, Kikuchi C, Woehl JL, Teijaro JR, et al. (September 2021). "Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells". ACS Central Science. 7 (9): 1508–1515. doi:10.1021/acscentsci.1c00525. PMC 8461770. PMID 34584952.
Silva M, Silva Z, Marques G, Ferro T, Gonçalves M, Monteiro M, et al. (July 2016). "Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses". Oncotarget. 7 (27): 41053–41066. doi:10.18632/oncotarget.9419. ISSN 1949-2553. PMC 5173042. PMID 27203391.
Balneger N, Cornelissen LA, Wassink M, Moons SJ, Boltje TJ, Bar-Ephraim YE, et al. (February 2022). "Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions". Cellular and Molecular Life Sciences. 79 (2): 98. doi:10.1007/s00018-021-04027-x. ISSN 1420-682X. PMC 8799591. PMID 35089436.
Hosoya N, Miura T, Kawana-Tachikawa A, Koibuchi T, Shioda T, Odawara T, et al. (March 2008). "Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells". Journal of Medical Virology. 80 (3): 373–82. doi:10.1002/jmv.21052. PMID 18205221. S2CID 31337462.
Parks CL (2017). "Replication-Competent Viral Vectors for Vaccine Delivery". Human Vaccines. Elsevier. pp. 25–63. doi:10.1016/b978-0-12-802302-0.00001-7. ISBN 978-0-12-802302-0.
Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T, et al. (August 1999). "Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication". FEBS Letters. 456 (2): 221–6. Bibcode:1999FEBSL.456..221S. doi:10.1016/s0014-5793(99)00960-6. PMID 10456313. S2CID 1285541.
Chare ER, Gould EA, Holmes EC (October 2003). "Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses". The Journal of General Virology. 84 (Pt 10): 2691–2703. doi:10.1099/vir.0.19277-0. PMID 13679603.
Han GZ, Worobey M (August 2011). "Homologous recombination in negative sense RNA viruses". Viruses. 3 (8): 1358–1373. doi:10.3390/v3081358. PMC 3185808. PMID 21994784.
Kolakofsky D, Roux L, Garcin D, Ruigrok RW (July 2005). "Paramyxovirus mRNA editing, the "rule of six" and error catastrophe: a hypothesis". The Journal of General Virology. 86 (Pt 7): 1869–1877. doi:10.1099/vir.0.80986-0. PMID 15958664.
Englund JA, Moscona A (2014), Kaslow RA, Stanberry LR, Le Duc JW (eds.), "Paramyxoviruses: Parainfluenza Viruses", Viral Infections of Humans, Boston, MA: Springer US, pp. 579–600, doi:10.1007/978-1-4899-7448-8_25, ISBN 978-1-4899-7447-1
Ikegame S, Beaty SM, Stevens C, Won T, Park A, Sachs D, et al. (October 2020). Lowen AC (ed.). "Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticity". PLOS Pathogens. 16 (10): e1008877. doi:10.1371/journal.ppat.1008877. PMC 7577504. PMID 33035269.
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (December 1995). "A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus". The EMBO Journal. 14 (24): 6087–94. doi:10.1002/j.1460-2075.1995.tb00299.x. PMC 394733. PMID 8557028.
Pfaller CK, Cattaneo R, Schnell MJ (May 2015). "Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics". Virology. 60th Anniversary Issue. 479: 331–344. doi:10.1016/j.virol.2015.01.029. PMC 4557643. PMID 25702088.
Beaty SM, Park A, Won ST, Hong P, Lyons M, Vigant F, et al. (March 2017). "Paramyxoviridae Reverse Genetics Systems". mSphere. 2 (2). doi:10.1128/mSphere.00376-16. PMC 5371697. PMID 28405630.
Liu H, Albina E, Gil P, Minet C, de Almeida RS (September 2017). "Two-plasmid system to increase the rescue efficiency of paramyxoviruses by reverse genetics: The example of rescuing Newcastle Disease Virus". Virology. 509: 42–51. doi:10.1016/j.virol.2017.06.003. PMID 28595094.
Liu H, de Almeida RS, Gil P, Albina E (November 2017). "Comparison of the efficiency of different newcastle disease virus reverse genetics systems". Journal of Virological Methods. 249: 111–116. doi:10.1016/j.jviromet.2017.08.024. PMID 28867302.
Bajimaya S, Hayashi T, Takimoto T (2017). "Rescue of Sendai Virus from Cloned cDNA". Reverse Genetics of RNA Viruses. Methods in Molecular Biology. Vol. 1602. New York, NY: Springer. pp. 103–110. doi:10.1007/978-1-4939-6964-7_7. ISBN 978-1-4939-6962-3. PMID 28508216.
Yoshizaki M, Hironaka T, Iwasaki H, Ban H, Tokusumi Y, Iida A, et al. (September 2006). "Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity". The Journal of Gene Medicine. 8 (9): 1151–1159. doi:10.1002/jgm.938. PMID 16841365. S2CID 39942120.
Inoue M, Tokusumi Y, Ban H, Kanaya T, Shirakura M, Tokusumi T, et al. (June 2003). "A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading". Journal of Virology. 77 (11): 6419–6429. doi:10.1128/JVI.77.11.6419-6429.2003. PMC 155001. PMID 12743299.
Mostafa HH, Vogel P, Srinivasan A, Russell CJ (September 2016). "Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone". PLOS Pathogens. 12 (9): e1005875. doi:10.1371/journal.ppat.1005875. PMC 5010285. PMID 27589232.
Hasan MK, Kato A, Shioda T, Sakai Y, Yu D, Nagai Y (November 1997). "Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus". The Journal of General Virology. 78 (11): 2813–20. doi:10.1099/0022-1317-78-11-2813. PMID 9367367.
Chambers R, Takimoto T (June 2010). "Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles". PLOS ONE. 5 (6): e10994. Bibcode:2010PLoSO...510994C. doi:10.1371/journal.pone.0010994. PMC 2881874. PMID 20543880.
Agungpriyono DR, Yamaguchi R, Uchida K, Tohya Y, Kato A, Nagai Y, et al. (February 2000). "Green fluorescent protein gene insertion of Sendai Virus infection in nude mice: possibility as an infection tracer". The Journal of Veterinary Medical Science. 62 (2): 223–8. doi:10.1292/jvms.62.223. PMID 10720198.
Miyazaki M, Segawa H, Yamashita T, Zhu Y, Takizawa K, Hasegawa M, et al. (2010-11-23). "Construction and characterization of a fluorescent sendai virus carrying the gene for envelope fusion protein fused with enhanced green fluorescent protein". Bioscience, Biotechnology, and Biochemistry. 74 (11): 2293–8. doi:10.1271/bbb.100511. PMID 21071846. S2CID 43669142.
Villenave R, Touzelet O, Thavagnanam S, Sarlang S, Parker J, Skibinski G, et al. (November 2010). "Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells". Journal of Virology. 84 (22): 11718–28. doi:10.1128/JVI.00798-10. PMC 2977906. PMID 20810726.
Touzelet O, Loukili N, Pelet T, Fairley D, Curran J, Power UF (March 2009). "De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene". Virus Research. 140 (1–2): 40–48. doi:10.1016/j.virusres.2008.10.019. PMID 19084562.
Strähle L, Marq JB, Brini A, Hausmann S, Kolakofsky D, Garcin D (November 2007). "Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins". Journal of Virology. 81 (22): 12227–37. doi:10.1128/JVI.01300-07. PMC 2169027. PMID 17804509.
Gosselin-Grenet AS, Mottet-Osman G, Roux L (September 2010). "Sendai virus particle production: basic requirements and role of the SYWST motif present in HN cytoplasmic tail". Virology. 405 (2): 439–447. doi:10.1016/j.virol.2010.06.030. PMID 20633915.
Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA (March 2011). "Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus". Journal of Virology. 85 (6): 2771–80. doi:10.1128/jvi.02065-10. PMC 3067931. PMID 21228237.
Rawling J, García-Barreno B, Melero JA (June 2008). "Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity". Journal of Virology. 82 (12): 5986–98. doi:10.1128/jvi.00078-08. PMC 2395136. PMID 18385247.
Portner A, Scroggs RA, Naeve CW (April 1987). "The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization". Virology. 157 (2): 556–9. doi:10.1016/0042-6822(87)90301-1. PMID 2435061.
Park A, Hong P, Won ST, Thibault PA, Vigant F, Oguntuyo KY, et al. (2016-08-24). "Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing". Molecular Therapy: Methods & Clinical Development. 3: 16057. doi:10.1038/mtm.2016.57. PMC 4996130. PMID 27606350.
Corral T, Ver LS, Mottet G, Cano O, García-Barreno B, Calder LJ, et al. (April 2007). "High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system". BMC Biotechnology. 7 (1): 17. doi:10.1186/1472-6750-7-17. PMC 1852797. PMID 17411439.
Grygoryev D, Ekstrom T, Manalo E, Link JM, Alshaikh A, Keith D, et al. (March 2024). "Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells". Heliyon. 10 (5): e27221. Bibcode:2024Heliy..1027221G. doi:10.1016/j.heliyon.2024.e27221. PMC 10923719. PMID 38463758.
Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, et al. (2014-12-05). "New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood". PLOS ONE. 9 (12): e113052. Bibcode:2014PLoSO...9k3052F. doi:10.1371/journal.pone.0113052. PMC 4257541. PMID 25479600.
Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, et al. (February 2003). "Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells". Gene Therapy. 10 (3): 272–7. doi:10.1038/sj.gt.3301877. PMID 12571635. S2CID 22415369.
Okumura T, Horie Y, Lai CY, Lin HT, Shoda H, Natsumoto B, et al. (June 2019). "Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34⁺ cells using the auto-erasable Sendai virus vector". Stem Cell Research & Therapy. 10 (1): 185. doi:10.1186/s13287-019-1273-2. PMC 6591940. PMID 31234949.
Seki T, Yuasa S, Fukuda K (March 2012). "Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus". Nature Protocols. 7 (4): 718–28. doi:10.1038/nprot.2012.015. PMID 22422317. S2CID 41397031.
Charlesworth CT, Nakauchi H (November 2022). "An optimized Sendai viral vector platform for reprogramming to naive pluripotency". Cell Reports Methods. 2 (11): 100349. doi:10.1016/j.crmeth.2022.100349. PMC 9701616. PMID 36452874.
Sano M, Nakasu A, Ohtaka M, Nakanishi M (December 2019). "A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs". Molecular Therapy. Methods & Clinical Development. 15: 371–382. doi:10.1016/j.omtm.2019.10.012. PMC 6889074. PMID 31828179.
Moriya C, Horiba S, Kurihara K, Kamada T, Takahara Y, Inoue M, et al. (November 2011). "Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies". Vaccine. 29 (47): 8557–8563. doi:10.1016/j.vaccine.2011.09.028. PMID 21939708.
Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, et al. (January 2012). "Sendai virus-based RSV vaccine protects African green monkeys from RSV infection". Vaccine. 30 (5): 959–68. doi:10.1016/j.vaccine.2011.11.046. PMC 3256274. PMID 22119594.
Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, et al. (May 2015). "Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats". International Immunology. 27 (5): 229–36. doi:10.1093/intimm/dxu107. PMC 4406265. PMID 25477211.
Hu Z, Gu L, Li CL, Shu T, Lowrie DB, Fan XY (2018). "The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine". Frontiers in Immunology. 9: 1796. doi:10.3389/fimmu.2018.01796. PMC 6085409. PMID 30123219.
Hu Z, Xia J, Wu J, Zhao H, Ji P, Gu L, et al. (December 2024). "A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis". Emerging Microbes & Infections. 13 (1): 2300463. doi:10.1080/22221751.2023.2300463. ISSN 2222-1751. PMC 10769537. PMID 38164736.
Moreno-Fierros L, García-Silva I, Rosales-Mendoza S (August 2020). "Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?". Expert Opinion on Biological Therapy. 20 (8): 831–836. doi:10.1080/14712598.2020.1767062. PMID 32380868. S2CID 218556295.
Travis CR (2020-09-30). "As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention". Frontiers in Immunology. 11: 591897. doi:10.3389/fimmu.2020.591897. PMC 7561361. PMID 33117404.
Sealy R, Jones BG, Surman SL, Hurwitz JL (September 2010). "Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1". Vaccine. 28 (41): 6749–6756. doi:10.1016/j.vaccine.2010.07.068. PMC 2950074. PMID 20682364.
Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, et al. (May 2017). "Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice". Molecular Therapy. 25 (5): 1222–1233. doi:10.1016/j.ymthe.2017.02.018. PMC 5417795. PMID 28342639.
Yang Y, Ren L, Dong X, Wu X (2005-05-01). "108. The Complete Nucleotide Sequence of Sendai Virus Isolate BB1 and Comparison with Other Isolates". Molecular Therapy. 11: S44. doi:10.1016/j.ymthe.2005.06.469.
Shi LY, Li M, Yuan LJ, Wang Q, Li XM (2008). "A new paramyxovirus, Tianjin strain, isolated from common cotton-eared marmoset: genome characterization and structural protein sequence analysis". Archives of Virology. 153 (9): 1715–23. doi:10.1007/s00705-008-0184-9. PMID 18696006. S2CID 6151471.
Liang Y, Wu X, Zhang J, Xiao L, Yang Y, Bai X, et al. (December 2012). "Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis". FEMS Immunology and Medical Microbiology. 66 (3): 419–426. doi:10.1111/1574-695X.12008. PMID 23163873.
Ishii H, Nomura T, Yamamoto H, Nishizawa M, Thu Hau TT, Harada S, et al. (February 2022). "Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8⁺ T cell responses". Cell Reports. Medicine. 3 (2): 100520. doi:10.1016/j.xcrm.2022.100520. PMC 8768424. PMID 35233545.
Scheid A, Choppin PW (February 1974). "Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus". Virology. 57 (2): 475–90. doi:10.1016/0042-6822(74)90187-1. PMID 4361457.
Azarm KD, Lee B (January 2020). "Differential Features of Fusion Activation within the Paramyxoviridae". Viruses. 12 (2): 161. doi:10.3390/v12020161. PMC 7077268. PMID 32019182.
Yamada H, Hayata S, Omata-Yamada T, Taira H, Mizumoto K, Iwasaki K (1990). "Association of the Sendai virus C protein with nucleocapsids". Archives of Virology. 113 (3–4): 245–53. doi:10.1007/bf01316677. PMID 2171459. S2CID 24592567.
Garcin D, Curran J, Itoh M, Kolakofsky D (August 2001). "Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response". Journal of Virology. 75 (15): 6800–7. doi:10.1128/JVI.75.15.6800-6807.2001. PMC 114406. PMID 11435558.
Curran J, Kolakofsky D (January 1988). "Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA". The EMBO Journal. 7 (1): 245–51. doi:10.1002/j.1460-2075.1988.tb02806.x. PMC 454264. PMID 2834203.
Dillon PJ, Gupta KC (February 1989). "Expression of five proteins from the Sendai virus P/C mRNA in infected cells". Journal of Virology. 63 (2): 974–7. doi:10.1128/JVI.63.2.974-977.1989. PMC 247778. PMID 2536120.
de Breyne S, Simonet V, Pelet T, Curran J (January 2003). "Identification of a cis-acting element required for shunt-mediated translational initiation of the Sendai virus Y proteins". Nucleic Acids Research. 31 (2): 608–18. doi:10.1093/nar/gkg143. PMC 140508. PMID 12527769.
Curran J, Kolakofsky D (September 1988). "Scanning independent ribosomal initiation of the Sendai virus X protein". The EMBO Journal. 7 (9): 2869–74. doi:10.1002/j.1460-2075.1988.tb03143.x. PMC 457080. PMID 2846286.
Irie T, Nagata N, Yoshida T, Sakaguchi T (February 2008). "Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles". Virology. 371 (1): 108–20. doi:10.1016/j.virol.2007.09.020. PMID 18028977.
Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, et al. (July 2005). "AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding". Journal of Virology. 79 (14): 8933–41. doi:10.1128/JVI.79.14.8933-8941.2005. PMC 1168738. PMID 15994787.
Payne V, Kam PC (July 2004). "Mast cell tryptase: a review of its physiology and clinical significance". Anaesthesia. 59 (7): 695–703. doi:10.1111/j.1365-2044.2004.03757.x. PMID 15200544. S2CID 7611291.
Chen Y, Shiota M, Ohuchi M, Towatari T, Tashiro J, Murakami M, et al. (June 2000). "Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization". European Journal of Biochemistry. 267 (11): 3189–97. doi:10.1046/j.1432-1327.2000.01346.x. PMID 10824103.
Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H (December 1992). "Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity". Journal of Virology. 66 (12): 7211–6. doi:10.1128/JVI.66.12.7211-7216.1992. PMC 240423. PMID 1331518.
Kido H, Niwa Y, Beppu Y, Towatari T (1996). "Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus". Advances in Enzyme Regulation. 36: 325–47. doi:10.1016/0065-2571(95)00016-X. PMID 8869754.
Le TQ, Kawachi M, Yamada H, Shiota M, Okumura Y, Kido H (April 2006). "Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain". Biological Chemistry. 387 (4): 467–75. doi:10.1515/BC.2006.062. PMID 16606346. S2CID 11969821.
Murakami M, Towatari T, Ohuchi M, Shiota M, Akao M, Okumura Y, et al. (May 2001). "Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus". European Journal of Biochemistry. 268 (10): 2847–55. doi:10.1046/j.1432-1327.2001.02166.x. PMID 11358500.
Abe M, Tahara M, Sakai K, Yamaguchi H, Kanou K, Shirato K, et al. (November 2013). "TMPRSS2 is an activating protease for respiratory parainfluenza viruses". Journal of Virology. 87 (21): 11930–5. doi:10.1128/JVI.01490-13. PMC 3807344. PMID 23966399.
Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y (December 1990). "An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo". The EMBO Journal. 9 (12): 4189–95. doi:10.1002/j.1460-2075.1990.tb07643.x. PMC 552195. PMID 2174359.
Ogasawara T, Gotoh B, Suzuki H, Asaka J, Shimokata K, Rott R, et al. (February 1992). "Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo". The EMBO Journal. 11 (2): 467–72. doi:10.1002/j.1460-2075.1992.tb05076.x. PMC 556476. PMID 1371460.
Gotoh B, Yamauchi F, Ogasawara T, Nagai Y (January 1992). "Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation". FEBS Letters. 296 (3): 274–8. Bibcode:1992FEBSL.296..274G. doi:10.1016/0014-5793(92)80303-x. PMID 1537403. S2CID 33852517.
Lam A, Kirkland OO, Anderson PF, Seetharaman N, Vujovic D, Thibault PA, et al. (2021-11-23). "Single virus assay reveals membrane determinants and mechanistic features of Sendai virus binding". Biophysical Journal. 121 (6): 956–965. Bibcode:2022BpJ...121..956L. doi:10.1016/j.bpj.2022.02.011. PMC 8943810. PMID 35150620. S2CID 246715171.
Matveeva OV, Shabalina SA (December 2020). "Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy". Cancers. 12 (12): 3659. doi:10.3390/cancers12123659. PMC 7762160. PMID 33291506.
Villar E, Barroso IM (February 2006). "Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview". Glycoconjugate Journal. 23 (1–2): 5–17. doi:10.1007/s10719-006-5433-0. PMID 16575518. S2CID 21083897.
Stockert RJ (July 1995). "The asialoglycoprotein receptor: relationships between structure, function, and expression". Physiological Reviews. 75 (3): 591–609. doi:10.1152/physrev.1995.75.3.591. PMID 7624395.
Suzuki Y, Suzuki T, Matsumoto M (June 1983). "Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane". Journal of Biochemistry. 93 (6): 1621–33. doi:10.1093/oxfordjournals.jbchem.a134301. PMID 6309760.
Oku N, Nojima S, Inoue K (August 1981). "Studies on the interaction of Sendai virus with liposomal membranes. Sendai virus-induced agglutination of liposomes containing glycophorin". Biochimica et Biophysica Acta (BBA) - Biomembranes. 646 (1): 36–42. doi:10.1016/0005-2736(81)90269-8. PMID 6168285.
Müthing J (September 1996). "Influenza A and Sendai viruses preferentially bind to fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes". Carbohydrate Research. 290 (2): 217–24. doi:10.1016/0008-6215(96)00149-8. PMID 8823909.
Holmgren J, Svennerholm L, Elwing H, Fredman P, Strannegård O (April 1980). "Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides". Proceedings of the National Academy of Sciences of the United States of America. 77 (4): 1947–50. Bibcode:1980PNAS...77.1947H. doi:10.1073/pnas.77.4.1947. PMC 348626. PMID 6246515.
"Correction: Specific Gangliosides Function as Host Cell Receptors for Sendai Virus". Proceedings of the National Academy of Sciences. 79 (3): 951. 1982-02-01. Bibcode:1982PNAS...79Q.951.. doi:10.1073/pnas.79.3.951.
Suzuki Y, Suzuki T, Matsunaga M, Matsumoto M (April 1985). "Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus". Journal of Biochemistry. 97 (4): 1189–99. doi:10.1093/oxfordjournals.jbchem.a135164. PMID 2993261.
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, et al. (May 2001). "Receptor specificities of human respiroviruses". Journal of Virology. 75 (10): 4604–13. doi:10.1128/JVI.75.10.4604-4613.2001. PMC 114213. PMID 11312330.
Umeda M, Nojima S, Inoue K (February 1984). "Activity of human erythrocyte gangliosides as a receptor to HVJ". Virology. 133 (1): 172–82. doi:10.1016/0042-6822(84)90436-7. PMID 6322427.
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, et al. (May 2001). "Receptor specificities of human respiroviruses". Journal of Virology. 75 (10): 4604–13. doi:10.1128/jvi.75.10.4604-4613.2001. PMC 114213. PMID 11312330.
Mariethoz J, Khatib K, Campbell MP, Packer NH, Mullen E, Lisacek F (2014-10-20). "SugarBindDB: Resource of Pathogen Lectin-Glycan Interactions". Glycoscience: Biology and Medicine. Springer Japan. pp. 275–282. doi:10.1007/978-4-431-54841-6_28. ISBN 9784431548409.
Chang A, Dutch RE (April 2012). "Paramyxovirus fusion and entry: multiple paths to a common end". Viruses. 4 (4): 613–36. doi:10.3390/v4040613. PMC 3347325. PMID 22590688.
Lamb RA, Jardetzky TS (August 2007). "Structural basis of viral invasion: lessons from paramyxovirus F". Current Opinion in Structural Biology. 17 (4): 427–36. doi:10.1016/j.sbi.2007.08.016. PMC 2086805. PMID 17870467.
Haywood AM (November 2010). "Membrane uncoating of intact enveloped viruses". Journal of Virology. 84 (21): 10946–55. doi:10.1128/JVI.00229-10. PMC 2953184. PMID 20668081.
Jardetzky TS, Lamb RA (April 2014). "Activation of paramyxovirus membrane fusion and virus entry". Current Opinion in Virology. 5: 24–33. doi:10.1016/j.coviro.2014.01.005. PMC 4028362. PMID 24530984.
Whelan SP, Barr JN, Wertz GW (2004). "Transcription and Replication of Nonsegmented Negative-Strand RNA Viruses". Biology of Negative Strand RNA Viruses: The Power of Reverse Genetics. Current Topics in Microbiology and Immunology. Vol. 283. Berlin, Heidelberg: Springer. pp. 61–119. doi:10.1007/978-3-662-06099-5_3. ISBN 978-3-642-07375-5. PMID 15298168.
Noton SL, Fearns R (May 2015). "Initiation and regulation of paramyxovirus transcription and replication". Virology. 479: 545–354. doi:10.1016/j.virol.2015.01.014. PMC 4424093. PMID 25683441.
Ogino T, Kobayashi M, Iwama M, Mizumoto K (February 2005). "Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA". The Journal of Biological Chemistry. 280 (6): 4429–35. doi:10.1074/jbc.M411167200. PMID 15574411. S2CID 27655763.
Myers TM, Moyer SA (February 1997). "An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis". Journal of Virology. 71 (2): 918–24. doi:10.1128/JVI.71.2.918-924.1997. PMC 191139. PMID 8995608.
Ryu SW (2017). "Other Negative-Strand RNA Viruses". Molecular Virology of Human Pathogenic Viruses. Elsevier. pp. 213–224. doi:10.1016/b978-0-12-800838-6.00016-3. ISBN 978-0-12-800838-6. S2CID 88812845.
Wiegand MA, Bossow S, Schlecht S, Neubert WJ (2007-12-15). "De Novo Synthesis of N and P Proteins as a Key Step in Sendai Virus Gene Expression". Journal of Virology. 81 (24): 13835–13844. doi:10.1128/jvi.00914-07. ISSN 0022-538X. PMC 2168830. PMID 17855540.
Latorre P, Kolakofsky D, Curran J (September 1998). "Sendai virus Y proteins are initiated by a ribosomal shunt". Molecular and Cellular Biology. 18 (9): 5021–31. doi:10.1128/mcb.18.9.5021. PMC 109087. PMID 9710586.
Harrison MS, Sakaguchi T, Schmitt AP (September 2010). "Paramyxovirus assembly and budding: building particles that transmit infections". The International Journal of Biochemistry & Cell Biology. 42 (9): 1416–1429. doi:10.1016/j.biocel.2010.04.005. PMC 2910131. PMID 20398786.
Miazza V, Mottet-Osman G, Startchick S, Chaponnier C, Roux L (February 2011). "Sendai virus induced cytoplasmic actin remodeling correlates with efficient virus particle production". Virology. 410 (1): 7–16. doi:10.1016/j.virol.2010.10.003. PMID 21075412.
Ito M, Takeuchi T, Nishio M, Kawano M, Komada H, Tsurudome M, et al. (November 2004). "Early stage of establishment of persistent Sendai virus infection: unstable dynamic phase and then selection of viruses which are tightly cell associated, temperature sensitive, and capable of establishing persistent infection". Journal of Virology. 78 (21): 11939–11951. doi:10.1128/JVI.78.21.11939-11951.2004. PMC 523293. PMID 15479834.
Iwata M, Kawabata R, Morimoto N, Takeuchi RF, Sakaguchi T, Irie T, et al. (2024-04-02). "Evolutionary engineering and characterization of Sendai virus mutants capable of persistent infection and autonomous production". Frontiers in Virology. 4. doi:10.3389/fviro.2024.1363092. ISSN 2673-818X.
Coakley C, Peter C, Fabry S, Chattopadhyay S (August 2017). "Establishment of a Human Cell Line Persistently Infected with Sendai Virus". Bio-Protocol. 7 (16): e2512. doi:10.21769/BioProtoc.2512. PMC 8413619. PMID 34541174.
Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Yamashita M, Sen GC (January 2013). "Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus". Journal of Virology. 87 (1): 16–24. doi:10.1128/JVI.01853-12. PMC 3536409. PMID 23077293.
Mercado-López X, Cotter CR, Kim WK, Sun Y, Muñoz L, Tapia K, et al. (November 2013). "Highly immunostimulatory RNA derived from a Sendai virus defective viral genome". Vaccine. 31 (48): 5713–5721. doi:10.1016/j.vaccine.2013.09.040. PMC 4406099. PMID 24099876.
Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, et al. (October 2017). "Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence". Nature Communications. 8 (1): 799. Bibcode:2017NatCo...8..799X. doi:10.1038/s41467-017-00909-6. PMC 5630589. PMID 28986577.
Genoyer E, López CB (February 2019). "Defective Viral Genomes Alter How Sendai Virus Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production of Viral Particles among Infected Cells". Journal of Virology. 93 (4). doi:10.1128/JVI.01579-18. PMC 6364009. PMID 30463965.
Pablo-Maiso L, Echeverría I, Rius-Rocabert S, Luján L, Garcin D, Andrés D, et al. (April 2020). "Sendai Virus, a Strong Inducer of Anti-Lentiviral State in Ovine Cells". Vaccines. 8 (2): 206. doi:10.3390/vaccines8020206. PMC 7349755. PMID 32365702.
Faísca P, Desmecht D (February 2007). "Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date". Research in Veterinary Science. 82 (1): 115–125. doi:10.1016/j.rvsc.2006.03.009. PMID 16759680.
Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA (March 2011). "Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus". Journal of Virology. 85 (6): 2771–80. doi:10.1128/JVI.02065-10. PMC 3067931. PMID 21228237.
Hoekstra D, Klappe K, Hoff H, Nir S (April 1989). "Mechanism of fusion of Sendai virus: role of hydrophobic interactions and mobility constraints of viral membrane proteins. Effects of polyethylene glycol". The Journal of Biological Chemistry. 264 (12): 6786–92. doi:10.1016/S0021-9258(18)83498-6. PMID 2540161.
Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A (December 2002). "Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion". Journal of Virology. 76 (24): 13028–33. doi:10.1128/JVI.76.24.13028-13033.2002. PMC 136693. PMID 12438628.
Novick SL, Hoekstra D (October 1988). "Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labeling". Proceedings of the National Academy of Sciences of the United States of America. 85 (20): 7433–7. Bibcode:1988PNAS...85.7433N. doi:10.1073/pnas.85.20.7433. PMC 282205. PMID 2845406.
Chandra S, Kalaivani R, Kumar M, Srinivasan N, Sarkar DP (December 2017). Bassereau P (ed.). "Sendai virus recruits cellular villin to remodel actin cytoskeleton during fusion with hepatocytes". Molecular Biology of the Cell. 28 (26): 3801–3814. doi:10.1091/mbc.e17-06-0400. PMC 5739296. PMID 29074568.
Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melén K, Julkunen I (October 1999). "Impaired antiviral response in human hepatoma cells". Virology. 263 (2): 364–75. doi:10.1006/viro.1999.9983. PMID 10544109.
Shah NR, Sunderland A, Grdzelishvili VZ (June 2010). "Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin". PLOS ONE. 5 (6): e11265. Bibcode:2010PLoSO...511265S. doi:10.1371/journal.pone.0011265. PMC 2889835. PMID 20582319.
Sumpter R, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. (March 2005). "Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I". Journal of Virology. 79 (5): 2689–99. doi:10.1128/JVI.79.5.2689-2699.2005. PMC 548482. PMID 15708988.
Lallemand C, Blanchard B, Palmieri M, Lebon P, May E, Tovey MG (January 2007). "Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB". Oncogene. 26 (3): 328–38. doi:10.1038/sj.onc.1209795. PMID 16832344. S2CID 25830890.
Buggele WA, Horvath CM (August 2013). "MicroRNA profiling of Sendai virus-infected A549 cells identifies miR-203 as an interferon-inducible regulator of IFIT1/ISG56". Journal of Virology. 87 (16): 9260–70. doi:10.1128/JVI.01064-13. PMC 3754065. PMID 23785202.
Zainutdinov SS, Grazhdantseva AA, Kochetkov DV, Chumakov PM, Netesov SV, Matveeva OV, et al. (2017-10-01). "Change in Oncolytic Activity of Sendai Virus during Adaptation to Cell Cultures". Molecular Genetics, Microbiology and Virology. 32 (4): 212–217. doi:10.3103/S0891416817040115. S2CID 46958676.
Espada CE, Sari L, Cahill MP, Yang H, Phillips S, Martinez N, et al. (July 2023). "SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection". The Journal of Biological Chemistry. 299 (7): 104925. doi:10.1016/j.jbc.2023.104925. PMC 10404699. PMID 37328105.
Belova AA, Sosnovtseva AO, Lipatova AV, Njushko KM, Volchenko NN, Belyakov MM, et al. (2017-01-01). "[Biomarkers of prostate cancer sensitivity to the Sendai virus]". Molekuliarnaia Biologiia. 51 (1): 94–103. doi:10.1134/S0026893317010046. PMID 28251971. S2CID 34514102.
Itoh M, Wang XL, Suzuki Y, Homma M (September 1992). "Mutation of the HANA protein of Sendai virus by passage in eggs". Virology. 190 (1): 356–64. doi:10.1016/0042-6822(92)91222-g. PMID 1326808.
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV (2019). "Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes". Oncolytic Virotherapy. 8: 9–26. doi:10.2147/OV.S176523. PMC 6636189. PMID 31372363.
Sakaguchi T, Kiyotani K, Sakaki M, Fujii Y, Yoshida T (March 1994). "A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains". Archives of Virology. 135 (1–2): 159–64. doi:10.1007/bf01309773. PMID 8198441. S2CID 12180965.
Itoh M, Isegawa Y, Hotta H, Homma M (December 1997). "Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells". The Journal of General Virology. 78 (12): 3207–15. doi:10.1099/0022-1317-78-12-3207. PMID 9400971.
Kiyotani K, Takao S, Sakaguchi T, Yoshida T (July 1990). "Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity". Virology. 177 (1): 65–74. doi:10.1016/0042-6822(90)90460-9. PMID 2162116.
Kiyotani K, Sakaguchi T, Fujii Y, Yoshida T (2001). "Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells". Archives of Virology. 146 (5): 893–908. doi:10.1007/s007050170123. PMID 11448028. S2CID 21947750.
Kolakofsky D (August 1976). "Isolation and characterization of Sendai virus DI-RNAs". Cell. 8 (4): 547–555. doi:10.1016/0092-8674(76)90223-3. PMID 182384. S2CID 32399729.
Kolakofsky D (March 1979). "Studies on the generation and amplification of sendai virus defective-interfering genomes". Virology. 93 (2): 589–593. doi:10.1016/0042-6822(79)90263-0. PMID 222059.
Killip MJ, Young DF, Gatherer D, Ross CS, Short JA, Davison AJ, et al. (May 2013). "Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction". Journal of Virology. 87 (9): 4798–4807. doi:10.1128/JVI.03383-12. PMC 3624313. PMID 23449801.
Yoshida A, Kawabata R, Honda T, Sakai K, Ami Y, Sakaguchi T, et al. (March 2018). "A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes". Journal of Virology. 92 (5). doi:10.1128/JVI.02094-17. PMC 5809723. PMID 29237838.
Strahle L, Garcin D, Kolakofsky D (July 2006). "Sendai virus defective-interfering genomes and the activation of interferon-beta". Virology. 351 (1): 101–111. doi:10.1016/j.virol.2006.03.022. PMID 16631220.
Sánchez-Aparicio MT, Garcin D, Rice CM, Kolakofsky D, García-Sastre A, Baum A (June 2017). "Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA". The Journal of General Virology. 98 (6): 1282–1293. doi:10.1099/jgv.0.000815. PMC 5962894. PMID 28631605.
Tatsumoto N, Arditi M, Yamashita M (September 2018). "Sendai Virus Propagation Using Chicken Eggs". Bio-Protocol. 8 (18). doi:10.21769/BioProtoc.3009. PMC 6200407. PMID 30370318.
Pappas C, Matsuoka Y, Swayne DE, Donis RO (November 2007). "Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness". Clinical and Vaccine Immunology. 14 (11): 1425–1432. doi:10.1128/CVI.00174-07. PMC 2168170. PMID 17913860.
Tatsumoto N, Miyauchi T, Arditi M, Yamashita M (November 2018). "Quantification of Infectious Sendai Virus Using Plaque Assay". Bio-Protocol. 8 (21). doi:10.21769/BioProtoc.3068. PMC 6289198. PMID 30547053.
Killian ML (2008). "Hemagglutination Assay for the Avian Influenza Virus". Avian Influenza Virus. Methods in Molecular Biology. Vol. 436. Totowa, NJ: Humana Press. pp. 47–52. doi:10.1007/978-1-59745-279-3_7. ISBN 978-1-58829-939-0. PMID 18370040.

dx.doi.org

"Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer". Lung Cancer. 13 (1): 93. August 1995. doi:10.1016/0169-5002(95)90215-5. ISSN 0169-5002.

expasy.org

viralzone.expasy.org

"Respirovirus". ViralZone.

genome.jp

"KEGG GLYCAN: G00111". www.genome.jp. Retrieved 2019-08-13.
"KEGG GLYCAN: G00116". www.genome.jp. Retrieved 2019-08-13.
"KEGG GLYCAN: G00117". www.genome.jp. Retrieved 2019-08-13.
"KEGG GLYCAN: G00197". www.genome.jp. Retrieved 2019-08-13.
"KEGG GLYCAN: G00112". www.genome.jp. Retrieved 2019-08-13.
"KEGG GLYCAN: G00122". www.genome.jp. Retrieved 2019-08-13.
"DBGET search - GLYCAN". www.genome.jp. Retrieved 2019-08-15.

ghostarchive.org

Treatment of advanced metastatic cancers with oncolytic Sendai virus, 20 April 2014, archived from the original on 2021-12-19, retrieved 2019-08-21

handle.net

hdl.handle.net

Simon AY, Moritoh K, Torigoe D, Asano A, Sasaki N, Agui T (December 2009). "Multigenic control of resistance to Sendai virus infection in mice". Infection, Genetics and Evolution. 9 (6): 1253–9. Bibcode:2009InfGE...9.1253S. doi:10.1016/j.meegid.2009.08.011. hdl:2115/42554. PMID 19733691.
Sugiyama M, Kakeji Y, Tsujitani S, Harada Y, Onimaru M, Yoshida K, et al. (March 2011). "Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites". Molecular Cancer Therapeutics. 10 (3): 540–549. doi:10.1158/1535-7163.MCT-10-0479. hdl:2324/25486. PMID 21209070. S2CID 37616710.

harvard.edu

ui.adsabs.harvard.edu

Köhler G, Milstein C (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. PMID 1172191. S2CID 4161444.
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009). "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 85 (8): 348–62. Bibcode:2009PJAB...85..348F. doi:10.2183/pjab.85.348. PMC 3621571. PMID 19838014.
Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. (August 2011). "Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors". Proceedings of the National Academy of Sciences of the United States of America. 108 (34): 14234–9. Bibcode:2011PNAS..10814234B. doi:10.1073/pnas.1103509108. PMC 3161531. PMID 21821793.
Simon AY, Moritoh K, Torigoe D, Asano A, Sasaki N, Agui T (December 2009). "Multigenic control of resistance to Sendai virus infection in mice". Infection, Genetics and Evolution. 9 (6): 1253–9. Bibcode:2009InfGE...9.1253S. doi:10.1016/j.meegid.2009.08.011. hdl:2115/42554. PMID 19733691.
Irie T, Nagata N, Igarashi T, Okamoto I, Sakaguchi T (May 2010). "Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses". PLOS ONE. 5 (5): e10719. Bibcode:2010PLoSO...510719I. doi:10.1371/journal.pone.0010719. PMC 2873429. PMID 20502666.
Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE, et al. (September 2022). "IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation". Proceedings of the National Academy of Sciences of the United States of America. 119 (37): e2121385119. Bibcode:2022PNAS..11921385P. doi:10.1073/pnas.2121385119. PMC 9478676. PMID 36067309.
Yamaguchi M, Kitagawa Y, Zhou M, Itoh M, Gotoh B (January 2014). "An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction". FEBS Letters. 588 (1): 28–34. Bibcode:2014FEBSL.588...28Y. doi:10.1016/j.febslet.2013.11.015. PMID 24269682. S2CID 24831300.
Irie T, Yoshida A, Sakaguchi T (2013-08-09). "Clustered basic amino acids of the small sendai virus C protein Y1 are critical to its RAN GTPase-mediated nuclear localization". PLOS ONE. 8 (8): e73740. Bibcode:2013PLoSO...873740I. doi:10.1371/journal.pone.0073740. PMC 3739745. PMID 23951363.
Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, et al. (December 2004). "The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter". Proceedings of the National Academy of Sciences of the United States of America. 101 (49): 17264–9. Bibcode:2004PNAS..10117264A. doi:10.1073/pnas.0407639101. PMC 535396. PMID 15563593.
Génin P, Lin R, Hiscott J, Civas A (2012). "Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression". PLOS ONE. 7 (6): e38336. Bibcode:2012PLoSO...738336G. doi:10.1371/journal.pone.0038336. PMC 3369917. PMID 22685561.
Mandhana R, Horvath CM (November 2018). "Sendai Virus Infection Induces Expression of Novel RNAs in Human Cells". Scientific Reports. 8 (1): 16815. Bibcode:2018NatSR...816815M. doi:10.1038/s41598-018-35231-8. PMC 6235974. PMID 30429577.
Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A (March 2007). "Autophagy-dependent viral recognition by plasmacytoid dendritic cells". Science. 315 (5817): 1398–401. Bibcode:2007Sci...315.1398L. CiteSeerX 10.1.1.657.3208. doi:10.1126/science.1136880. PMID 17272685. S2CID 11549012.
Suzuki H, Kurooka M, Hiroaki Y, Fujiyoshi Y, Kaneda Y (April 2008). "Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner". FEBS Letters. 582 (9): 1325–9. Bibcode:2008FEBSL.582.1325S. doi:10.1016/j.febslet.2008.03.011. PMID 18358837. S2CID 207607018.
Zimmermann M, Armeanu-Ebinger S, Bossow S, Lampe J, Smirnow I, Schenk A, et al. (2014). "Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors". PLOS ONE. 9 (3): e90508. Bibcode:2014PLoSO...990508Z. doi:10.1371/journal.pone.0090508. PMC 3944018. PMID 24598703.
Qian M, Tan HM, Yu N, Wang T, Zhang Q (April 2018). "Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells". Biomedical and Environmental Sciences. 31 (4): 280–289. Bibcode:2018BioES..31..280Q. doi:10.3967/bes2018.036. PMID 29773091.
Zhang Q, Yuan WF, Zhai GQ, Zhu SY, Xue ZF, Zhu HF, et al. (October 2012). "Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression". Biomedical and Environmental Sciences. 25 (5): 509–16. Bibcode:2012BioES..25..509Z. doi:10.3967/0895-3988.2012.05.003. PMID 23122307.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–73. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Markwell MA, Portner A, Schwartz AL (February 1985). "An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein". Proceedings of the National Academy of Sciences of the United States of America. 82 (4): 978–82. Bibcode:1985PNAS...82..978M. doi:10.1073/pnas.82.4.978. PMC 397176. PMID 2983337.
Singh AR, Joshi S, Zulcic M, Alcaraz M, Garlich JR, Morales GA, et al. (2016-03-03). Castresana JS (ed.). "PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma". PLOS ONE. 11 (3): e0150836. Bibcode:2016PLoSO..1150836S. doi:10.1371/journal.pone.0150836. PMC 4777592. PMID 26938241.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–4973. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Martin P, Papayannopoulou T (June 1982). "HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression". Science. 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. doi:10.1126/science.6177045. PMID 6177045.
Yogeeswaran G, Salk PL (June 1981). "Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines". Science. 212 (4502): 1514–6. Bibcode:1981Sci...212.1514Y. doi:10.1126/science.7233237. PMID 7233237.
Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S (July 1980). "Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line". Proceedings of the National Academy of Sciences of the United States of America. 77 (7): 4336–9. Bibcode:1980PNAS...77.4336P. doi:10.1073/pnas.77.7.4336. PMC 349829. PMID 6933486.
Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T, et al. (August 1999). "Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication". FEBS Letters. 456 (2): 221–6. Bibcode:1999FEBSL.456..221S. doi:10.1016/s0014-5793(99)00960-6. PMID 10456313. S2CID 1285541.
Chambers R, Takimoto T (June 2010). "Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles". PLOS ONE. 5 (6): e10994. Bibcode:2010PLoSO...510994C. doi:10.1371/journal.pone.0010994. PMC 2881874. PMID 20543880.
Grygoryev D, Ekstrom T, Manalo E, Link JM, Alshaikh A, Keith D, et al. (March 2024). "Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells". Heliyon. 10 (5): e27221. Bibcode:2024Heliy..1027221G. doi:10.1016/j.heliyon.2024.e27221. PMC 10923719. PMID 38463758.
Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, et al. (2014-12-05). "New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood". PLOS ONE. 9 (12): e113052. Bibcode:2014PLoSO...9k3052F. doi:10.1371/journal.pone.0113052. PMC 4257541. PMID 25479600.
Gotoh B, Yamauchi F, Ogasawara T, Nagai Y (January 1992). "Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation". FEBS Letters. 296 (3): 274–8. Bibcode:1992FEBSL.296..274G. doi:10.1016/0014-5793(92)80303-x. PMID 1537403. S2CID 33852517.
Lam A, Kirkland OO, Anderson PF, Seetharaman N, Vujovic D, Thibault PA, et al. (2021-11-23). "Single virus assay reveals membrane determinants and mechanistic features of Sendai virus binding". Biophysical Journal. 121 (6): 956–965. Bibcode:2022BpJ...121..956L. doi:10.1016/j.bpj.2022.02.011. PMC 8943810. PMID 35150620. S2CID 246715171.
Holmgren J, Svennerholm L, Elwing H, Fredman P, Strannegård O (April 1980). "Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides". Proceedings of the National Academy of Sciences of the United States of America. 77 (4): 1947–50. Bibcode:1980PNAS...77.1947H. doi:10.1073/pnas.77.4.1947. PMC 348626. PMID 6246515.
"Correction: Specific Gangliosides Function as Host Cell Receptors for Sendai Virus". Proceedings of the National Academy of Sciences. 79 (3): 951. 1982-02-01. Bibcode:1982PNAS...79Q.951.. doi:10.1073/pnas.79.3.951.
Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, et al. (October 2017). "Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence". Nature Communications. 8 (1): 799. Bibcode:2017NatCo...8..799X. doi:10.1038/s41467-017-00909-6. PMC 5630589. PMID 28986577.
Novick SL, Hoekstra D (October 1988). "Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labeling". Proceedings of the National Academy of Sciences of the United States of America. 85 (20): 7433–7. Bibcode:1988PNAS...85.7433N. doi:10.1073/pnas.85.20.7433. PMC 282205. PMID 2845406.
Shah NR, Sunderland A, Grdzelishvili VZ (June 2010). "Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin". PLOS ONE. 5 (6): e11265. Bibcode:2010PLoSO...511265S. doi:10.1371/journal.pone.0011265. PMC 2889835. PMID 20582319.

iastate.edu

cfsph.iastate.edu

"Sendai virus". Swine Health Information Center. Iowa State University, Center for Food Security and Public Health, College of Veterinary Medicine. September 2015.

ictvonline.org

talk.ictvonline.org

Walker P (15 June 2015). "Implementation of taxon-wide non-Latinized binomial species names in the family Rhabdoviridae" (PDF). International Committee on Taxonomy of Viruses (ICTV). p. 7. Retrieved 6 February 2019.

missouri.edu

dora.missouri.edu

"Sendai Virus". Diseases of Research Animals.

nature.com

"Conventional dendritic cells - Latest research and news | Nature". www.nature.com. Retrieved 4 February 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Faísca P, Desmecht D (February 2007). "Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date". Research in Veterinary Science. 82 (1): 115–125. doi:10.1016/j.rvsc.2006.03.009. PMID 16759680.
Saga K, Kaneda Y (2015). "Oncolytic Sendai virus-based virotherapy for cancer: recent advances". Oncolytic Virotherapy. 4: 141–7. doi:10.2147/OV.S66419. PMC 4918391. PMID 27512677.
Matveeva OV, Kochneva GV, Netesov SV, Onikienko SB, Chumakov PM (April 2015). "Mechanisms of Oncolysis by Paramyxovirus Sendai". Acta Naturae. 7 (2): 6–16. doi:10.32607/20758251-2015-7-2-6-16. PMC 4463408. PMID 26085940. Material was copied from this source, which is available under a Creative Commons Attribution License.
Ilyinskaya GV, Mukhina EV, Soboleva AV, Matveeva OV, Chumakov PM (2018). "Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)". Frontiers in Veterinary Science. 5: 116. doi:10.3389/fvets.2018.00116. PMC 5995045. PMID 29915788.
Köhler G, Milstein C (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. PMID 1172191. S2CID 4161444.
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009). "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 85 (8): 348–62. Bibcode:2009PJAB...85..348F. doi:10.2183/pjab.85.348. PMC 3621571. PMID 19838014.
Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. (August 2011). "Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors". Proceedings of the National Academy of Sciences of the United States of America. 108 (34): 14234–9. Bibcode:2011PNAS..10814234B. doi:10.1073/pnas.1103509108. PMC 3161531. PMID 21821793.
Russell CJ, Hurwitz JL (2015-12-09). "Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses". Expert Review of Vaccines. 15 (2): 189–200. doi:10.1586/14760584.2016.1114418. PMC 4957581. PMID 26648515.
Russell CJ, Hurwitz JL (May 2021). "Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses". Viruses. 13 (6): 1023. doi:10.3390/v13061023. PMC 8230104. PMID 34072332.
Hu Z, Jiang W, Gu L, Qiao D, Shu T, Lowrie DB, et al. (December 2019). "Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines". Journal of Molecular Medicine. 97 (12): 1685–1694. doi:10.1007/s00109-019-01844-3. PMID 31786669. S2CID 208359634.
Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, et al. (February 2021). "Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults". Human Vaccines & Immunotherapeutics. 17 (2): 554–559. doi:10.1080/21645515.2020.1779517. PMC 7899675. PMID 32750273.
Seki S, Matano T (2016). "Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses". Expert Review of Vaccines. 15 (1): 119–127. doi:10.1586/14760584.2016.1105747. PMID 26512881. S2CID 27197590.
Nyombayire J, Anzala O, Gazzard B, Karita E, Bergin P, Hayes P, et al. (January 2017). "First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens". The Journal of Infectious Diseases. 215 (1): 95–104. doi:10.1093/infdis/jiw500. PMC 5225252. PMID 28077588.
Morimoto S, Saeki K, Takeshita M, Hirano K, Shirakawa M, Yamada Y, et al. (January 2023). "Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model". Genes to Cells. 28 (1): 29–41. doi:10.1111/gtc.12992. PMID 36401755. S2CID 253671438.
Flecknell PA, Parry R, Needham JR, Ridley RM, Baker HF, Bowes P (April 1983). "Respiratory disease associated with parainfluenza Type I (Sendai) virus in a colony of marmosets (Callithrix jacchus)". Laboratory Animals. 17 (2): 111–113. doi:10.1258/002367783780959448. PMID 6306336. S2CID 7413539.
López CB, Yount JS, Hermesh T, Moran TM (May 2006). "Sendai virus infection induces efficient adaptive immunity independently of type I interferons". Journal of Virology. 80 (9): 4538–4545. doi:10.1128/JVI.80.9.4538-4545.2006. PMC 1472017. PMID 16611914.
Faisca P, Anh DB, Desmecht DJ (November 2005). "Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains". American Journal of Physiology. Lung Cellular and Molecular Physiology. 289 (5): L777 – L787. doi:10.1152/ajplung.00240.2005. PMID 16006482.
Burke CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, et al. (July 2011). "Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy". PLOS Pathogens. 7 (7): e1002134. doi:10.1371/journal.ppat.1002134. PMC 3131265. PMID 21750677.
Parker JC, Whiteman MD, Richter CB (January 1978). "Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents". Infection and Immunity. 19 (1): 123–30. doi:10.1128/IAI.19.1.123-130.1978. PMC 414057. PMID 203530.
Brownstein DG, Winkler S (April 1986). "Genetic resistance to lethal Sendai virus pneumonia: virus replication and interferon production in C57BL/6J and DBA/2J mice". Laboratory Animal Science. 36 (2): 126–9. PMID 2422437.
Simon AY, Moritoh K, Torigoe D, Asano A, Sasaki N, Agui T (December 2009). "Multigenic control of resistance to Sendai virus infection in mice". Infection, Genetics and Evolution. 9 (6): 1253–9. Bibcode:2009InfGE...9.1253S. doi:10.1016/j.meegid.2009.08.011. hdl:2115/42554. PMID 19733691.
Breider MA, Adams LG, Womack JE (December 1987). "Influence of interferon in natural resistance of mice to Sendai virus pneumonia". American Journal of Veterinary Research. 48 (12): 1746–50. PMID 2449103.
Sangster M, Smith FS, Coleclough C, Hurwitz JL (September 1995). "Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection". Virology. 212 (1): 13–9. doi:10.1006/viro.1995.1448. PMID 7676623.
Stone AE, Giguere S, Castleman WL (November 2003). "IL-12 reduces the severity of Sendai virus-induced bronchiolar inflammation and remodeling". Cytokine. 24 (3): 103–13. doi:10.1016/j.cyto.2003.07.005. PMID 14581004.
Kraft V, Meyer B (June 1986). "Diagnosis of murine infections in relation to test methods employed". Laboratory Animal Science. 36 (3): 271–6. PMID 3014210.
Eaton GJ, Lerro A, Custer RP, Crane AR (August 1982). "Eradication of Sendai pneumonitis from a conventional mouse colony". Laboratory Animal Science. 32 (4): 384–6. PMID 6292576.
Kiyotani K, Sakaguchi T, Kato A, Nagai Y, Yoshida T (March 2007). "Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice". Virology. 359 (1): 82–91. doi:10.1016/j.virol.2006.08.053. PMID 17027894.
Irie T, Nagata N, Igarashi T, Okamoto I, Sakaguchi T (May 2010). "Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses". PLOS ONE. 5 (5): e10719. Bibcode:2010PLoSO...510719I. doi:10.1371/journal.pone.0010719. PMC 2873429. PMID 20502666.
Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y (April 2001). "Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis". Journal of Virology. 75 (8): 3802–10. doi:10.1128/JVI.75.8.3802-3810.2001. PMC 114871. PMID 11264369.
Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE, et al. (September 2022). "IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation". Proceedings of the National Academy of Sciences of the United States of America. 119 (37): e2121385119. Bibcode:2022PNAS..11921385P. doi:10.1073/pnas.2121385119. PMC 9478676. PMID 36067309.
Koyama AH, Irie H, Kato A, Nagai Y, Adachi A (April 2003). "Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins". Microbes and Infection. 5 (5): 373–8. doi:10.1016/S1286-4579(03)00043-1. PMID 12737992.
Yamaguchi M, Kitagawa Y, Zhou M, Itoh M, Gotoh B (January 2014). "An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction". FEBS Letters. 588 (1): 28–34. Bibcode:2014FEBSL.588...28Y. doi:10.1016/j.febslet.2013.11.015. PMID 24269682. S2CID 24831300.
Kitagawa Y, Yamaguchi M, Kohno M, Sakai M, Itoh M, Gotoh B (2020). "Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling". FEBS Letters. 594 (5): 864–877. doi:10.1002/1873-3468.13670. PMID 31705658. S2CID 207944272.
Irie T, Yoshida A, Sakaguchi T (2013-08-09). "Clustered basic amino acids of the small sendai virus C protein Y1 are critical to its RAN GTPase-mediated nuclear localization". PLOS ONE. 8 (8): e73740. Bibcode:2013PLoSO...873740I. doi:10.1371/journal.pone.0073740. PMC 3739745. PMID 23951363.
Oda K, Matoba Y, Irie T, Kawabata R, Fukushi M, Sugiyama M, et al. (November 2015). "Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein". Journal of Virology. 89 (22): 11487–99. doi:10.1128/JVI.01887-15. PMC 4645678. PMID 26339056.
Oda K, Oda T, Matoba Y, Sato M, Irie T, Sakaguchi T (December 2017). "Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling". The Journal of Biological Chemistry. 292 (48): 19752–19766. doi:10.1074/jbc.m117.786285. PMC 5712616. PMID 28978648.
Odkhuu E, Komatsu T, Naiki Y, Koide N, Yokochi T (November 2014). "Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling". International Immunopharmacology. 23 (1): 267–72. doi:10.1016/j.intimp.2014.09.012. PMID 25242386.
Odkhuu E, Komatsu T, Koide N, Naiki Y, Takeuchi K, Tanaka Y, et al. (October 2018). "Sendai virus C protein limits NO production in infected RAW264.7 macrophages". Innate Immunity. 24 (7): 430–438. doi:10.1177/1753425918796619. PMC 6830875. PMID 30189760.
MacMicking J, Xie QW, Nathan C (1997). "Nitric oxide and macrophage function". Annual Review of Immunology. 15 (1): 323–50. doi:10.1146/annurev.immunol.15.1.323. PMID 9143691.
Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B (October 2008). "Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA". Journal of Virology. 82 (20): 10102–10. doi:10.1128/JVI.00599-08. PMC 2566265. PMID 18684815.
Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, et al. (December 2004). "The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter". Proceedings of the National Academy of Sciences of the United States of America. 101 (49): 17264–9. Bibcode:2004PNAS..10117264A. doi:10.1073/pnas.0407639101. PMC 535396. PMID 15563593.
Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, et al. (March 2007). "mda-5, but not RIG-I, is a common target for paramyxovirus V proteins". Virology. 359 (1): 190–200. doi:10.1016/j.virol.2006.09.023. PMID 17049367.
Sánchez-Aparicio MT, Feinman LJ, García-Sastre A, Shaw ML (March 2018). "Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling". Journal of Virology. 92 (6). doi:10.1128/JVI.01960-17. PMC 5827389. PMID 29321315.
Morita N, Tanaka Y, Odkhuu E, Naiki Y, Komatsu T, Koide N (February 2020). "Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages". Microbes and Infection. 22 (8): 322–330. doi:10.1016/j.micinf.2020.01.005. PMID 32032681. S2CID 211064429.
Komatsu T, Tanaka Y, Kitagawa Y, Koide N, Naiki Y, Morita N, et al. (October 2018). "Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly". Journal of Virology. 92 (19): e00842–18. doi:10.1128/JVI.00842-18. PMC 6146803. PMID 30021903.
Rochat S, Komada H, Kolakofsky D (July 1992). "Loss of V protein expression in human parainfluenza virus type 1 is not a recent event". Virus Research. 24 (2): 137–44. doi:10.1016/0168-1702(92)90002-q. PMID 1326826.
Odkhuu E, Komatsu T, Koide N, Naiki Y, Takeuchi K, Tanaka Y, et al. (October 2018). "Sendai virus C protein limits NO production in infected RAW264.7 macrophages". Innate Immunity. 24 (7): 430–438. doi:10.1177/1753425918796619. PMC 6830875. PMID 30189760.
Qiao D, Janke BH, Elankumaran S (August 2009). "Molecular characterization of glycoprotein genes and phylogenetic analysis of two swine paramyxoviruses isolated from United States". Virus Genes. 39 (1): 53–65. doi:10.1007/s11262-009-0353-2. PMID 19337823. S2CID 7100230.
Qiao D, Janke BH, Elankumaran S (January 2010). "Complete genome sequence and pathogenicity of two swine parainfluenzavirus 3 isolates from pigs in the United States". Journal of Virology. 84 (2): 686–94. doi:10.1128/JVI.00847-09. PMC 2798373. PMID 19906928.
Lau SK, Woo PC, Wu Y, Wong AY, Wong BH, Lau CC, et al. (October 2013). "Identification and characterization of a novel paramyxovirus, porcine parainfluenza virus 1, from deceased pigs". The Journal of General Virology. 94 (Pt 10): 2184–90. doi:10.1099/vir.0.052985-0. PMID 23918408.
Palinski RM, Chen Z, Henningson JN, Lang Y, Rowland RR, Fang Y, et al. (February 2016). "Widespread detection and characterization of porcine parainfluenza virus 1 in pigs in the USA". The Journal of General Virology. 97 (2): 281–286. doi:10.1099/jgv.0.000343. PMID 26581410.
Slobod KS, Shenep JL, Luján-Zilbermann J, Allison K, Brown B, Scroggs RA, et al. (August 2004). "Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults". Vaccine. 22 (23–24): 3182–6. doi:10.1016/j.vaccine.2004.01.053. PMID 15297072.
Skiadopoulos MH, Surman SR, Riggs JM, Elkins WR, St Claire M, Nishio M, et al. (May 2002). "Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees". Virology. 297 (1): 153–60. doi:10.1006/viro.2002.1416. PMID 12083845.
Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, et al. (March 2015). "Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children". Clinical and Vaccine Immunology. 22 (3): 298–303. doi:10.1128/CVI.00618-14. PMC 4340902. PMID 25552633.
Hara H, Hara H, Hironaka T, Inoue M, Iida A, Shu T, et al. (June 2011). "Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors". Human Vaccines. 7 (6): 639–45. doi:10.4161/hv.7.6.15408. PMID 21508675. S2CID 24481304.
Moriya C, Horiba S, Inoue M, Iida A, Hara H, Shu T, et al. (July 2008). "Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques". Biochemical and Biophysical Research Communications. 371 (4): 850–4. doi:10.1016/j.bbrc.2008.04.156. PMID 18466766.
Kuroya M, Ishida N (August 1953). "Newborn virus pneumonitis (type Sendai). II. The isolation of a new virus possessing hemagglutinin activity". Yokohama Medical Bulletin. 4 (4): 217–33. PMID 13137076.
Kuroya M, Ishida N, Shiratori T (June 1953). "Newborn virus pneumonitis (type Sendai). II. The isolation of a new virus". The Tohoku Journal of Experimental Medicine. 58 (1): 62. doi:10.1620/tjem.58.62. PMID 13102529.
Fukumi H, Nishikawa F, Kitayama T (August 1954). "A pneumotropic virus from mice causing hemagglutination". Japanese Journal of Medical Science & Biology. 7 (4): 345–63. doi:10.7883/yoken1952.7.345. PMID 13232830.
Ishida N, Homma M (1978). "Sendai virus". Advances in Virus Research. 23: 349–83. doi:10.1016/S0065-3527(08)60103-7. ISBN 9780120398232. PMID 219669.
Griesenbach U, McLachlan G, Owaki T, Somerton L, Shu T, Baker A, et al. (February 2011). "Validation of recombinant Sendai virus in a non-natural host model". Gene Therapy. 18 (2): 182–8. doi:10.1038/gt.2010.131. PMID 20962870. S2CID 23293412.
Bousse T, Chambers RL, Scroggs RA, Portner A, Takimoto T (October 2006). "Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment". Virus Research. 121 (1): 23–32. doi:10.1016/j.virusres.2006.03.012. PMID 16677733.
Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, et al. (April 2000). "The IRF-3 transcription factor mediates Sendai virus-induced apoptosis". Journal of Virology. 74 (8): 3781–92. doi:10.1128/jvi.74.8.3781-3792.2000. PMC 111887. PMID 10729153.
Cantell K, Hirvonen S, Kauppinen HL, Myllylä G (1981). "[4] Production of interferon in human leukocytes from normal donors with the use of Sendai virus". Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods in Enzymology. Vol. 78. pp. 29–38. doi:10.1016/0076-6879(81)78094-7. ISBN 9780121819781. PMID 6173603.
Miettinen M, Sareneva T, Julkunen I, Matikainen S (October 2001). "IFNs activate toll-like receptor gene expression in viral infections". Genes and Immunity. 2 (6): 349–55. doi:10.1038/sj.gene.6363791. PMID 11607792. S2CID 5819381.
Lappalainen J, Rintahaka J, Kovanen PT, Matikainen S, Eklund KK (April 2013). "Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells". Clinical and Experimental Immunology. 172 (1): 121–8. doi:10.1111/cei.12042. PMC 3719938. PMID 23480192.
Neerincx A, Lautz K, Menning M, Kremmer E, Zigrino P, Hösel M, et al. (August 2010). "A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses". The Journal of Biological Chemistry. 285 (34): 26223–32. doi:10.1074/jbc.M110.109736. PMC 2924034. PMID 20538593.
Seth RB, Sun L, Ea CK, Chen ZJ (September 2005). "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3". Cell. 122 (5): 669–682. doi:10.1016/j.cell.2005.08.012. PMID 16125763. S2CID 11104354.
Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, et al. (April 2009). "RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1". The Journal of Biological Chemistry. 284 (16): 10774–10782. doi:10.1074/jbc.M807272200. PMC 2667765. PMID 19224920.
Gitlin L, Benoit L, Song C, Cella M, Gilfillan S, Holtzman MJ, et al. (January 2010). "Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo". PLOS Pathogens. 6 (1): e1000734. doi:10.1371/journal.ppat.1000734. PMC 2809771. PMID 20107606.
Servant MJ, Grandvaux N, tenOever BR, Duguay D, Lin R, Hiscott J (March 2003). "Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA". The Journal of Biological Chemistry. 278 (11): 9441–7. doi:10.1074/jbc.M209851200. PMID 12524442. S2CID 19096582.
Barnes BJ, Moore PA, Pitha PM (June 2001). "Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes". The Journal of Biological Chemistry. 276 (26): 23382–90. doi:10.1074/jbc.M101216200. PMID 11303025. S2CID 26896371.
Hua J, Liao MJ, Rashidbaigi A (July 1996). "Cytokines induced by Sendai virus in human peripheral blood leukocytes". Journal of Leukocyte Biology. 60 (1): 125–8. doi:10.1002/jlb.60.1.125. PMID 8699116. S2CID 28976518.
Costas MA, Mella D, Criscuolo M, Díaz A, Finkielman S, Nahmod VE, et al. (December 1993). "Superinduction of mitogen-stimulated interferon-gamma production and other lymphokines by Sendai virus". Journal of Interferon Research. 13 (6): 407–12. doi:10.1089/jir.1993.13.407. PMID 8151134.
Zidovec S, Mazuran R (February 1999). "Sendai virus induces various cytokines in human peripheral blood leukocytes: different susceptibility of cytokine molecules to low pH". Cytokine. 11 (2): 140–3. doi:10.1006/cyto.1998.0411. PMID 10089135.
Nyman TA, Tölö H, Parkkinen J, Kalkkinen N (January 1998). "Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes". The Biochemical Journal. 329 (Pt 2): 295–302. doi:10.1042/bj3290295. PMC 1219044. PMID 9425112.
Zeng J, Fournier P, Schirrmacher V (May 2002). "Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus". Virology. 297 (1): 19–30. doi:10.1006/viro.2002.1413. PMID 12083832.
Génin P, Lin R, Hiscott J, Civas A (2012). "Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression". PLOS ONE. 7 (6): e38336. Bibcode:2012PLoSO...738336G. doi:10.1371/journal.pone.0038336. PMC 3369917. PMID 22685561.
Mandhana R, Horvath CM (November 2018). "Sendai Virus Infection Induces Expression of Novel RNAs in Human Cells". Scientific Reports. 8 (1): 16815. Bibcode:2018NatSR...816815M. doi:10.1038/s41598-018-35231-8. PMC 6235974. PMID 30429577.
Milone MC, Fitzgerald-Bocarsly P (September 1998). "The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses". Journal of Immunology. 161 (5): 2391–9. doi:10.4049/jimmunol.161.5.2391. PMID 9725235. S2CID 30673547.
Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV (September 1997). "Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria". Scandinavian Journal of Immunology. 46 (3): 235–41. doi:10.1046/j.1365-3083.1997.d01-120.x. PMID 9315110. S2CID 40570647.
Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A (March 2007). "Autophagy-dependent viral recognition by plasmacytoid dendritic cells". Science. 315 (5817): 1398–401. Bibcode:2007Sci...315.1398L. CiteSeerX 10.1.1.657.3208. doi:10.1126/science.1136880. PMID 17272685. S2CID 11549012.
Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, et al. (December 2003). "Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells". Journal of Leukocyte Biology. 74 (6): 1125–38. doi:10.1189/jlb.0603255. PMID 12960254. S2CID 12030752.
Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (March 2000). "CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen". Journal of Immunology. 164 (6): 2978–86. doi:10.4049/jimmunol.164.6.2978. PMID 10706685. S2CID 20588521.
Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, Tschopp J, et al. (February 2010). "Quantitative proteomics reveals subset-specific viral recognition in dendritic cells". Immunity. 32 (2): 279–89. doi:10.1016/j.immuni.2010.01.013. PMID 20171123.
Kiener R, Fleischmann M, Wiegand MA, Lemmermann NA, Schwegler C, Kaufmann C, et al. (August 2018). "Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors". Journal of Virology. 92 (15). doi:10.1128/JVI.00569-18. PMC 6052310. PMID 29769344.
Donnelly RP, Kotenko SV (August 2010). "Interferon-lambda: a new addition to an old family". Journal of Interferon & Cytokine Research. 30 (8): 555–64. doi:10.1089/jir.2010.0078. PMC 2925029. PMID 20712453.
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, et al. (September 2012). "Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells". Journal of Immunology. 189 (6): 2735–45. doi:10.4049/jimmunol.1102038. PMC 3579503. PMID 22891284.
Suzuki H, Kurooka M, Hiroaki Y, Fujiyoshi Y, Kaneda Y (April 2008). "Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner". FEBS Letters. 582 (9): 1325–9. Bibcode:2008FEBSL.582.1325S. doi:10.1016/j.febslet.2008.03.011. PMID 18358837. S2CID 207607018.
Kawaguchi Y, Miyamoto Y, Inoue T, Kaneda Y (May 2009). "Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle". International Journal of Cancer. 124 (10): 2478–87. doi:10.1002/ijc.24234. PMID 19173282. S2CID 33289879.
Lin HY, Davis PJ, Thacore HR (December 1991). "Production of human interferon-beta by Sendai virus and poly(rI).poly(rC): inhibition by neomycin". Journal of Interferon Research. 11 (6): 365–9. doi:10.1089/jir.1991.11.365. PMID 1666117.
Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagnæs-Hansen F, et al. (April 2012). "TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice". The Journal of Clinical Investigation. 122 (4): 1368–76. doi:10.1172/JCI60893. PMC 3314467. PMID 22426207.
Ito Y, Hosaka Y (March 1983). "Component(s) of Sendai virus that can induce interferon in mouse spleen cells". Infection and Immunity. 39 (3): 1019–23. doi:10.1128/IAI.39.3.1019-1023.1983. PMC 348058. PMID 6301988.
Subramanian G, Kuzmanovic T, Zhang Y, Peter CB, Veleeparambil M, Chakravarti R, et al. (January 2018). "A new mechanism of interferon's antiviral action: Induction of autophagy, essential for paramyxovirus replication, is inhibited by the interferon stimulated gene, TDRD7". PLOS Pathogens. 14 (1): e1006877. doi:10.1371/journal.ppat.1006877. PMC 5806901. PMID 29381763.
Wetzel JL, Fensterl V, Sen GC (December 2014). "Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon". Journal of Virology. 88 (23): 13593–601. doi:10.1128/JVI.02201-14. PMC 4248979. PMID 25231314.
Haller O, Kochs G (January 2011). "Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity". Journal of Interferon & Cytokine Research. 31 (1): 79–87. doi:10.1089/jir.2010.0076. PMID 21166595.
Peters K, Chattopadhyay S, Sen GC (April 2008). "IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence". Journal of Virology. 82 (7): 3500–8. doi:10.1128/JVI.02536-07. PMC 2268502. PMID 18216110.
Pirhonen J, Matikainen S, Julkunen I (November 2002). "Regulation of virus-induced IL-12 and IL-23 expression in human macrophages". Journal of Immunology. 169 (10): 5673–5678. doi:10.4049/jimmunol.169.10.5673. PMID 12421946.
Ittah M, Miceli-Richard C, Lebon P, Pallier C, Lepajolec C, Mariette X (2011). "Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type". Journal of Innate Immunity. 3 (2): 200–7. doi:10.1159/000321194. PMID 21051868. S2CID 6699971.
Johansson E, Domeika K, Berg M, Alm GV, Fossum C (February 2003). "Characterisation of porcine monocyte-derived dendritic cells according to their cytokine profile". Veterinary Immunology and Immunopathology. 91 (3–4): 183–97. doi:10.1016/s0165-2427(02)00310-0. PMID 12586481.
Li S, Nishikawa T, Kaneda Y (December 2017). "Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells". Cancer Science. 108 (12): 2333–2341. doi:10.1111/cas.13408. PMC 5715349. PMID 28945328.
Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, et al. (December 2006). "Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA". The Journal of Biological Chemistry. 281 (48): 36560–8. doi:10.1074/jbc.M607594200. PMID 17008311. S2CID 23488241.
Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T, et al. (October 2013). "The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity". Journal of Immunology. 191 (8): 4358–66. doi:10.4049/jimmunol.1301170. PMC 3848201. PMID 24048902.
Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN (April 2013). "The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation". Cell. 153 (2): 348–61. doi:10.1016/j.cell.2013.02.054. PMC 3632354. PMID 23582325.
Ryan LK, Diamond G (June 2017). "Modulation of Human β-Defensin-1 Production by Viruses". Viruses. 9 (6): 153. doi:10.3390/v9060153. PMC 5490828. PMID 28635669.
Ryan LK, Dai J, Yin Z, Megjugorac N, Uhlhorn V, Yim S, et al. (August 2011). "Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity". Journal of Leukocyte Biology. 90 (2): 343–56. doi:10.1189/jlb.0209079. PMC 3133436. PMID 21551252.
Öhman T, Söderholm S, Paidikondala M, Lietzén N, Matikainen S, Nyman TA (June 2015). "Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells". Proteomics. 15 (12): 2087–2097. doi:10.1002/pmic.201400586. PMID 25764225. S2CID 32610482.
Nakanishi M, Otsu M (October 2012). "Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine". Current Gene Therapy. 12 (5): 410–6. doi:10.2174/156652312802762518. PMC 3504922. PMID 22920683.
Russell CJ, Hurwitz JL (May 2021). "Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses". Viruses. 13 (6): 1023. doi:10.3390/v13061023. PMC 8230104. PMID 34072332.
Kinoh H, Inoue M, Washizawa K, Yamamoto T, Fujikawa S, Tokusumi Y, et al. (July 2004). "Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases". Gene Therapy. 11 (14): 1137–45. doi:10.1038/sj.gt.3302272. PMID 15085175. S2CID 10376042.
Kinoh H, Inoue M (January 2008). "New cancer therapy using genetically-engineered oncolytic Sendai virus vector". Frontiers in Bioscience. 13 (13): 2327–34. doi:10.2741/2847. PMID 17981715. S2CID 25851804.
Tatsuta K, Tanaka S, Tajiri T, Shibata S, Komaru A, Ueda Y, et al. (February 2009). "Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene". Gene Therapy. 16 (2): 240–51. doi:10.1038/gt.2008.161. PMID 18987675. S2CID 27976395.
Zimmermann M, Armeanu-Ebinger S, Bossow S, Lampe J, Smirnow I, Schenk A, et al. (2014). "Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors". PLOS ONE. 9 (3): e90508. Bibcode:2014PLoSO...990508Z. doi:10.1371/journal.pone.0090508. PMC 3944018. PMID 24598703.
Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, et al. (June 2019). "Oncolytic Sendai virus-induced tumor-specific immunoresponses suppress "simulated metastasis" of squamous cell carcinoma in an immunocompetent mouse model". Head & Neck. 41 (6): 1676–1686. doi:10.1002/hed.25642. PMID 30620422. S2CID 58561289.
Yonemitsu Y, Ueda Y, Kinoh H, Hasegawa M (January 2008). "Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen". Frontiers in Bioscience. 13 (13): 1892–8. doi:10.2741/2809. PMID 17981677.
Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, et al. (August 2019). "Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model". Molecular Cancer Therapeutics. 18 (8): 1430–1438. doi:10.1158/1535-7163.MCT-18-1372. PMID 31171582. S2CID 174812921.
Iwadate Y, Inoue M, Saegusa T, Tokusumi Y, Kinoh H, Hasegawa M, et al. (May 2005). "Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats". Clinical Cancer Research. 11 (10): 3821–7. doi:10.1158/1078-0432.CCR-04-1485. PMID 15897582. S2CID 37657020.
Tanaka M, Shimbo T, Kikuchi Y, Matsuda M, Kaneda Y (April 2010). "Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon". International Journal of Cancer. 126 (8): 1982–1991. doi:10.1002/ijc.24965. PMID 19830690. S2CID 3414189.
Qian M, Tan HM, Yu N, Wang T, Zhang Q (April 2018). "Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells". Biomedical and Environmental Sciences. 31 (4): 280–289. Bibcode:2018BioES..31..280Q. doi:10.3967/bes2018.036. PMID 29773091.
Kurooka M, Kaneda Y (January 2007). "Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells". Cancer Research. 67 (1): 227–36. doi:10.1158/0008-5472.CAN-06-1615. PMID 17210703.
Fujihara A, Kurooka M, Miki T, Kaneda Y (January 2008). "Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation". Cancer Immunology, Immunotherapy. 57 (1): 73–84. doi:10.1007/s00262-007-0351-y. PMC 11030187. PMID 17602226. S2CID 8779015.
Nishikawa T, Tung LY, Kaneda Y (December 2014). "Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice". Molecular Therapy. 22 (12): 2046–55. doi:10.1038/mt.2014.128. PMC 4429689. PMID 25023327.
Zhang Q, Yuan WF, Zhai GQ, Zhu SY, Xue ZF, Zhu HF, et al. (October 2012). "Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression". Biomedical and Environmental Sciences. 25 (5): 509–16. Bibcode:2012BioES..25..509Z. doi:10.3967/0895-3988.2012.05.003. PMID 23122307.
Saga K, Tamai K, Yamazaki T, Kaneda Y (February 2013). "Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production". Clinical Cancer Research. 19 (3): 668–79. doi:10.1158/1078-0432.CCR-12-1947. PMID 23251005. S2CID 14105282.
Wheelock EF, Dingle JH (September 1964). "Observations on the Repeated Administration of Viruses to a Patient With Acute Leukemia. A Preliminary Report". The New England Journal of Medicine. 271 (13): 645–51. doi:10.1056/NEJM196409242711302. PMID 14170843.
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV (July 2019). "Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes". Oncolytic Virotherapy. 8: 9–26. doi:10.2147/ov.s176523. PMC 6636189. PMID 31372363.
Zainutdinov SS, Tikunov AY, Matveeva OV, Netesov SV, Kochneva GV (August 2016). "Complete Genome Sequence of the Oncolytic Sendai virus Strain Moscow". Genome Announcements. 4 (4). doi:10.1128/genomeA.00818-16. PMC 4982289. PMID 27516510.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, et al. (June 2020). "Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study". Cancer Immunology, Immunotherapy. 69 (6): 1131–1140. doi:10.1007/s00262-020-02509-8. PMC 11027698. PMID 32047956. S2CID 211074332.
Matveeva OV, Chumakov PM (November 2018). "Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses". Reviews in Medical Virology. 28 (6): e2008. doi:10.1002/rmv.2008. PMC 6906582. PMID 30209859.
Liang JX, Liang Y, Gao W (May 2016). "Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis". OncoTargets and Therapy. 9: 3113–25. doi:10.2147/ott.s102389. PMC 4888715. PMID 27307752.
Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ (2018-05-11). "Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy". Frontiers in Oncology. 8: 150. doi:10.3389/fonc.2018.00150. PMC 5958677. PMID 29795807.
Fuster MM, Esko JD (July 2005). "The sweet and sour of cancer: glycans as novel therapeutic targets". Nature Reviews. Cancer. 5 (7): 526–542. doi:10.1038/nrc1649. PMID 16069816. S2CID 10330140.
Noguchi M, Sato N, Sugimori H, Mori K, Oshimi K (October 2001). "A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells". Leukemia Research. 25 (10): 847–53. doi:10.1016/s0145-2126(01)00036-4. PMID 11532516.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–73. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Hatano K, Miyamoto Y, Nonomura N, Kaneda Y (October 2011). "Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells". International Journal of Cancer. 129 (8): 1838–47. doi:10.1002/ijc.25860. PMID 21165949. S2CID 7765966.
Hamasaki H, Aoyagi M, Kasama T, Handa S, Hirakawa K, Taki T (January 1999). "GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1437 (1): 93–9. doi:10.1016/s1388-1981(98)00003-1. PMID 9931455.
Vukelić Z, Kalanj-Bognar S, Froesch M, Bîndila L, Radić B, Allen M, et al. (May 2007). "Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization". Glycobiology. 17 (5): 504–15. doi:10.1093/glycob/cwm012. PMID 17293353.
Markwell MA, Portner A, Schwartz AL (February 1985). "An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein". Proceedings of the National Academy of Sciences of the United States of America. 82 (4): 978–82. Bibcode:1985PNAS...82..978M. doi:10.1073/pnas.82.4.978. PMC 397176. PMID 2983337.
Bitzer M, Lauer U, Baumann C, Spiegel M, Gregor M, Neubert WJ (July 1997). "Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry". Journal of Virology. 71 (7): 5481–6. doi:10.1128/JVI.71.7.5481-5486.1997. PMC 191789. PMID 9188621.
Yu CJ, Shih JY, Lee YC, Shun CT, Yuan A, Yang PC (January 2005). "Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer". Lung Cancer. 47 (1): 59–67. doi:10.1016/j.lungcan.2004.05.018. PMID 15603855.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–1783. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698. S2CID 17515010.
Ariga T, Bhat S, Kanda T, Yamawaki M, Tai T, Kushi Y, et al. (April 1996). "Expression and localization of Lewis(x) glycolipids and GD1a ganglioside in human glioma cells". Glycoconjugate Journal. 13 (2): 135–145. doi:10.1007/BF00731487. PMID 8737237. S2CID 11831860.
Cuello HA, Ferreira GM, Gulino CA, Toledo AG, Segatori VI, Gabri MR (December 2020). "Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma". Oncotarget. 11 (52): 4822–4835. doi:10.18632/oncotarget.27850. PMC 7779250. PMID 33447350.
Son MJ, Woolard K, Nam DH, Lee J, Fine HA (May 2009). "SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma". Cell Stem Cell. 4 (5): 440–452. doi:10.1016/j.stem.2009.03.003. PMC 7227614. PMID 19427293.
Mao XG, Zhang X, Xue XY, Guo G, Wang P, Zhang W, et al. (December 2009). "Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15". Translational Oncology. 2 (4): 247–257. doi:10.1593/tlo.09136. PMC 2781066. PMID 19956386.
Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J, et al. (February 2010). "CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors". BMC Cancer. 10 (1): 66. doi:10.1186/1471-2407-10-66. PMC 2841664. PMID 20181261.
Ward RJ, Lee L, Graham K, Satkunendran T, Yoshikawa K, Ling E, et al. (June 2009). "Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma". Cancer Research. 69 (11): 4682–4690. doi:10.1158/0008-5472.CAN-09-0342. PMID 19487286.
Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, et al. (February 2009). "Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma". Cancer Cell. 15 (2): 135–147. doi:10.1016/j.ccr.2008.12.016. PMC 2664097. PMID 19185848.
Singh AR, Joshi S, Zulcic M, Alcaraz M, Garlich JR, Morales GA, et al. (2016-03-03). Castresana JS (ed.). "PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma". PLOS ONE. 11 (3): e0150836. Bibcode:2016PLoSO..1150836S. doi:10.1371/journal.pone.0150836. PMC 4777592. PMID 26938241.
Fukuoka K, Narita N, Saijo N (May 1998). "Increased expression of sialyl Lewis(x) antigen is associated with distant metastasis in lung cancer patients: immunohistochemical study on bronchofiberscopic biopsy specimens". Lung Cancer. 20 (2): 109–116. doi:10.1016/s0169-5002(98)00016-6. PMID 9711529.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, et al. (April 1997). "Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis". Diseases of the Colon and Rectum. 40 (4): 420–431. doi:10.1007/bf02258386. PMID 9106690. S2CID 24770173.
Nakagoe T, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, et al. (March 2001). "Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels". Journal of Gastroenterology. 36 (3): 166–172. doi:10.1007/s005350170124. PMID 11291879. S2CID 25161348.
Yamadera M, Shinto E, Tsuda H, Kajiwara Y, Naito Y, Hase K, et al. (January 2018). "Sialyl Lewis^x expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer". Oncology Letters. 15 (1): 221–228. doi:10.3892/ol.2017.7340. PMC 5769389. PMID 29391881.
Trinchera M, Aronica A, Dall'Olio F (February 2017). "Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers". Biology. 6 (1): 16. doi:10.3390/biology6010016. PMC 5372009. PMID 28241499.
Nakagoe T, Fukushima K, Sawai T, Tsuji T, Jibiki M, Nanashima A, et al. (January 2002). "Increased expression of sialyl Lewis(x) antigen as a prognostic factor in patients with stage 0, I, and II gastric cancer". Cancer Letters. 175 (2): 213–221. doi:10.1016/S0304-3835(01)00705-4. PMID 11741750.
Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, et al. (May 2002). "Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer". Journal of Cancer Research and Clinical Oncology. 128 (5): 257–264. doi:10.1007/s00432-002-0334-5. PMID 12029441. S2CID 24553989.
Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, et al. (May 2005). "Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis". Anticancer Research. 25 (3A): 1615–1622. PMID 16033070.
Carrascal MA, Silva M, Ferreira JA, Azevedo R, Ferreira D, Silva AM, et al. (September 2018). "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer". Biochimica et Biophysica Acta (BBA) - General Subjects. 1862 (9): 2069–2080. doi:10.1016/j.bbagen.2018.05.013. PMID 29777742. S2CID 29167912.
Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL (August 2004). "Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin". Cancer Research. 64 (15): 5261–5269. doi:10.1158/0008-5472.CAN-04-0691. PMID 15289332. S2CID 11632075.
Munkley J (March 2017). "Glycosylation is a global target for androgen control in prostate cancer cells". Endocrine-Related Cancer. 24 (3): R49 – R64. doi:10.1530/erc-16-0569. PMID 28159857.
Idikio HA (November 1997). "Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer". Glycoconjugate Journal. 14 (7): 875–877. doi:10.1023/a:1018502424487. PMID 9511995. S2CID 28112794.
Fujii Y, Yoshida M, Chien LJ, Kihara K, Kageyama Y, Yasukochi Y, et al. (2000). "Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium". Urologia Internationalis. 64 (3): 129–133. doi:10.1159/000030512. PMID 10859542. S2CID 23332254.
Liang JX, Liang Y, Gao W (2016). "Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis". OncoTargets and Therapy. 9: 3113–3125. doi:10.2147/OTT.S102389. PMC 4888715. PMID 27307752.
Macher BA, Beckstead JH (1990-01-01). "Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells". Leukemia Research. 14 (2): 119–130. doi:10.1016/0145-2126(90)90040-G. PMID 1690317.
Majdic O, Bettelheim P, Stockinger H, Aberer W, Liszka K, Lutz D, et al. (May 1984). "M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells". International Journal of Cancer. 33 (5): 617–623. doi:10.1002/ijc.2910330511. PMID 6724736. S2CID 20483491.
Noguchi M, Sato N, Sugimori H, Mori K, Oshimi K (October 2001). "A minor E-selectin ligand, CD65, is critical for extravascular infiltration of acute myeloid leukemia cells". Leukemia Research. 25 (10): 847–853. doi:10.1016/s0145-2126(01)00036-4. PMID 11532516.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–4973. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Chahlavi A, Rayman P, Richmond AL, Biswas K, Zhang R, Vogelbaum M, et al. (June 2005). "Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70". Cancer Research. 65 (12): 5428–5438. doi:10.1158/0008-5472.CAN-04-4395. PMID 15958592.
Hatano K, Miyamoto Y, Nonomura N, Kaneda Y (October 2011). "Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells". International Journal of Cancer. 129 (8): 1838–1847. doi:10.1002/ijc.25860. PMID 21165949. S2CID 7765966.
Hamasaki H, Aoyagi M, Kasama T, Handa S, Hirakawa K, Taki T (January 1999). "GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1437 (1): 93–99. doi:10.1016/S1388-1981(98)00003-1. PMID 9931455.
Merritt WD, Sztein MB, Taylor B, Reaman GH (December 1991). "Immunoreactivity of leukemic lymphoblasts of T-cell and B-cell precursor origin with monoclonal anti-GD3 and anti-GM3 antibodies". Leukemia. 5 (12): 1087–1091. PMID 1774957.
Westrick MA, Lee WM, Macher BA (December 1983). "Isolation and characterization of gangliosides from chronic myelogenous leukemia cells". Cancer Research. 43 (12 Pt 1): 5890–5894. PMID 6580065.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–83. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698.
Britten CJ, Bird MI (February 1997). "Chemical modification of an alpha 3-fucosyltransferase; definition of amino acid residues essential for enzyme activity". Biochimica et Biophysica Acta (BBA) - General Subjects. 1334 (1): 57–64. doi:10.1016/s0304-4165(96)00076-1. PMID 9042366.
de Vries T, Knegtel RM, Holmes EH, Macher BA (October 2001). "Fucosyltransferases: structure/function studies". Glycobiology. 11 (10): 119R – 128R. doi:10.1093/glycob/11.10.119r. PMID 11588153.
Shetterly S, Jost F, Watson SR, Knegtel R, Macher BA, Holmes EH (August 2007). "Site-specific fucosylation of sialylated polylactosamines by alpha1,3/4-fucosyltransferases-V and -VI Is defined by amino acids near the N terminus of the catalytic domain". The Journal of Biological Chemistry. 282 (34): 24882–92. doi:10.1074/jbc.m702395200. PMID 17604274. S2CID 27689343.
Trinchera M, Aronica A, Dall'Olio F (February 2017). "Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers". Biology. 6 (1): 16. doi:10.3390/biology6010016. PMC 5372009. PMID 28241499.
Ngamukote S, Yanagisawa M, Ariga T, Ando S, Yu RK (December 2007). "Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains". Journal of Neurochemistry. 103 (6): 2327–41. doi:10.1111/j.1471-4159.2007.04910.x. PMID 17883393. S2CID 21405747.
Xu W, Kozak CA, Desnick RJ (April 1995). "Uroporphyrinogen-III synthase: molecular cloning, nucleotide sequence, expression of a mouse full-length cDNA, and its localization on mouse chromosome 7". Genomics. 26 (3): 556–62. doi:10.1016/0888-7543(95)80175-l. PMID 7607680.
Vandermeersch S, Vanbeselaere J, Delannoy CP, Drolez A, Mysiorek C, Guérardel Y, et al. (April 2015). "Accumulation of GD1α Ganglioside in MDA-MB-231 Breast Cancer Cells Expressing ST6GalNAc V". Molecules. 20 (4): 6913–24. doi:10.3390/molecules20046913. PMC 6272744. PMID 25913930.
Chandrasekaran EV, Xue J, Xia J, Locke RD, Patil SA, Neelamegham S, et al. (November 2011). "Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides". Biochemistry. 50 (44): 9475–87. doi:10.1021/bi200301w. PMC 3206213. PMID 21913655.
Hidalgo IJ, Raub TJ, Borchardt RT (March 1989). "Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability". Gastroenterology. 96 (3): 736–49. doi:10.1016/0016-5085(89)90897-4. PMID 2914637.
Katopodis P, Anikin V, Randeva HS, Spandidos DA, Chatha K, Kyrou I, et al. (August 2020). "Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19". International Journal of Oncology. 57 (2): 533–539. doi:10.3892/ijo.2020.5071. PMC 7307597. PMID 32468052.
Nilsson G, Blom T, Kusche-Gullberg M, Kjellén L, Butterfield JH, Sundström C, et al. (May 1994). "Phenotypic characterization of the human mast-cell line HMC-1". Scandinavian Journal of Immunology. 39 (5): 489–98. doi:10.1111/j.1365-3083.1994.tb03404.x. PMID 8191224. S2CID 28014083.
Martin P, Papayannopoulou T (June 1982). "HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression". Science. 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. doi:10.1126/science.6177045. PMID 6177045.
Xiao H, He M, Xie G, Liu Y, Zhao Y, Ye X, et al. (October 2019). "The release of tryptase from mast cells promote tumor cell metastasis via exosomes". BMC Cancer. 19 (1): 1015. doi:10.1186/s12885-019-6203-2. PMC 6819443. PMID 31664930.
Bedsaul JR, Zaritsky LA, Zoon KC (November 2016). "Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection". Journal of Interferon & Cytokine Research. 36 (11): 652–665. doi:10.1089/jir.2016.0051. PMC 5105340. PMID 27508859.
Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. (April 2017). "Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway". Cell Death and Differentiation. 24 (4): 615–625. doi:10.1038/cdd.2016.153. PMC 5384020. PMID 28060376.
Goto H, Ohta K, Matsumoto Y, Yumine N, Nishio M (September 2016). López S (ed.). "Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference". Journal of Virology. 90 (17): 7640–7646. doi:10.1128/JVI.01087-16. ISSN 0022-538X. PMC 4988132. PMID 27279623.
Miyara M, Chader D, Sage E, Sugiyama D, Nishikawa H, Bouvry D, et al. (2015-06-09). "Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans". Proceedings of the National Academy of Sciences. 112 (23): 7225–7230. doi:10.1073/pnas.1508224112. ISSN 0027-8424. PMC 4466753. PMID 26015572.
Ohishi K, Ishikura A, Nishida S, Abo H, Nakatsukasa H, Kawashima H (2024-06-01). "Sialyl Lewis X Defines an Activated and Functional Regulatory T Cell Subpopulation in Mice". The Journal of Immunology. 212 (11): 1627–1638. doi:10.4049/jimmunol.2300349. ISSN 0022-1767. PMID 38639586.
Ebert O, Shinozaki K, Kournioti C, Park MS, García-Sastre A, Woo SL (May 2004). "Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer". Cancer Research. 64 (9): 3265–70. doi:10.1158/0008-5472.CAN-03-3753. PMID 15126368.
Nakamori M, Fu X, Meng F, Jin A, Tao L, Bast RC, et al. (July 2003). "Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms". Clinical Cancer Research. 9 (7): 2727–33. PMID 12855653.
Altomonte J, Marozin S, Schmid RM, Ebert O (February 2010). "Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma". Molecular Therapy. 18 (2): 275–84. doi:10.1038/mt.2009.231. PMC 2839313. PMID 19809404.
Tai JA, Chang CY, Nishikawa T, Kaneda Y (August 2019). "Cancer immunotherapy using the Fusion gene of Sendai virus" (PDF). Cancer Gene Therapy. 27 (6): 498–508. doi:10.1038/s41417-019-0126-6. PMID 31383952. S2CID 199450913.
Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, et al. (March 2000). "Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth". Cancer Research. 60 (6): 1492–7. PMID 10749110.
Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, et al. (May 2001). "Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas". Human Gene Therapy. 12 (7): 811–21. doi:10.1089/104303401750148766. PMID 11339897.
Lin EH, Salon C, Brambilla E, Lavillette D, Szecsi J, Cosset FL, et al. (April 2010). "Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer". Cancer Gene Therapy. 17 (4): 256–65. doi:10.1038/cgt.2009.74. PMID 19893593. S2CID 11203950.
Kursunel MA, Esendagli G (June 2017). "Corrigendum to "The untold story of IFN-γ in cancer biology" [Cytokine Growth Factor Rev. 31 (2016) 73-81]". Cytokine & Growth Factor Reviews. 35: 97. doi:10.1016/j.cytogfr.2017.02.002. PMID 28258821.
Ikeda H, Old LJ, Schreiber RD (April 2002). "The roles of IFN gamma in protection against tumor development and cancer immunoediting". Cytokine & Growth Factor Reviews. 13 (2): 95–109. doi:10.1016/s1359-6101(01)00038-7. PMID 11900986.
Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, et al. (July 2005). "A critical function for type I interferons in cancer immunoediting". Nature Immunology. 6 (7): 722–9. doi:10.1038/ni1213. PMID 15951814. S2CID 20374688.
Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. (December 2007). "Interferons at age 50: past, current and future impact on biomedicine". Nature Reviews. Drug Discovery. 6 (12): 975–90. doi:10.1038/nrd2422. PMC 7097588. PMID 18049472. S2CID 583709.
Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C, et al. (April 2000). "Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach". The American Journal of Pathology. 156 (4): 1381–93. doi:10.1016/S0002-9440(10)65007-9. PMC 1876903. PMID 10751362.
Yogeeswaran G, Salk PL (June 1981). "Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines". Science. 212 (4502): 1514–6. Bibcode:1981Sci...212.1514Y. doi:10.1126/science.7233237. PMID 7233237.
Passaniti A, Hart GW (June 1988). "Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures". The Journal of Biological Chemistry. 263 (16): 7591–603. doi:10.1016/S0021-9258(18)68540-0. PMID 3372501.
Bresalier RS, Rockwell RW, Dahiya R, Duh QY, Kim YS (February 1990). "Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis". Cancer Research. 50 (4): 1299–307. PMID 2297775.
Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S (July 1980). "Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line". Proceedings of the National Academy of Sciences of the United States of America. 77 (7): 4336–9. Bibcode:1980PNAS...77.4336P. doi:10.1073/pnas.77.7.4336. PMC 349829. PMID 6933486.
Benedetto A, Elia G, Sala A, Belardelli F (January 1989). "Hyposialylation of high-molecular-weight membrane glycoproteins parallels the loss of metastatic potential in wheat-germ agglutinin-resistant Friend leukemia cells". International Journal of Cancer. 43 (1): 126–33. doi:10.1002/ijc.2910430124. PMID 2910824. S2CID 24704777.
Hsu CC, Lin TW, Chang WW, Wu CY, Lo WH, Wang PH, et al. (February 2005). "Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids". Gynecologic Oncology. 96 (2): 415–22. doi:10.1016/j.ygyno.2004.10.010. PMID 15661230.
Chang WW, Yu CY, Lin TW, Wang PH, Tsai YC (March 2006). "Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells". Biochemical and Biophysical Research Communications. 341 (2): 614–9. doi:10.1016/j.bbrc.2005.12.216. PMID 16427612.
Chiang CH, Wang CH, Chang HC, More SV, Li WS, Hung WC (May 2010). "A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling". Journal of Cellular Physiology. 223 (2): 492–9. doi:10.1002/jcp.22068. PMID 20112294. S2CID 24218458.
Cohen M, Elkabets M, Perlmutter M, Porgador A, Voronov E, Apte RN, et al. (November 2010). "Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting". Journal of Immunology. 185 (10): 5869–78. doi:10.4049/jimmunol.1001635. PMID 20956342. S2CID 45698975.
Bossart KN, Fusco DL, Broder CC (2013). "Paramyxovirus Entry". Viral Entry into Host Cells. Advances in Experimental Medicine and Biology. Vol. 790. New York, NY: Springer. pp. 95–127. doi:10.1007/978-1-4614-7651-1_6. ISBN 978-1-4614-7650-4. PMC 8782154. PMID 23884588.
Powell LD, Whiteheart SW, Hart GW (July 1987). "Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction". Journal of Immunology. 139 (1): 262–70. doi:10.4049/jimmunol.139.1.262. PMID 2953814. S2CID 25762755.
Tyagarajan K, Forte JG, Townsend RR (January 1996). "Exoglycosidase purity and linkage specificity: assessment using oligosaccharide substrates and high-pH anion-exchange chromatography with pulsed amperometric detection". Glycobiology. 6 (1): 83–93. doi:10.1093/glycob/6.1.83. PMID 8991514.
Drzeniek R, Gauhe A (February 1970). "Differences in substrate specificity of myxovirus neuraminidases". Biochemical and Biophysical Research Communications. 38 (4): 651–6. doi:10.1016/0006-291x(70)90630-3. PMID 5443707.
Brostrom MA, Bruening G, Bankowski RA (December 1971). "Comparison of neuraminidases of paramyxoviruses with immunologically dissimilar hemagglutinins". Virology. 46 (3): 856–65. doi:10.1016/0042-6822(71)90086-9. PMID 4332979.
Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, et al. (August 2009). "Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase". Journal of Virology. 83 (16): 8108–21. doi:10.1128/JVI.00211-09. PMC 2715740. PMID 19515783.
Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O (September 2001). "Recognition of viral hemagglutinins by NKp44 but not by NKp30". European Journal of Immunology. 31 (9): 2680–9. doi:10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A. PMID 11536166. S2CID 22437769.
Schirrmacher V, Haas C, Bonifer R, Ertel C (July 1997). "Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection". Clinical Cancer Research. 3 (7): 1135–48. PMID 9815793.
Ueda Y, Hasegawa M, Yonemitsu Y (2009). "Sendai Virus for Cancer Immunotherapy". Viral Applications of Green Fluorescent Protein. Methods in Molecular Biology. Vol. 515. Totowa, NJ: Humana Press. pp. 299–308. doi:10.1007/978-1-59745-559-6_21. ISBN 978-1-934115-87-9. PMID 19378123.
Harada Y, Yonemitsu Y (June 2011). "Dramatic improvement of DC-based immunotherapy against various malignancies". Frontiers in Bioscience. 16 (6): 2233–2242. doi:10.2741/3850. PMID 21622173. S2CID 30195748.
Shibata S, Okano S, Yonemitsu Y, Onimaru M, Sata S, Nagata-Takeshita H, et al. (September 2006). "Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene". Journal of Immunology. 177 (6): 3564–3576. doi:10.4049/jimmunol.177.6.3564. PMID 16951315. S2CID 20134438.
Okano S, Yonemitsu Y, Shirabe K, Kakeji Y, Maehara Y, Harada M, et al. (February 2011). "Provision of continuous maturation signaling to dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virus". Journal of Immunology. 186 (3): 1828–1839. doi:10.4049/jimmunol.0901641. PMID 21187441. S2CID 36653582.
Sugiyama M, Kakeji Y, Tsujitani S, Harada Y, Onimaru M, Yoshida K, et al. (March 2011). "Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites". Molecular Cancer Therapeutics. 10 (3): 540–549. doi:10.1158/1535-7163.MCT-10-0479. hdl:2324/25486. PMID 21209070. S2CID 37616710.
Yoneyama Y, Ueda Y, Akutsu Y, Matsunaga A, Shimada H, Kato T, et al. (March 2007). "Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells". Biochemical and Biophysical Research Communications. 355 (1): 129–135. doi:10.1016/j.bbrc.2007.01.132. PMID 17292867.
Komaru A, Ueda Y, Furuya A, Tanaka S, Yoshida K, Kato T, et al. (October 2009). "Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus". Journal of Immunology. 183 (7): 4211–4219. doi:10.4049/jimmunol.0803845. PMID 19734206. S2CID 39194525.
Kato T, Ueda Y, Kinoh H, Yoneyama Y, Matsunaga A, Komaru A, et al. (November 2010). "RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer". Neoplasia. 12 (11): 906–914. doi:10.1593/neo.10732. PMC 2978913. PMID 21076616.
Edgar LJ, Thompson AJ, Vartabedian VF, Kikuchi C, Woehl JL, Teijaro JR, et al. (September 2021). "Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells". ACS Central Science. 7 (9): 1508–1515. doi:10.1021/acscentsci.1c00525. PMC 8461770. PMID 34584952.
Silva M, Silva Z, Marques G, Ferro T, Gonçalves M, Monteiro M, et al. (July 2016). "Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses". Oncotarget. 7 (27): 41053–41066. doi:10.18632/oncotarget.9419. ISSN 1949-2553. PMC 5173042. PMID 27203391.
Balneger N, Cornelissen LA, Wassink M, Moons SJ, Boltje TJ, Bar-Ephraim YE, et al. (February 2022). "Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions". Cellular and Molecular Life Sciences. 79 (2): 98. doi:10.1007/s00018-021-04027-x. ISSN 1420-682X. PMC 8799591. PMID 35089436.
Hosoya N, Miura T, Kawana-Tachikawa A, Koibuchi T, Shioda T, Odawara T, et al. (March 2008). "Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells". Journal of Medical Virology. 80 (3): 373–82. doi:10.1002/jmv.21052. PMID 18205221. S2CID 31337462.
Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T, et al. (August 1999). "Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication". FEBS Letters. 456 (2): 221–6. Bibcode:1999FEBSL.456..221S. doi:10.1016/s0014-5793(99)00960-6. PMID 10456313. S2CID 1285541.
Chare ER, Gould EA, Holmes EC (October 2003). "Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses". The Journal of General Virology. 84 (Pt 10): 2691–2703. doi:10.1099/vir.0.19277-0. PMID 13679603.
Han GZ, Worobey M (August 2011). "Homologous recombination in negative sense RNA viruses". Viruses. 3 (8): 1358–1373. doi:10.3390/v3081358. PMC 3185808. PMID 21994784.
Kolakofsky D, Roux L, Garcin D, Ruigrok RW (July 2005). "Paramyxovirus mRNA editing, the "rule of six" and error catastrophe: a hypothesis". The Journal of General Virology. 86 (Pt 7): 1869–1877. doi:10.1099/vir.0.80986-0. PMID 15958664.
Ikegame S, Beaty SM, Stevens C, Won T, Park A, Sachs D, et al. (October 2020). Lowen AC (ed.). "Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticity". PLOS Pathogens. 16 (10): e1008877. doi:10.1371/journal.ppat.1008877. PMC 7577504. PMID 33035269.
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (December 1995). "A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus". The EMBO Journal. 14 (24): 6087–94. doi:10.1002/j.1460-2075.1995.tb00299.x. PMC 394733. PMID 8557028.
Pfaller CK, Cattaneo R, Schnell MJ (May 2015). "Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics". Virology. 60th Anniversary Issue. 479: 331–344. doi:10.1016/j.virol.2015.01.029. PMC 4557643. PMID 25702088.
Beaty SM, Park A, Won ST, Hong P, Lyons M, Vigant F, et al. (March 2017). "Paramyxoviridae Reverse Genetics Systems". mSphere. 2 (2). doi:10.1128/mSphere.00376-16. PMC 5371697. PMID 28405630.
Liu H, Albina E, Gil P, Minet C, de Almeida RS (September 2017). "Two-plasmid system to increase the rescue efficiency of paramyxoviruses by reverse genetics: The example of rescuing Newcastle Disease Virus". Virology. 509: 42–51. doi:10.1016/j.virol.2017.06.003. PMID 28595094.
Liu H, de Almeida RS, Gil P, Albina E (November 2017). "Comparison of the efficiency of different newcastle disease virus reverse genetics systems". Journal of Virological Methods. 249: 111–116. doi:10.1016/j.jviromet.2017.08.024. PMID 28867302.
Bajimaya S, Hayashi T, Takimoto T (2017). "Rescue of Sendai Virus from Cloned cDNA". Reverse Genetics of RNA Viruses. Methods in Molecular Biology. Vol. 1602. New York, NY: Springer. pp. 103–110. doi:10.1007/978-1-4939-6964-7_7. ISBN 978-1-4939-6962-3. PMID 28508216.
Yoshizaki M, Hironaka T, Iwasaki H, Ban H, Tokusumi Y, Iida A, et al. (September 2006). "Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity". The Journal of Gene Medicine. 8 (9): 1151–1159. doi:10.1002/jgm.938. PMID 16841365. S2CID 39942120.
Inoue M, Tokusumi Y, Ban H, Kanaya T, Shirakura M, Tokusumi T, et al. (June 2003). "A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading". Journal of Virology. 77 (11): 6419–6429. doi:10.1128/JVI.77.11.6419-6429.2003. PMC 155001. PMID 12743299.
Mostafa HH, Vogel P, Srinivasan A, Russell CJ (September 2016). "Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone". PLOS Pathogens. 12 (9): e1005875. doi:10.1371/journal.ppat.1005875. PMC 5010285. PMID 27589232.
Hasan MK, Kato A, Shioda T, Sakai Y, Yu D, Nagai Y (November 1997). "Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus". The Journal of General Virology. 78 (11): 2813–20. doi:10.1099/0022-1317-78-11-2813. PMID 9367367.
Chambers R, Takimoto T (June 2010). "Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles". PLOS ONE. 5 (6): e10994. Bibcode:2010PLoSO...510994C. doi:10.1371/journal.pone.0010994. PMC 2881874. PMID 20543880.
Agungpriyono DR, Yamaguchi R, Uchida K, Tohya Y, Kato A, Nagai Y, et al. (February 2000). "Green fluorescent protein gene insertion of Sendai Virus infection in nude mice: possibility as an infection tracer". The Journal of Veterinary Medical Science. 62 (2): 223–8. doi:10.1292/jvms.62.223. PMID 10720198.
Miyazaki M, Segawa H, Yamashita T, Zhu Y, Takizawa K, Hasegawa M, et al. (2010-11-23). "Construction and characterization of a fluorescent sendai virus carrying the gene for envelope fusion protein fused with enhanced green fluorescent protein". Bioscience, Biotechnology, and Biochemistry. 74 (11): 2293–8. doi:10.1271/bbb.100511. PMID 21071846. S2CID 43669142.
Villenave R, Touzelet O, Thavagnanam S, Sarlang S, Parker J, Skibinski G, et al. (November 2010). "Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells". Journal of Virology. 84 (22): 11718–28. doi:10.1128/JVI.00798-10. PMC 2977906. PMID 20810726.
Touzelet O, Loukili N, Pelet T, Fairley D, Curran J, Power UF (March 2009). "De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene". Virus Research. 140 (1–2): 40–48. doi:10.1016/j.virusres.2008.10.019. PMID 19084562.
Strähle L, Marq JB, Brini A, Hausmann S, Kolakofsky D, Garcin D (November 2007). "Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins". Journal of Virology. 81 (22): 12227–37. doi:10.1128/JVI.01300-07. PMC 2169027. PMID 17804509.
Gosselin-Grenet AS, Mottet-Osman G, Roux L (September 2010). "Sendai virus particle production: basic requirements and role of the SYWST motif present in HN cytoplasmic tail". Virology. 405 (2): 439–447. doi:10.1016/j.virol.2010.06.030. PMID 20633915.
Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA (March 2011). "Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus". Journal of Virology. 85 (6): 2771–80. doi:10.1128/jvi.02065-10. PMC 3067931. PMID 21228237.
Rawling J, García-Barreno B, Melero JA (June 2008). "Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity". Journal of Virology. 82 (12): 5986–98. doi:10.1128/jvi.00078-08. PMC 2395136. PMID 18385247.
Portner A, Scroggs RA, Naeve CW (April 1987). "The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization". Virology. 157 (2): 556–9. doi:10.1016/0042-6822(87)90301-1. PMID 2435061.
Park A, Hong P, Won ST, Thibault PA, Vigant F, Oguntuyo KY, et al. (2016-08-24). "Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing". Molecular Therapy: Methods & Clinical Development. 3: 16057. doi:10.1038/mtm.2016.57. PMC 4996130. PMID 27606350.
Corral T, Ver LS, Mottet G, Cano O, García-Barreno B, Calder LJ, et al. (April 2007). "High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system". BMC Biotechnology. 7 (1): 17. doi:10.1186/1472-6750-7-17. PMC 1852797. PMID 17411439.
Grygoryev D, Ekstrom T, Manalo E, Link JM, Alshaikh A, Keith D, et al. (March 2024). "Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells". Heliyon. 10 (5): e27221. Bibcode:2024Heliy..1027221G. doi:10.1016/j.heliyon.2024.e27221. PMC 10923719. PMID 38463758.
Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, et al. (2014-12-05). "New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood". PLOS ONE. 9 (12): e113052. Bibcode:2014PLoSO...9k3052F. doi:10.1371/journal.pone.0113052. PMC 4257541. PMID 25479600.
Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, et al. (February 2003). "Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells". Gene Therapy. 10 (3): 272–7. doi:10.1038/sj.gt.3301877. PMID 12571635. S2CID 22415369.
Okumura T, Horie Y, Lai CY, Lin HT, Shoda H, Natsumoto B, et al. (June 2019). "Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34⁺ cells using the auto-erasable Sendai virus vector". Stem Cell Research & Therapy. 10 (1): 185. doi:10.1186/s13287-019-1273-2. PMC 6591940. PMID 31234949.
Seki T, Yuasa S, Fukuda K (March 2012). "Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus". Nature Protocols. 7 (4): 718–28. doi:10.1038/nprot.2012.015. PMID 22422317. S2CID 41397031.
Charlesworth CT, Nakauchi H (November 2022). "An optimized Sendai viral vector platform for reprogramming to naive pluripotency". Cell Reports Methods. 2 (11): 100349. doi:10.1016/j.crmeth.2022.100349. PMC 9701616. PMID 36452874.
Sano M, Nakasu A, Ohtaka M, Nakanishi M (December 2019). "A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs". Molecular Therapy. Methods & Clinical Development. 15: 371–382. doi:10.1016/j.omtm.2019.10.012. PMC 6889074. PMID 31828179.
Moriya C, Horiba S, Kurihara K, Kamada T, Takahara Y, Inoue M, et al. (November 2011). "Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies". Vaccine. 29 (47): 8557–8563. doi:10.1016/j.vaccine.2011.09.028. PMID 21939708.
Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, et al. (January 2012). "Sendai virus-based RSV vaccine protects African green monkeys from RSV infection". Vaccine. 30 (5): 959–68. doi:10.1016/j.vaccine.2011.11.046. PMC 3256274. PMID 22119594.
Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, et al. (May 2015). "Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats". International Immunology. 27 (5): 229–36. doi:10.1093/intimm/dxu107. PMC 4406265. PMID 25477211.
Hu Z, Gu L, Li CL, Shu T, Lowrie DB, Fan XY (2018). "The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine". Frontiers in Immunology. 9: 1796. doi:10.3389/fimmu.2018.01796. PMC 6085409. PMID 30123219.
Hu Z, Xia J, Wu J, Zhao H, Ji P, Gu L, et al. (December 2024). "A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis". Emerging Microbes & Infections. 13 (1): 2300463. doi:10.1080/22221751.2023.2300463. ISSN 2222-1751. PMC 10769537. PMID 38164736.
Moreno-Fierros L, García-Silva I, Rosales-Mendoza S (August 2020). "Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?". Expert Opinion on Biological Therapy. 20 (8): 831–836. doi:10.1080/14712598.2020.1767062. PMID 32380868. S2CID 218556295.
Travis CR (2020-09-30). "As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention". Frontiers in Immunology. 11: 591897. doi:10.3389/fimmu.2020.591897. PMC 7561361. PMID 33117404.
Sealy R, Jones BG, Surman SL, Hurwitz JL (September 2010). "Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1". Vaccine. 28 (41): 6749–6756. doi:10.1016/j.vaccine.2010.07.068. PMC 2950074. PMID 20682364.
Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, et al. (May 2017). "Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice". Molecular Therapy. 25 (5): 1222–1233. doi:10.1016/j.ymthe.2017.02.018. PMC 5417795. PMID 28342639.
Shi LY, Li M, Yuan LJ, Wang Q, Li XM (2008). "A new paramyxovirus, Tianjin strain, isolated from common cotton-eared marmoset: genome characterization and structural protein sequence analysis". Archives of Virology. 153 (9): 1715–23. doi:10.1007/s00705-008-0184-9. PMID 18696006. S2CID 6151471.
Liang Y, Wu X, Zhang J, Xiao L, Yang Y, Bai X, et al. (December 2012). "Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis". FEMS Immunology and Medical Microbiology. 66 (3): 419–426. doi:10.1111/1574-695X.12008. PMID 23163873.
Ishii H, Nomura T, Yamamoto H, Nishizawa M, Thu Hau TT, Harada S, et al. (February 2022). "Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8⁺ T cell responses". Cell Reports. Medicine. 3 (2): 100520. doi:10.1016/j.xcrm.2022.100520. PMC 8768424. PMID 35233545.
Scheid A, Choppin PW (February 1974). "Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus". Virology. 57 (2): 475–90. doi:10.1016/0042-6822(74)90187-1. PMID 4361457.
Azarm KD, Lee B (January 2020). "Differential Features of Fusion Activation within the Paramyxoviridae". Viruses. 12 (2): 161. doi:10.3390/v12020161. PMC 7077268. PMID 32019182.
Yamada H, Hayata S, Omata-Yamada T, Taira H, Mizumoto K, Iwasaki K (1990). "Association of the Sendai virus C protein with nucleocapsids". Archives of Virology. 113 (3–4): 245–53. doi:10.1007/bf01316677. PMID 2171459. S2CID 24592567.
Garcin D, Curran J, Itoh M, Kolakofsky D (August 2001). "Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response". Journal of Virology. 75 (15): 6800–7. doi:10.1128/JVI.75.15.6800-6807.2001. PMC 114406. PMID 11435558.
Curran J, Kolakofsky D (January 1988). "Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA". The EMBO Journal. 7 (1): 245–51. doi:10.1002/j.1460-2075.1988.tb02806.x. PMC 454264. PMID 2834203.
Dillon PJ, Gupta KC (February 1989). "Expression of five proteins from the Sendai virus P/C mRNA in infected cells". Journal of Virology. 63 (2): 974–7. doi:10.1128/JVI.63.2.974-977.1989. PMC 247778. PMID 2536120.
de Breyne S, Simonet V, Pelet T, Curran J (January 2003). "Identification of a cis-acting element required for shunt-mediated translational initiation of the Sendai virus Y proteins". Nucleic Acids Research. 31 (2): 608–18. doi:10.1093/nar/gkg143. PMC 140508. PMID 12527769.
Curran J, Kolakofsky D (September 1988). "Scanning independent ribosomal initiation of the Sendai virus X protein". The EMBO Journal. 7 (9): 2869–74. doi:10.1002/j.1460-2075.1988.tb03143.x. PMC 457080. PMID 2846286.
Irie T, Nagata N, Yoshida T, Sakaguchi T (February 2008). "Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles". Virology. 371 (1): 108–20. doi:10.1016/j.virol.2007.09.020. PMID 18028977.
Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, et al. (July 2005). "AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding". Journal of Virology. 79 (14): 8933–41. doi:10.1128/JVI.79.14.8933-8941.2005. PMC 1168738. PMID 15994787.
Payne V, Kam PC (July 2004). "Mast cell tryptase: a review of its physiology and clinical significance". Anaesthesia. 59 (7): 695–703. doi:10.1111/j.1365-2044.2004.03757.x. PMID 15200544. S2CID 7611291.
Chen Y, Shiota M, Ohuchi M, Towatari T, Tashiro J, Murakami M, et al. (June 2000). "Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization". European Journal of Biochemistry. 267 (11): 3189–97. doi:10.1046/j.1432-1327.2000.01346.x. PMID 10824103.
Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H (December 1992). "Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity". Journal of Virology. 66 (12): 7211–6. doi:10.1128/JVI.66.12.7211-7216.1992. PMC 240423. PMID 1331518.
Kido H, Niwa Y, Beppu Y, Towatari T (1996). "Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus". Advances in Enzyme Regulation. 36: 325–47. doi:10.1016/0065-2571(95)00016-X. PMID 8869754.
Le TQ, Kawachi M, Yamada H, Shiota M, Okumura Y, Kido H (April 2006). "Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain". Biological Chemistry. 387 (4): 467–75. doi:10.1515/BC.2006.062. PMID 16606346. S2CID 11969821.
Murakami M, Towatari T, Ohuchi M, Shiota M, Akao M, Okumura Y, et al. (May 2001). "Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus". European Journal of Biochemistry. 268 (10): 2847–55. doi:10.1046/j.1432-1327.2001.02166.x. PMID 11358500.
Abe M, Tahara M, Sakai K, Yamaguchi H, Kanou K, Shirato K, et al. (November 2013). "TMPRSS2 is an activating protease for respiratory parainfluenza viruses". Journal of Virology. 87 (21): 11930–5. doi:10.1128/JVI.01490-13. PMC 3807344. PMID 23966399.
Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y (December 1990). "An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo". The EMBO Journal. 9 (12): 4189–95. doi:10.1002/j.1460-2075.1990.tb07643.x. PMC 552195. PMID 2174359.
Ogasawara T, Gotoh B, Suzuki H, Asaka J, Shimokata K, Rott R, et al. (February 1992). "Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo". The EMBO Journal. 11 (2): 467–72. doi:10.1002/j.1460-2075.1992.tb05076.x. PMC 556476. PMID 1371460.
Gotoh B, Yamauchi F, Ogasawara T, Nagai Y (January 1992). "Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation". FEBS Letters. 296 (3): 274–8. Bibcode:1992FEBSL.296..274G. doi:10.1016/0014-5793(92)80303-x. PMID 1537403. S2CID 33852517.
Lam A, Kirkland OO, Anderson PF, Seetharaman N, Vujovic D, Thibault PA, et al. (2021-11-23). "Single virus assay reveals membrane determinants and mechanistic features of Sendai virus binding". Biophysical Journal. 121 (6): 956–965. Bibcode:2022BpJ...121..956L. doi:10.1016/j.bpj.2022.02.011. PMC 8943810. PMID 35150620. S2CID 246715171.
Matveeva OV, Shabalina SA (December 2020). "Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy". Cancers. 12 (12): 3659. doi:10.3390/cancers12123659. PMC 7762160. PMID 33291506.
Villar E, Barroso IM (February 2006). "Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview". Glycoconjugate Journal. 23 (1–2): 5–17. doi:10.1007/s10719-006-5433-0. PMID 16575518. S2CID 21083897.
Stockert RJ (July 1995). "The asialoglycoprotein receptor: relationships between structure, function, and expression". Physiological Reviews. 75 (3): 591–609. doi:10.1152/physrev.1995.75.3.591. PMID 7624395.
Suzuki Y, Suzuki T, Matsumoto M (June 1983). "Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane". Journal of Biochemistry. 93 (6): 1621–33. doi:10.1093/oxfordjournals.jbchem.a134301. PMID 6309760.
Oku N, Nojima S, Inoue K (August 1981). "Studies on the interaction of Sendai virus with liposomal membranes. Sendai virus-induced agglutination of liposomes containing glycophorin". Biochimica et Biophysica Acta (BBA) - Biomembranes. 646 (1): 36–42. doi:10.1016/0005-2736(81)90269-8. PMID 6168285.
Müthing J (September 1996). "Influenza A and Sendai viruses preferentially bind to fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes". Carbohydrate Research. 290 (2): 217–24. doi:10.1016/0008-6215(96)00149-8. PMID 8823909.
Holmgren J, Svennerholm L, Elwing H, Fredman P, Strannegård O (April 1980). "Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides". Proceedings of the National Academy of Sciences of the United States of America. 77 (4): 1947–50. Bibcode:1980PNAS...77.1947H. doi:10.1073/pnas.77.4.1947. PMC 348626. PMID 6246515.
Suzuki Y, Suzuki T, Matsunaga M, Matsumoto M (April 1985). "Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus". Journal of Biochemistry. 97 (4): 1189–99. doi:10.1093/oxfordjournals.jbchem.a135164. PMID 2993261.
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, et al. (May 2001). "Receptor specificities of human respiroviruses". Journal of Virology. 75 (10): 4604–13. doi:10.1128/JVI.75.10.4604-4613.2001. PMC 114213. PMID 11312330.
Umeda M, Nojima S, Inoue K (February 1984). "Activity of human erythrocyte gangliosides as a receptor to HVJ". Virology. 133 (1): 172–82. doi:10.1016/0042-6822(84)90436-7. PMID 6322427.
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, et al. (May 2001). "Receptor specificities of human respiroviruses". Journal of Virology. 75 (10): 4604–13. doi:10.1128/jvi.75.10.4604-4613.2001. PMC 114213. PMID 11312330.
Chang A, Dutch RE (April 2012). "Paramyxovirus fusion and entry: multiple paths to a common end". Viruses. 4 (4): 613–36. doi:10.3390/v4040613. PMC 3347325. PMID 22590688.
Lamb RA, Jardetzky TS (August 2007). "Structural basis of viral invasion: lessons from paramyxovirus F". Current Opinion in Structural Biology. 17 (4): 427–36. doi:10.1016/j.sbi.2007.08.016. PMC 2086805. PMID 17870467.
Haywood AM (November 2010). "Membrane uncoating of intact enveloped viruses". Journal of Virology. 84 (21): 10946–55. doi:10.1128/JVI.00229-10. PMC 2953184. PMID 20668081.
Jardetzky TS, Lamb RA (April 2014). "Activation of paramyxovirus membrane fusion and virus entry". Current Opinion in Virology. 5: 24–33. doi:10.1016/j.coviro.2014.01.005. PMC 4028362. PMID 24530984.
Whelan SP, Barr JN, Wertz GW (2004). "Transcription and Replication of Nonsegmented Negative-Strand RNA Viruses". Biology of Negative Strand RNA Viruses: The Power of Reverse Genetics. Current Topics in Microbiology and Immunology. Vol. 283. Berlin, Heidelberg: Springer. pp. 61–119. doi:10.1007/978-3-662-06099-5_3. ISBN 978-3-642-07375-5. PMID 15298168.
Noton SL, Fearns R (May 2015). "Initiation and regulation of paramyxovirus transcription and replication". Virology. 479: 545–354. doi:10.1016/j.virol.2015.01.014. PMC 4424093. PMID 25683441.
Ogino T, Kobayashi M, Iwama M, Mizumoto K (February 2005). "Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA". The Journal of Biological Chemistry. 280 (6): 4429–35. doi:10.1074/jbc.M411167200. PMID 15574411. S2CID 27655763.
Myers TM, Moyer SA (February 1997). "An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis". Journal of Virology. 71 (2): 918–24. doi:10.1128/JVI.71.2.918-924.1997. PMC 191139. PMID 8995608.
Wiegand MA, Bossow S, Schlecht S, Neubert WJ (2007-12-15). "De Novo Synthesis of N and P Proteins as a Key Step in Sendai Virus Gene Expression". Journal of Virology. 81 (24): 13835–13844. doi:10.1128/jvi.00914-07. ISSN 0022-538X. PMC 2168830. PMID 17855540.
Latorre P, Kolakofsky D, Curran J (September 1998). "Sendai virus Y proteins are initiated by a ribosomal shunt". Molecular and Cellular Biology. 18 (9): 5021–31. doi:10.1128/mcb.18.9.5021. PMC 109087. PMID 9710586.
Harrison MS, Sakaguchi T, Schmitt AP (September 2010). "Paramyxovirus assembly and budding: building particles that transmit infections". The International Journal of Biochemistry & Cell Biology. 42 (9): 1416–1429. doi:10.1016/j.biocel.2010.04.005. PMC 2910131. PMID 20398786.
Miazza V, Mottet-Osman G, Startchick S, Chaponnier C, Roux L (February 2011). "Sendai virus induced cytoplasmic actin remodeling correlates with efficient virus particle production". Virology. 410 (1): 7–16. doi:10.1016/j.virol.2010.10.003. PMID 21075412.
Ito M, Takeuchi T, Nishio M, Kawano M, Komada H, Tsurudome M, et al. (November 2004). "Early stage of establishment of persistent Sendai virus infection: unstable dynamic phase and then selection of viruses which are tightly cell associated, temperature sensitive, and capable of establishing persistent infection". Journal of Virology. 78 (21): 11939–11951. doi:10.1128/JVI.78.21.11939-11951.2004. PMC 523293. PMID 15479834.
Coakley C, Peter C, Fabry S, Chattopadhyay S (August 2017). "Establishment of a Human Cell Line Persistently Infected with Sendai Virus". Bio-Protocol. 7 (16): e2512. doi:10.21769/BioProtoc.2512. PMC 8413619. PMID 34541174.
Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Yamashita M, Sen GC (January 2013). "Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus". Journal of Virology. 87 (1): 16–24. doi:10.1128/JVI.01853-12. PMC 3536409. PMID 23077293.
Mercado-López X, Cotter CR, Kim WK, Sun Y, Muñoz L, Tapia K, et al. (November 2013). "Highly immunostimulatory RNA derived from a Sendai virus defective viral genome". Vaccine. 31 (48): 5713–5721. doi:10.1016/j.vaccine.2013.09.040. PMC 4406099. PMID 24099876.
Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, et al. (October 2017). "Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence". Nature Communications. 8 (1): 799. Bibcode:2017NatCo...8..799X. doi:10.1038/s41467-017-00909-6. PMC 5630589. PMID 28986577.
Genoyer E, López CB (February 2019). "Defective Viral Genomes Alter How Sendai Virus Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production of Viral Particles among Infected Cells". Journal of Virology. 93 (4). doi:10.1128/JVI.01579-18. PMC 6364009. PMID 30463965.
Pablo-Maiso L, Echeverría I, Rius-Rocabert S, Luján L, Garcin D, Andrés D, et al. (April 2020). "Sendai Virus, a Strong Inducer of Anti-Lentiviral State in Ovine Cells". Vaccines. 8 (2): 206. doi:10.3390/vaccines8020206. PMC 7349755. PMID 32365702.
Faísca P, Desmecht D (February 2007). "Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date". Research in Veterinary Science. 82 (1): 115–125. doi:10.1016/j.rvsc.2006.03.009. PMID 16759680.
Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA (March 2011). "Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus". Journal of Virology. 85 (6): 2771–80. doi:10.1128/JVI.02065-10. PMC 3067931. PMID 21228237.
Hoekstra D, Klappe K, Hoff H, Nir S (April 1989). "Mechanism of fusion of Sendai virus: role of hydrophobic interactions and mobility constraints of viral membrane proteins. Effects of polyethylene glycol". The Journal of Biological Chemistry. 264 (12): 6786–92. doi:10.1016/S0021-9258(18)83498-6. PMID 2540161.
Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A (December 2002). "Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion". Journal of Virology. 76 (24): 13028–33. doi:10.1128/JVI.76.24.13028-13033.2002. PMC 136693. PMID 12438628.
Novick SL, Hoekstra D (October 1988). "Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labeling". Proceedings of the National Academy of Sciences of the United States of America. 85 (20): 7433–7. Bibcode:1988PNAS...85.7433N. doi:10.1073/pnas.85.20.7433. PMC 282205. PMID 2845406.
Chandra S, Kalaivani R, Kumar M, Srinivasan N, Sarkar DP (December 2017). Bassereau P (ed.). "Sendai virus recruits cellular villin to remodel actin cytoskeleton during fusion with hepatocytes". Molecular Biology of the Cell. 28 (26): 3801–3814. doi:10.1091/mbc.e17-06-0400. PMC 5739296. PMID 29074568.
Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melén K, Julkunen I (October 1999). "Impaired antiviral response in human hepatoma cells". Virology. 263 (2): 364–75. doi:10.1006/viro.1999.9983. PMID 10544109.
Shah NR, Sunderland A, Grdzelishvili VZ (June 2010). "Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin". PLOS ONE. 5 (6): e11265. Bibcode:2010PLoSO...511265S. doi:10.1371/journal.pone.0011265. PMC 2889835. PMID 20582319.
Sumpter R, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. (March 2005). "Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I". Journal of Virology. 79 (5): 2689–99. doi:10.1128/JVI.79.5.2689-2699.2005. PMC 548482. PMID 15708988.
Lallemand C, Blanchard B, Palmieri M, Lebon P, May E, Tovey MG (January 2007). "Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB". Oncogene. 26 (3): 328–38. doi:10.1038/sj.onc.1209795. PMID 16832344. S2CID 25830890.
Buggele WA, Horvath CM (August 2013). "MicroRNA profiling of Sendai virus-infected A549 cells identifies miR-203 as an interferon-inducible regulator of IFIT1/ISG56". Journal of Virology. 87 (16): 9260–70. doi:10.1128/JVI.01064-13. PMC 3754065. PMID 23785202.
Espada CE, Sari L, Cahill MP, Yang H, Phillips S, Martinez N, et al. (July 2023). "SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection". The Journal of Biological Chemistry. 299 (7): 104925. doi:10.1016/j.jbc.2023.104925. PMC 10404699. PMID 37328105.
Belova AA, Sosnovtseva AO, Lipatova AV, Njushko KM, Volchenko NN, Belyakov MM, et al. (2017-01-01). "[Biomarkers of prostate cancer sensitivity to the Sendai virus]". Molekuliarnaia Biologiia. 51 (1): 94–103. doi:10.1134/S0026893317010046. PMID 28251971. S2CID 34514102.
Itoh M, Wang XL, Suzuki Y, Homma M (September 1992). "Mutation of the HANA protein of Sendai virus by passage in eggs". Virology. 190 (1): 356–64. doi:10.1016/0042-6822(92)91222-g. PMID 1326808.
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV (2019). "Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes". Oncolytic Virotherapy. 8: 9–26. doi:10.2147/OV.S176523. PMC 6636189. PMID 31372363.
Sakaguchi T, Kiyotani K, Sakaki M, Fujii Y, Yoshida T (March 1994). "A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains". Archives of Virology. 135 (1–2): 159–64. doi:10.1007/bf01309773. PMID 8198441. S2CID 12180965.
Itoh M, Isegawa Y, Hotta H, Homma M (December 1997). "Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells". The Journal of General Virology. 78 (12): 3207–15. doi:10.1099/0022-1317-78-12-3207. PMID 9400971.
Kiyotani K, Takao S, Sakaguchi T, Yoshida T (July 1990). "Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity". Virology. 177 (1): 65–74. doi:10.1016/0042-6822(90)90460-9. PMID 2162116.
Zhdanov VM, Bukrinskaya AG (1961). "Autoradiographic study of the penetration of Sendai virus into tissue culture cells. I. Preparation of Sendai virus labelled with radioactive isotopes". Problems of Virology. 6: 588–93. PMID 14040447.
Kiyotani K, Sakaguchi T, Fujii Y, Yoshida T (2001). "Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells". Archives of Virology. 146 (5): 893–908. doi:10.1007/s007050170123. PMID 11448028. S2CID 21947750.
Kolakofsky D (August 1976). "Isolation and characterization of Sendai virus DI-RNAs". Cell. 8 (4): 547–555. doi:10.1016/0092-8674(76)90223-3. PMID 182384. S2CID 32399729.
Kolakofsky D (March 1979). "Studies on the generation and amplification of sendai virus defective-interfering genomes". Virology. 93 (2): 589–593. doi:10.1016/0042-6822(79)90263-0. PMID 222059.
Killip MJ, Young DF, Gatherer D, Ross CS, Short JA, Davison AJ, et al. (May 2013). "Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction". Journal of Virology. 87 (9): 4798–4807. doi:10.1128/JVI.03383-12. PMC 3624313. PMID 23449801.
Yoshida A, Kawabata R, Honda T, Sakai K, Ami Y, Sakaguchi T, et al. (March 2018). "A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes". Journal of Virology. 92 (5). doi:10.1128/JVI.02094-17. PMC 5809723. PMID 29237838.
Strahle L, Garcin D, Kolakofsky D (July 2006). "Sendai virus defective-interfering genomes and the activation of interferon-beta". Virology. 351 (1): 101–111. doi:10.1016/j.virol.2006.03.022. PMID 16631220.
Sánchez-Aparicio MT, Garcin D, Rice CM, Kolakofsky D, García-Sastre A, Baum A (June 2017). "Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA". The Journal of General Virology. 98 (6): 1282–1293. doi:10.1099/jgv.0.000815. PMC 5962894. PMID 28631605.
Tatsumoto N, Arditi M, Yamashita M (September 2018). "Sendai Virus Propagation Using Chicken Eggs". Bio-Protocol. 8 (18). doi:10.21769/BioProtoc.3009. PMC 6200407. PMID 30370318.
Pappas C, Matsuoka Y, Swayne DE, Donis RO (November 2007). "Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness". Clinical and Vaccine Immunology. 14 (11): 1425–1432. doi:10.1128/CVI.00174-07. PMC 2168170. PMID 17913860.
Tatsumoto N, Miyauchi T, Arditi M, Yamashita M (November 2018). "Quantification of Infectious Sendai Virus Using Plaque Assay". Bio-Protocol. 8 (21). doi:10.21769/BioProtoc.3068. PMC 6289198. PMID 30547053.
Killian ML (2008). "Hemagglutination Assay for the Avian Influenza Virus". Avian Influenza Virus. Methods in Molecular Biology. Vol. 436. Totowa, NJ: Humana Press. pp. 47–52. doi:10.1007/978-1-59745-279-3_7. ISBN 978-1-58829-939-0. PMID 18370040.

ncbi.nlm.nih.gov

Saga K, Kaneda Y (2015). "Oncolytic Sendai virus-based virotherapy for cancer: recent advances". Oncolytic Virotherapy. 4: 141–7. doi:10.2147/OV.S66419. PMC 4918391. PMID 27512677.
Matveeva OV, Kochneva GV, Netesov SV, Onikienko SB, Chumakov PM (April 2015). "Mechanisms of Oncolysis by Paramyxovirus Sendai". Acta Naturae. 7 (2): 6–16. doi:10.32607/20758251-2015-7-2-6-16. PMC 4463408. PMID 26085940. Material was copied from this source, which is available under a Creative Commons Attribution License.
Ilyinskaya GV, Mukhina EV, Soboleva AV, Matveeva OV, Chumakov PM (2018). "Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)". Frontiers in Veterinary Science. 5: 116. doi:10.3389/fvets.2018.00116. PMC 5995045. PMID 29915788.
Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009). "Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 85 (8): 348–62. Bibcode:2009PJAB...85..348F. doi:10.2183/pjab.85.348. PMC 3621571. PMID 19838014.
Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. (August 2011). "Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors". Proceedings of the National Academy of Sciences of the United States of America. 108 (34): 14234–9. Bibcode:2011PNAS..10814234B. doi:10.1073/pnas.1103509108. PMC 3161531. PMID 21821793.
Russell CJ, Hurwitz JL (2015-12-09). "Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses". Expert Review of Vaccines. 15 (2): 189–200. doi:10.1586/14760584.2016.1114418. PMC 4957581. PMID 26648515.
Russell CJ, Hurwitz JL (May 2021). "Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses". Viruses. 13 (6): 1023. doi:10.3390/v13061023. PMC 8230104. PMID 34072332.
Scaggs Huang F, Bernstein DI, Slobod KS, Portner A, Takimoto T, Russell CJ, et al. (February 2021). "Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults". Human Vaccines & Immunotherapeutics. 17 (2): 554–559. doi:10.1080/21645515.2020.1779517. PMC 7899675. PMID 32750273.
Nyombayire J, Anzala O, Gazzard B, Karita E, Bergin P, Hayes P, et al. (January 2017). "First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens". The Journal of Infectious Diseases. 215 (1): 95–104. doi:10.1093/infdis/jiw500. PMC 5225252. PMID 28077588.
Nicklas W, Bleich A, Mähler M (2012-01-01). "Chapter 3.2 - Viral Infections of Laboratory Mice". In Hedrich HJ (ed.). The Laboratory Mouse (Second ed.). Academic Press. pp. 427–480. doi:10.1016/B978-0-12-382008-2.00019-2. ISBN 9780123820082. PMC 7150319.
López CB, Yount JS, Hermesh T, Moran TM (May 2006). "Sendai virus infection induces efficient adaptive immunity independently of type I interferons". Journal of Virology. 80 (9): 4538–4545. doi:10.1128/JVI.80.9.4538-4545.2006. PMC 1472017. PMID 16611914.
Burke CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, et al. (July 2011). "Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy". PLOS Pathogens. 7 (7): e1002134. doi:10.1371/journal.ppat.1002134. PMC 3131265. PMID 21750677.
Parker JC, Whiteman MD, Richter CB (January 1978). "Susceptibility of inbred and outbred mouse strains to Sendai virus and prevalence of infection in laboratory rodents". Infection and Immunity. 19 (1): 123–30. doi:10.1128/IAI.19.1.123-130.1978. PMC 414057. PMID 203530.
Irie T, Nagata N, Igarashi T, Okamoto I, Sakaguchi T (May 2010). "Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses". PLOS ONE. 5 (5): e10719. Bibcode:2010PLoSO...510719I. doi:10.1371/journal.pone.0010719. PMC 2873429. PMID 20502666.
Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y (April 2001). "Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis". Journal of Virology. 75 (8): 3802–10. doi:10.1128/JVI.75.8.3802-3810.2001. PMC 114871. PMID 11264369.
Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE, et al. (September 2022). "IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation". Proceedings of the National Academy of Sciences of the United States of America. 119 (37): e2121385119. Bibcode:2022PNAS..11921385P. doi:10.1073/pnas.2121385119. PMC 9478676. PMID 36067309.
Irie T, Yoshida A, Sakaguchi T (2013-08-09). "Clustered basic amino acids of the small sendai virus C protein Y1 are critical to its RAN GTPase-mediated nuclear localization". PLOS ONE. 8 (8): e73740. Bibcode:2013PLoSO...873740I. doi:10.1371/journal.pone.0073740. PMC 3739745. PMID 23951363.
Oda K, Matoba Y, Irie T, Kawabata R, Fukushi M, Sugiyama M, et al. (November 2015). "Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein". Journal of Virology. 89 (22): 11487–99. doi:10.1128/JVI.01887-15. PMC 4645678. PMID 26339056.
Oda K, Oda T, Matoba Y, Sato M, Irie T, Sakaguchi T (December 2017). "Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling". The Journal of Biological Chemistry. 292 (48): 19752–19766. doi:10.1074/jbc.m117.786285. PMC 5712616. PMID 28978648.
Odkhuu E, Komatsu T, Koide N, Naiki Y, Takeuchi K, Tanaka Y, et al. (October 2018). "Sendai virus C protein limits NO production in infected RAW264.7 macrophages". Innate Immunity. 24 (7): 430–438. doi:10.1177/1753425918796619. PMC 6830875. PMID 30189760.
Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B (October 2008). "Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA". Journal of Virology. 82 (20): 10102–10. doi:10.1128/JVI.00599-08. PMC 2566265. PMID 18684815.
Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, et al. (December 2004). "The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter". Proceedings of the National Academy of Sciences of the United States of America. 101 (49): 17264–9. Bibcode:2004PNAS..10117264A. doi:10.1073/pnas.0407639101. PMC 535396. PMID 15563593.
Sánchez-Aparicio MT, Feinman LJ, García-Sastre A, Shaw ML (March 2018). "Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling". Journal of Virology. 92 (6). doi:10.1128/JVI.01960-17. PMC 5827389. PMID 29321315.
Komatsu T, Tanaka Y, Kitagawa Y, Koide N, Naiki Y, Morita N, et al. (October 2018). "Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly". Journal of Virology. 92 (19): e00842–18. doi:10.1128/JVI.00842-18. PMC 6146803. PMID 30021903.
Odkhuu E, Komatsu T, Koide N, Naiki Y, Takeuchi K, Tanaka Y, et al. (October 2018). "Sendai virus C protein limits NO production in infected RAW264.7 macrophages". Innate Immunity. 24 (7): 430–438. doi:10.1177/1753425918796619. PMC 6830875. PMID 30189760.
Qiao D, Janke BH, Elankumaran S (January 2010). "Complete genome sequence and pathogenicity of two swine parainfluenzavirus 3 isolates from pigs in the United States". Journal of Virology. 84 (2): 686–94. doi:10.1128/JVI.00847-09. PMC 2798373. PMID 19906928.
Adderson E, Branum K, Sealy RE, Jones BG, Surman SL, Penkert R, et al. (March 2015). "Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children". Clinical and Vaccine Immunology. 22 (3): 298–303. doi:10.1128/CVI.00618-14. PMC 4340902. PMID 25552633.
Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, et al. (April 2000). "The IRF-3 transcription factor mediates Sendai virus-induced apoptosis". Journal of Virology. 74 (8): 3781–92. doi:10.1128/jvi.74.8.3781-3792.2000. PMC 111887. PMID 10729153.
Lappalainen J, Rintahaka J, Kovanen PT, Matikainen S, Eklund KK (April 2013). "Intracellular RNA recognition pathway activates strong anti-viral response in human mast cells". Clinical and Experimental Immunology. 172 (1): 121–8. doi:10.1111/cei.12042. PMC 3719938. PMID 23480192.
Neerincx A, Lautz K, Menning M, Kremmer E, Zigrino P, Hösel M, et al. (August 2010). "A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses". The Journal of Biological Chemistry. 285 (34): 26223–32. doi:10.1074/jbc.M110.109736. PMC 2924034. PMID 20538593.
Mikkelsen SS, Jensen SB, Chiliveru S, Melchjorsen J, Julkunen I, Gaestel M, et al. (April 2009). "RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells: dependence on TRAF2 and TAK1". The Journal of Biological Chemistry. 284 (16): 10774–10782. doi:10.1074/jbc.M807272200. PMC 2667765. PMID 19224920.
Gitlin L, Benoit L, Song C, Cella M, Gilfillan S, Holtzman MJ, et al. (January 2010). "Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo". PLOS Pathogens. 6 (1): e1000734. doi:10.1371/journal.ppat.1000734. PMC 2809771. PMID 20107606.
Nyman TA, Tölö H, Parkkinen J, Kalkkinen N (January 1998). "Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes". The Biochemical Journal. 329 (Pt 2): 295–302. doi:10.1042/bj3290295. PMC 1219044. PMID 9425112.
Génin P, Lin R, Hiscott J, Civas A (2012). "Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression". PLOS ONE. 7 (6): e38336. Bibcode:2012PLoSO...738336G. doi:10.1371/journal.pone.0038336. PMC 3369917. PMID 22685561.
Mandhana R, Horvath CM (November 2018). "Sendai Virus Infection Induces Expression of Novel RNAs in Human Cells". Scientific Reports. 8 (1): 16815. Bibcode:2018NatSR...816815M. doi:10.1038/s41598-018-35231-8. PMC 6235974. PMID 30429577.
Kiener R, Fleischmann M, Wiegand MA, Lemmermann NA, Schwegler C, Kaufmann C, et al. (August 2018). "Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors". Journal of Virology. 92 (15). doi:10.1128/JVI.00569-18. PMC 6052310. PMID 29769344.
Donnelly RP, Kotenko SV (August 2010). "Interferon-lambda: a new addition to an old family". Journal of Interferon & Cytokine Research. 30 (8): 555–64. doi:10.1089/jir.2010.0078. PMC 2925029. PMID 20712453.
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, et al. (September 2012). "Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells". Journal of Immunology. 189 (6): 2735–45. doi:10.4049/jimmunol.1102038. PMC 3579503. PMID 22891284.
Reinert LS, Harder L, Holm CK, Iversen MB, Horan KA, Dagnæs-Hansen F, et al. (April 2012). "TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice". The Journal of Clinical Investigation. 122 (4): 1368–76. doi:10.1172/JCI60893. PMC 3314467. PMID 22426207.
Ito Y, Hosaka Y (March 1983). "Component(s) of Sendai virus that can induce interferon in mouse spleen cells". Infection and Immunity. 39 (3): 1019–23. doi:10.1128/IAI.39.3.1019-1023.1983. PMC 348058. PMID 6301988.
Subramanian G, Kuzmanovic T, Zhang Y, Peter CB, Veleeparambil M, Chakravarti R, et al. (January 2018). "A new mechanism of interferon's antiviral action: Induction of autophagy, essential for paramyxovirus replication, is inhibited by the interferon stimulated gene, TDRD7". PLOS Pathogens. 14 (1): e1006877. doi:10.1371/journal.ppat.1006877. PMC 5806901. PMID 29381763.
Wetzel JL, Fensterl V, Sen GC (December 2014). "Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon". Journal of Virology. 88 (23): 13593–601. doi:10.1128/JVI.02201-14. PMC 4248979. PMID 25231314.
Peters K, Chattopadhyay S, Sen GC (April 2008). "IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence". Journal of Virology. 82 (7): 3500–8. doi:10.1128/JVI.02536-07. PMC 2268502. PMID 18216110.
Li S, Nishikawa T, Kaneda Y (December 2017). "Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells". Cancer Science. 108 (12): 2333–2341. doi:10.1111/cas.13408. PMC 5715349. PMID 28945328.
Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T, et al. (October 2013). "The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity". Journal of Immunology. 191 (8): 4358–66. doi:10.4049/jimmunol.1301170. PMC 3848201. PMID 24048902.
Subramanian N, Natarajan K, Clatworthy MR, Wang Z, Germain RN (April 2013). "The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation". Cell. 153 (2): 348–61. doi:10.1016/j.cell.2013.02.054. PMC 3632354. PMID 23582325.
Ryan LK, Diamond G (June 2017). "Modulation of Human β-Defensin-1 Production by Viruses". Viruses. 9 (6): 153. doi:10.3390/v9060153. PMC 5490828. PMID 28635669.
Ryan LK, Dai J, Yin Z, Megjugorac N, Uhlhorn V, Yim S, et al. (August 2011). "Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity". Journal of Leukocyte Biology. 90 (2): 343–56. doi:10.1189/jlb.0209079. PMC 3133436. PMID 21551252.
Nakanishi M, Otsu M (October 2012). "Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine". Current Gene Therapy. 12 (5): 410–6. doi:10.2174/156652312802762518. PMC 3504922. PMID 22920683.
Russell CJ, Hurwitz JL (May 2021). "Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses". Viruses. 13 (6): 1023. doi:10.3390/v13061023. PMC 8230104. PMID 34072332.
Zimmermann M, Armeanu-Ebinger S, Bossow S, Lampe J, Smirnow I, Schenk A, et al. (2014). "Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors". PLOS ONE. 9 (3): e90508. Bibcode:2014PLoSO...990508Z. doi:10.1371/journal.pone.0090508. PMC 3944018. PMID 24598703.
Fujihara A, Kurooka M, Miki T, Kaneda Y (January 2008). "Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation". Cancer Immunology, Immunotherapy. 57 (1): 73–84. doi:10.1007/s00262-007-0351-y. PMC 11030187. PMID 17602226. S2CID 8779015.
Nishikawa T, Tung LY, Kaneda Y (December 2014). "Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice". Molecular Therapy. 22 (12): 2046–55. doi:10.1038/mt.2014.128. PMC 4429689. PMID 25023327.
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV (July 2019). "Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes". Oncolytic Virotherapy. 8: 9–26. doi:10.2147/ov.s176523. PMC 6636189. PMID 31372363.
Zainutdinov SS, Tikunov AY, Matveeva OV, Netesov SV, Kochneva GV (August 2016). "Complete Genome Sequence of the Oncolytic Sendai virus Strain Moscow". Genome Announcements. 4 (4). doi:10.1128/genomeA.00818-16. PMC 4982289. PMID 27516510.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, et al. (June 2020). "Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study". Cancer Immunology, Immunotherapy. 69 (6): 1131–1140. doi:10.1007/s00262-020-02509-8. PMC 11027698. PMID 32047956. S2CID 211074332.
Matveeva OV, Chumakov PM (November 2018). "Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses". Reviews in Medical Virology. 28 (6): e2008. doi:10.1002/rmv.2008. PMC 6906582. PMID 30209859.
Liang JX, Liang Y, Gao W (May 2016). "Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis". OncoTargets and Therapy. 9: 3113–25. doi:10.2147/ott.s102389. PMC 4888715. PMID 27307752.
Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ (2018-05-11). "Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy". Frontiers in Oncology. 8: 150. doi:10.3389/fonc.2018.00150. PMC 5958677. PMID 29795807.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–73. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Markwell MA, Portner A, Schwartz AL (February 1985). "An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein". Proceedings of the National Academy of Sciences of the United States of America. 82 (4): 978–82. Bibcode:1985PNAS...82..978M. doi:10.1073/pnas.82.4.978. PMC 397176. PMID 2983337.
Bitzer M, Lauer U, Baumann C, Spiegel M, Gregor M, Neubert WJ (July 1997). "Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry". Journal of Virology. 71 (7): 5481–6. doi:10.1128/JVI.71.7.5481-5486.1997. PMC 191789. PMID 9188621.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–1783. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698. S2CID 17515010.
Cuello HA, Ferreira GM, Gulino CA, Toledo AG, Segatori VI, Gabri MR (December 2020). "Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma". Oncotarget. 11 (52): 4822–4835. doi:10.18632/oncotarget.27850. PMC 7779250. PMID 33447350.
Son MJ, Woolard K, Nam DH, Lee J, Fine HA (May 2009). "SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma". Cell Stem Cell. 4 (5): 440–452. doi:10.1016/j.stem.2009.03.003. PMC 7227614. PMID 19427293.
Mao XG, Zhang X, Xue XY, Guo G, Wang P, Zhang W, et al. (December 2009). "Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15". Translational Oncology. 2 (4): 247–257. doi:10.1593/tlo.09136. PMC 2781066. PMID 19956386.
Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J, et al. (February 2010). "CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors". BMC Cancer. 10 (1): 66. doi:10.1186/1471-2407-10-66. PMC 2841664. PMID 20181261.
Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, et al. (February 2009). "Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma". Cancer Cell. 15 (2): 135–147. doi:10.1016/j.ccr.2008.12.016. PMC 2664097. PMID 19185848.
Singh AR, Joshi S, Zulcic M, Alcaraz M, Garlich JR, Morales GA, et al. (2016-03-03). Castresana JS (ed.). "PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma". PLOS ONE. 11 (3): e0150836. Bibcode:2016PLoSO..1150836S. doi:10.1371/journal.pone.0150836. PMC 4777592. PMID 26938241.
Yamadera M, Shinto E, Tsuda H, Kajiwara Y, Naito Y, Hase K, et al. (January 2018). "Sialyl Lewis^x expression at the invasive front as a predictive marker of liver recurrence in stage II colorectal cancer". Oncology Letters. 15 (1): 221–228. doi:10.3892/ol.2017.7340. PMC 5769389. PMID 29391881.
Trinchera M, Aronica A, Dall'Olio F (February 2017). "Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers". Biology. 6 (1): 16. doi:10.3390/biology6010016. PMC 5372009. PMID 28241499.
Liang JX, Liang Y, Gao W (2016). "Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis". OncoTargets and Therapy. 9: 3113–3125. doi:10.2147/OTT.S102389. PMC 4888715. PMID 27307752.
Liang YJ, Ding Y, Levery SB, Lobaton M, Handa K, Hakomori SI (March 2013). "Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells". Proceedings of the National Academy of Sciences of the United States of America. 110 (13): 4968–4973. Bibcode:2013PNAS..110.4968L. doi:10.1073/pnas.1302825110. PMC 3612608. PMID 23479608.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–83. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698.
Trinchera M, Aronica A, Dall'Olio F (February 2017). "Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers". Biology. 6 (1): 16. doi:10.3390/biology6010016. PMC 5372009. PMID 28241499.
Vandermeersch S, Vanbeselaere J, Delannoy CP, Drolez A, Mysiorek C, Guérardel Y, et al. (April 2015). "Accumulation of GD1α Ganglioside in MDA-MB-231 Breast Cancer Cells Expressing ST6GalNAc V". Molecules. 20 (4): 6913–24. doi:10.3390/molecules20046913. PMC 6272744. PMID 25913930.
Chandrasekaran EV, Xue J, Xia J, Locke RD, Patil SA, Neelamegham S, et al. (November 2011). "Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides". Biochemistry. 50 (44): 9475–87. doi:10.1021/bi200301w. PMC 3206213. PMID 21913655.
Katopodis P, Anikin V, Randeva HS, Spandidos DA, Chatha K, Kyrou I, et al. (August 2020). "Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19". International Journal of Oncology. 57 (2): 533–539. doi:10.3892/ijo.2020.5071. PMC 7307597. PMID 32468052.
Xiao H, He M, Xie G, Liu Y, Zhao Y, Ye X, et al. (October 2019). "The release of tryptase from mast cells promote tumor cell metastasis via exosomes". BMC Cancer. 19 (1): 1015. doi:10.1186/s12885-019-6203-2. PMC 6819443. PMID 31664930.
Bedsaul JR, Zaritsky LA, Zoon KC (November 2016). "Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection". Journal of Interferon & Cytokine Research. 36 (11): 652–665. doi:10.1089/jir.2016.0051. PMC 5105340. PMID 27508859.
Schock SN, Chandra NV, Sun Y, Irie T, Kitagawa Y, Gotoh B, et al. (April 2017). "Induction of necroptotic cell death by viral activation of the RIG-I or STING pathway". Cell Death and Differentiation. 24 (4): 615–625. doi:10.1038/cdd.2016.153. PMC 5384020. PMID 28060376.
Goto H, Ohta K, Matsumoto Y, Yumine N, Nishio M (September 2016). López S (ed.). "Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference". Journal of Virology. 90 (17): 7640–7646. doi:10.1128/JVI.01087-16. ISSN 0022-538X. PMC 4988132. PMID 27279623.
Miyara M, Chader D, Sage E, Sugiyama D, Nishikawa H, Bouvry D, et al. (2015-06-09). "Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans". Proceedings of the National Academy of Sciences. 112 (23): 7225–7230. doi:10.1073/pnas.1508224112. ISSN 0027-8424. PMC 4466753. PMID 26015572.
Altomonte J, Marozin S, Schmid RM, Ebert O (February 2010). "Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma". Molecular Therapy. 18 (2): 275–84. doi:10.1038/mt.2009.231. PMC 2839313. PMID 19809404.
Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. (December 2007). "Interferons at age 50: past, current and future impact on biomedicine". Nature Reviews. Drug Discovery. 6 (12): 975–90. doi:10.1038/nrd2422. PMC 7097588. PMID 18049472. S2CID 583709.
Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C, et al. (April 2000). "Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach". The American Journal of Pathology. 156 (4): 1381–93. doi:10.1016/S0002-9440(10)65007-9. PMC 1876903. PMID 10751362.
Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S (July 1980). "Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line". Proceedings of the National Academy of Sciences of the United States of America. 77 (7): 4336–9. Bibcode:1980PNAS...77.4336P. doi:10.1073/pnas.77.7.4336. PMC 349829. PMID 6933486.
Bossart KN, Fusco DL, Broder CC (2013). "Paramyxovirus Entry". Viral Entry into Host Cells. Advances in Experimental Medicine and Biology. Vol. 790. New York, NY: Springer. pp. 95–127. doi:10.1007/978-1-4614-7651-1_6. ISBN 978-1-4614-7650-4. PMC 8782154. PMID 23884588.
Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, et al. (August 2009). "Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase". Journal of Virology. 83 (16): 8108–21. doi:10.1128/JVI.00211-09. PMC 2715740. PMID 19515783.
Kato T, Ueda Y, Kinoh H, Yoneyama Y, Matsunaga A, Komaru A, et al. (November 2010). "RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer". Neoplasia. 12 (11): 906–914. doi:10.1593/neo.10732. PMC 2978913. PMID 21076616.
Edgar LJ, Thompson AJ, Vartabedian VF, Kikuchi C, Woehl JL, Teijaro JR, et al. (September 2021). "Sialic Acid Ligands of CD28 Suppress Costimulation of T Cells". ACS Central Science. 7 (9): 1508–1515. doi:10.1021/acscentsci.1c00525. PMC 8461770. PMID 34584952.
Silva M, Silva Z, Marques G, Ferro T, Gonçalves M, Monteiro M, et al. (July 2016). "Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses". Oncotarget. 7 (27): 41053–41066. doi:10.18632/oncotarget.9419. ISSN 1949-2553. PMC 5173042. PMID 27203391.
Balneger N, Cornelissen LA, Wassink M, Moons SJ, Boltje TJ, Bar-Ephraim YE, et al. (February 2022). "Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions". Cellular and Molecular Life Sciences. 79 (2): 98. doi:10.1007/s00018-021-04027-x. ISSN 1420-682X. PMC 8799591. PMID 35089436.
Han GZ, Worobey M (August 2011). "Homologous recombination in negative sense RNA viruses". Viruses. 3 (8): 1358–1373. doi:10.3390/v3081358. PMC 3185808. PMID 21994784.
Ikegame S, Beaty SM, Stevens C, Won T, Park A, Sachs D, et al. (October 2020). Lowen AC (ed.). "Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticity". PLOS Pathogens. 16 (10): e1008877. doi:10.1371/journal.ppat.1008877. PMC 7577504. PMID 33035269.
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (December 1995). "A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus". The EMBO Journal. 14 (24): 6087–94. doi:10.1002/j.1460-2075.1995.tb00299.x. PMC 394733. PMID 8557028.
Pfaller CK, Cattaneo R, Schnell MJ (May 2015). "Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics". Virology. 60th Anniversary Issue. 479: 331–344. doi:10.1016/j.virol.2015.01.029. PMC 4557643. PMID 25702088.
Beaty SM, Park A, Won ST, Hong P, Lyons M, Vigant F, et al. (March 2017). "Paramyxoviridae Reverse Genetics Systems". mSphere. 2 (2). doi:10.1128/mSphere.00376-16. PMC 5371697. PMID 28405630.
Inoue M, Tokusumi Y, Ban H, Kanaya T, Shirakura M, Tokusumi T, et al. (June 2003). "A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading". Journal of Virology. 77 (11): 6419–6429. doi:10.1128/JVI.77.11.6419-6429.2003. PMC 155001. PMID 12743299.
Mostafa HH, Vogel P, Srinivasan A, Russell CJ (September 2016). "Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone". PLOS Pathogens. 12 (9): e1005875. doi:10.1371/journal.ppat.1005875. PMC 5010285. PMID 27589232.
Chambers R, Takimoto T (June 2010). "Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles". PLOS ONE. 5 (6): e10994. Bibcode:2010PLoSO...510994C. doi:10.1371/journal.pone.0010994. PMC 2881874. PMID 20543880.
Villenave R, Touzelet O, Thavagnanam S, Sarlang S, Parker J, Skibinski G, et al. (November 2010). "Cytopathogenesis of Sendai virus in well-differentiated primary pediatric bronchial epithelial cells". Journal of Virology. 84 (22): 11718–28. doi:10.1128/JVI.00798-10. PMC 2977906. PMID 20810726.
Strähle L, Marq JB, Brini A, Hausmann S, Kolakofsky D, Garcin D (November 2007). "Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins". Journal of Virology. 81 (22): 12227–37. doi:10.1128/JVI.01300-07. PMC 2169027. PMID 17804509.
Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA (March 2011). "Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus". Journal of Virology. 85 (6): 2771–80. doi:10.1128/jvi.02065-10. PMC 3067931. PMID 21228237.
Rawling J, García-Barreno B, Melero JA (June 2008). "Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity". Journal of Virology. 82 (12): 5986–98. doi:10.1128/jvi.00078-08. PMC 2395136. PMID 18385247.
Park A, Hong P, Won ST, Thibault PA, Vigant F, Oguntuyo KY, et al. (2016-08-24). "Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing". Molecular Therapy: Methods & Clinical Development. 3: 16057. doi:10.1038/mtm.2016.57. PMC 4996130. PMID 27606350.
Corral T, Ver LS, Mottet G, Cano O, García-Barreno B, Calder LJ, et al. (April 2007). "High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system". BMC Biotechnology. 7 (1): 17. doi:10.1186/1472-6750-7-17. PMC 1852797. PMID 17411439.
Grygoryev D, Ekstrom T, Manalo E, Link JM, Alshaikh A, Keith D, et al. (March 2024). "Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells". Heliyon. 10 (5): e27221. Bibcode:2024Heliy..1027221G. doi:10.1016/j.heliyon.2024.e27221. PMC 10923719. PMID 38463758.
Fujie Y, Fusaki N, Katayama T, Hamasaki M, Soejima Y, Soga M, et al. (2014-12-05). "New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood". PLOS ONE. 9 (12): e113052. Bibcode:2014PLoSO...9k3052F. doi:10.1371/journal.pone.0113052. PMC 4257541. PMID 25479600.
Okumura T, Horie Y, Lai CY, Lin HT, Shoda H, Natsumoto B, et al. (June 2019). "Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34⁺ cells using the auto-erasable Sendai virus vector". Stem Cell Research & Therapy. 10 (1): 185. doi:10.1186/s13287-019-1273-2. PMC 6591940. PMID 31234949.
Charlesworth CT, Nakauchi H (November 2022). "An optimized Sendai viral vector platform for reprogramming to naive pluripotency". Cell Reports Methods. 2 (11): 100349. doi:10.1016/j.crmeth.2022.100349. PMC 9701616. PMID 36452874.
Sano M, Nakasu A, Ohtaka M, Nakanishi M (December 2019). "A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs". Molecular Therapy. Methods & Clinical Development. 15: 371–382. doi:10.1016/j.omtm.2019.10.012. PMC 6889074. PMID 31828179.
Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, et al. (January 2012). "Sendai virus-based RSV vaccine protects African green monkeys from RSV infection". Vaccine. 30 (5): 959–68. doi:10.1016/j.vaccine.2011.11.046. PMC 3256274. PMID 22119594.
Zhan X, Slobod KS, Jones BG, Sealy RE, Takimoto T, Boyd K, et al. (May 2015). "Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats". International Immunology. 27 (5): 229–36. doi:10.1093/intimm/dxu107. PMC 4406265. PMID 25477211.
Hu Z, Gu L, Li CL, Shu T, Lowrie DB, Fan XY (2018). "The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine". Frontiers in Immunology. 9: 1796. doi:10.3389/fimmu.2018.01796. PMC 6085409. PMID 30123219.
Hu Z, Xia J, Wu J, Zhao H, Ji P, Gu L, et al. (December 2024). "A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis". Emerging Microbes & Infections. 13 (1): 2300463. doi:10.1080/22221751.2023.2300463. ISSN 2222-1751. PMC 10769537. PMID 38164736.
Travis CR (2020-09-30). "As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention". Frontiers in Immunology. 11: 591897. doi:10.3389/fimmu.2020.591897. PMC 7561361. PMID 33117404.
Sealy R, Jones BG, Surman SL, Hurwitz JL (September 2010). "Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1". Vaccine. 28 (41): 6749–6756. doi:10.1016/j.vaccine.2010.07.068. PMC 2950074. PMID 20682364.
Hu Z, Wong KW, Zhao HM, Wen HL, Ji P, Ma H, et al. (May 2017). "Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice". Molecular Therapy. 25 (5): 1222–1233. doi:10.1016/j.ymthe.2017.02.018. PMC 5417795. PMID 28342639.
Ishii H, Nomura T, Yamamoto H, Nishizawa M, Thu Hau TT, Harada S, et al. (February 2022). "Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8⁺ T cell responses". Cell Reports. Medicine. 3 (2): 100520. doi:10.1016/j.xcrm.2022.100520. PMC 8768424. PMID 35233545.
Azarm KD, Lee B (January 2020). "Differential Features of Fusion Activation within the Paramyxoviridae". Viruses. 12 (2): 161. doi:10.3390/v12020161. PMC 7077268. PMID 32019182.
Garcin D, Curran J, Itoh M, Kolakofsky D (August 2001). "Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response". Journal of Virology. 75 (15): 6800–7. doi:10.1128/JVI.75.15.6800-6807.2001. PMC 114406. PMID 11435558.
Curran J, Kolakofsky D (January 1988). "Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA". The EMBO Journal. 7 (1): 245–51. doi:10.1002/j.1460-2075.1988.tb02806.x. PMC 454264. PMID 2834203.
Dillon PJ, Gupta KC (February 1989). "Expression of five proteins from the Sendai virus P/C mRNA in infected cells". Journal of Virology. 63 (2): 974–7. doi:10.1128/JVI.63.2.974-977.1989. PMC 247778. PMID 2536120.
de Breyne S, Simonet V, Pelet T, Curran J (January 2003). "Identification of a cis-acting element required for shunt-mediated translational initiation of the Sendai virus Y proteins". Nucleic Acids Research. 31 (2): 608–18. doi:10.1093/nar/gkg143. PMC 140508. PMID 12527769.
Curran J, Kolakofsky D (September 1988). "Scanning independent ribosomal initiation of the Sendai virus X protein". The EMBO Journal. 7 (9): 2869–74. doi:10.1002/j.1460-2075.1988.tb03143.x. PMC 457080. PMID 2846286.
Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, et al. (July 2005). "AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding". Journal of Virology. 79 (14): 8933–41. doi:10.1128/JVI.79.14.8933-8941.2005. PMC 1168738. PMID 15994787.
Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H (December 1992). "Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity". Journal of Virology. 66 (12): 7211–6. doi:10.1128/JVI.66.12.7211-7216.1992. PMC 240423. PMID 1331518.
Abe M, Tahara M, Sakai K, Yamaguchi H, Kanou K, Shirato K, et al. (November 2013). "TMPRSS2 is an activating protease for respiratory parainfluenza viruses". Journal of Virology. 87 (21): 11930–5. doi:10.1128/JVI.01490-13. PMC 3807344. PMID 23966399.
Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y (December 1990). "An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo". The EMBO Journal. 9 (12): 4189–95. doi:10.1002/j.1460-2075.1990.tb07643.x. PMC 552195. PMID 2174359.
Ogasawara T, Gotoh B, Suzuki H, Asaka J, Shimokata K, Rott R, et al. (February 1992). "Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo". The EMBO Journal. 11 (2): 467–72. doi:10.1002/j.1460-2075.1992.tb05076.x. PMC 556476. PMID 1371460.
Lam A, Kirkland OO, Anderson PF, Seetharaman N, Vujovic D, Thibault PA, et al. (2021-11-23). "Single virus assay reveals membrane determinants and mechanistic features of Sendai virus binding". Biophysical Journal. 121 (6): 956–965. Bibcode:2022BpJ...121..956L. doi:10.1016/j.bpj.2022.02.011. PMC 8943810. PMID 35150620. S2CID 246715171.
Matveeva OV, Shabalina SA (December 2020). "Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy". Cancers. 12 (12): 3659. doi:10.3390/cancers12123659. PMC 7762160. PMID 33291506.
Holmgren J, Svennerholm L, Elwing H, Fredman P, Strannegård O (April 1980). "Sendai virus receptor: proposed recognition structure based on binding to plastic-adsorbed gangliosides". Proceedings of the National Academy of Sciences of the United States of America. 77 (4): 1947–50. Bibcode:1980PNAS...77.1947H. doi:10.1073/pnas.77.4.1947. PMC 348626. PMID 6246515.
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, et al. (May 2001). "Receptor specificities of human respiroviruses". Journal of Virology. 75 (10): 4604–13. doi:10.1128/JVI.75.10.4604-4613.2001. PMC 114213. PMID 11312330.
Suzuki T, Portner A, Scroggs RA, Uchikawa M, Koyama N, Matsuo K, et al. (May 2001). "Receptor specificities of human respiroviruses". Journal of Virology. 75 (10): 4604–13. doi:10.1128/jvi.75.10.4604-4613.2001. PMC 114213. PMID 11312330.
Chang A, Dutch RE (April 2012). "Paramyxovirus fusion and entry: multiple paths to a common end". Viruses. 4 (4): 613–36. doi:10.3390/v4040613. PMC 3347325. PMID 22590688.
Lamb RA, Jardetzky TS (August 2007). "Structural basis of viral invasion: lessons from paramyxovirus F". Current Opinion in Structural Biology. 17 (4): 427–36. doi:10.1016/j.sbi.2007.08.016. PMC 2086805. PMID 17870467.
Haywood AM (November 2010). "Membrane uncoating of intact enveloped viruses". Journal of Virology. 84 (21): 10946–55. doi:10.1128/JVI.00229-10. PMC 2953184. PMID 20668081.
Jardetzky TS, Lamb RA (April 2014). "Activation of paramyxovirus membrane fusion and virus entry". Current Opinion in Virology. 5: 24–33. doi:10.1016/j.coviro.2014.01.005. PMC 4028362. PMID 24530984.
Noton SL, Fearns R (May 2015). "Initiation and regulation of paramyxovirus transcription and replication". Virology. 479: 545–354. doi:10.1016/j.virol.2015.01.014. PMC 4424093. PMID 25683441.
Myers TM, Moyer SA (February 1997). "An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis". Journal of Virology. 71 (2): 918–24. doi:10.1128/JVI.71.2.918-924.1997. PMC 191139. PMID 8995608.
Wiegand MA, Bossow S, Schlecht S, Neubert WJ (2007-12-15). "De Novo Synthesis of N and P Proteins as a Key Step in Sendai Virus Gene Expression". Journal of Virology. 81 (24): 13835–13844. doi:10.1128/jvi.00914-07. ISSN 0022-538X. PMC 2168830. PMID 17855540.
Latorre P, Kolakofsky D, Curran J (September 1998). "Sendai virus Y proteins are initiated by a ribosomal shunt". Molecular and Cellular Biology. 18 (9): 5021–31. doi:10.1128/mcb.18.9.5021. PMC 109087. PMID 9710586.
Harrison MS, Sakaguchi T, Schmitt AP (September 2010). "Paramyxovirus assembly and budding: building particles that transmit infections". The International Journal of Biochemistry & Cell Biology. 42 (9): 1416–1429. doi:10.1016/j.biocel.2010.04.005. PMC 2910131. PMID 20398786.
Ito M, Takeuchi T, Nishio M, Kawano M, Komada H, Tsurudome M, et al. (November 2004). "Early stage of establishment of persistent Sendai virus infection: unstable dynamic phase and then selection of viruses which are tightly cell associated, temperature sensitive, and capable of establishing persistent infection". Journal of Virology. 78 (21): 11939–11951. doi:10.1128/JVI.78.21.11939-11951.2004. PMC 523293. PMID 15479834.
Coakley C, Peter C, Fabry S, Chattopadhyay S (August 2017). "Establishment of a Human Cell Line Persistently Infected with Sendai Virus". Bio-Protocol. 7 (16): e2512. doi:10.21769/BioProtoc.2512. PMC 8413619. PMID 34541174.
Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Yamashita M, Sen GC (January 2013). "Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus". Journal of Virology. 87 (1): 16–24. doi:10.1128/JVI.01853-12. PMC 3536409. PMID 23077293.
Mercado-López X, Cotter CR, Kim WK, Sun Y, Muñoz L, Tapia K, et al. (November 2013). "Highly immunostimulatory RNA derived from a Sendai virus defective viral genome". Vaccine. 31 (48): 5713–5721. doi:10.1016/j.vaccine.2013.09.040. PMC 4406099. PMID 24099876.
Xu J, Sun Y, Li Y, Ruthel G, Weiss SR, Raj A, et al. (October 2017). "Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence". Nature Communications. 8 (1): 799. Bibcode:2017NatCo...8..799X. doi:10.1038/s41467-017-00909-6. PMC 5630589. PMID 28986577.
Genoyer E, López CB (February 2019). "Defective Viral Genomes Alter How Sendai Virus Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production of Viral Particles among Infected Cells". Journal of Virology. 93 (4). doi:10.1128/JVI.01579-18. PMC 6364009. PMID 30463965.
Pablo-Maiso L, Echeverría I, Rius-Rocabert S, Luján L, Garcin D, Andrés D, et al. (April 2020). "Sendai Virus, a Strong Inducer of Anti-Lentiviral State in Ovine Cells". Vaccines. 8 (2): 206. doi:10.3390/vaccines8020206. PMC 7349755. PMID 32365702.
Rawling J, Cano O, Garcin D, Kolakofsky D, Melero JA (March 2011). "Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus". Journal of Virology. 85 (6): 2771–80. doi:10.1128/JVI.02065-10. PMC 3067931. PMID 21228237.
Takimoto T, Taylor GL, Connaris HC, Crennell SJ, Portner A (December 2002). "Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion". Journal of Virology. 76 (24): 13028–33. doi:10.1128/JVI.76.24.13028-13033.2002. PMC 136693. PMID 12438628.
Novick SL, Hoekstra D (October 1988). "Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labeling". Proceedings of the National Academy of Sciences of the United States of America. 85 (20): 7433–7. Bibcode:1988PNAS...85.7433N. doi:10.1073/pnas.85.20.7433. PMC 282205. PMID 2845406.
Chandra S, Kalaivani R, Kumar M, Srinivasan N, Sarkar DP (December 2017). Bassereau P (ed.). "Sendai virus recruits cellular villin to remodel actin cytoskeleton during fusion with hepatocytes". Molecular Biology of the Cell. 28 (26): 3801–3814. doi:10.1091/mbc.e17-06-0400. PMC 5739296. PMID 29074568.
Shah NR, Sunderland A, Grdzelishvili VZ (June 2010). "Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin". PLOS ONE. 5 (6): e11265. Bibcode:2010PLoSO...511265S. doi:10.1371/journal.pone.0011265. PMC 2889835. PMID 20582319.
Sumpter R, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, et al. (March 2005). "Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I". Journal of Virology. 79 (5): 2689–99. doi:10.1128/JVI.79.5.2689-2699.2005. PMC 548482. PMID 15708988.
Buggele WA, Horvath CM (August 2013). "MicroRNA profiling of Sendai virus-infected A549 cells identifies miR-203 as an interferon-inducible regulator of IFIT1/ISG56". Journal of Virology. 87 (16): 9260–70. doi:10.1128/JVI.01064-13. PMC 3754065. PMID 23785202.
Espada CE, Sari L, Cahill MP, Yang H, Phillips S, Martinez N, et al. (July 2023). "SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection". The Journal of Biological Chemistry. 299 (7): 104925. doi:10.1016/j.jbc.2023.104925. PMC 10404699. PMID 37328105.
Zainutdinov SS, Kochneva GV, Netesov SV, Chumakov PM, Matveeva OV (2019). "Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes". Oncolytic Virotherapy. 8: 9–26. doi:10.2147/OV.S176523. PMC 6636189. PMID 31372363.
Killip MJ, Young DF, Gatherer D, Ross CS, Short JA, Davison AJ, et al. (May 2013). "Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction". Journal of Virology. 87 (9): 4798–4807. doi:10.1128/JVI.03383-12. PMC 3624313. PMID 23449801.
Yoshida A, Kawabata R, Honda T, Sakai K, Ami Y, Sakaguchi T, et al. (March 2018). "A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes". Journal of Virology. 92 (5). doi:10.1128/JVI.02094-17. PMC 5809723. PMID 29237838.
Sánchez-Aparicio MT, Garcin D, Rice CM, Kolakofsky D, García-Sastre A, Baum A (June 2017). "Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA". The Journal of General Virology. 98 (6): 1282–1293. doi:10.1099/jgv.0.000815. PMC 5962894. PMID 28631605.
Tatsumoto N, Arditi M, Yamashita M (September 2018). "Sendai Virus Propagation Using Chicken Eggs". Bio-Protocol. 8 (18). doi:10.21769/BioProtoc.3009. PMC 6200407. PMID 30370318.
Pappas C, Matsuoka Y, Swayne DE, Donis RO (November 2007). "Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness". Clinical and Vaccine Immunology. 14 (11): 1425–1432. doi:10.1128/CVI.00174-07. PMC 2168170. PMID 17913860.
Tatsumoto N, Miyauchi T, Arditi M, Yamashita M (November 2018). "Quantification of Infectious Sendai Virus Using Plaque Assay". Bio-Protocol. 8 (21). doi:10.21769/BioProtoc.3068. PMC 6289198. PMID 30547053.

chem.nlm.nih.gov

Chambers M. "ChemIDplus - 71833-57-3 - OWMXULOUTAAVIX-HNZIOFRCSA-N - Sialosylparagloboside - Similar structures search, synonyms, formulas, resource links, and other chemical information". chem.nlm.nih.gov. Retrieved 2019-08-13.

pubchemdocs.ncbi.nlm.nih.gov

"About PubChem". pubchemdocs.ncbi.nlm.nih.gov. Retrieved 2019-08-15.

toxnet.nlm.nih.gov

"TOXNET". toxnet.nlm.nih.gov. Retrieved 2019-08-15.

osaka-u.ac.jp

ir.library.osaka-u.ac.jp

Tai JA, Chang CY, Nishikawa T, Kaneda Y (August 2019). "Cancer immunotherapy using the Fusion gene of Sendai virus" (PDF). Cancer Gene Therapy. 27 (6): 498–508. doi:10.1038/s41417-019-0126-6. PMID 31383952. S2CID 199450913.

patents.google.com

US 9526779, Matveeva O, Senina A, Slav V, Senin M, "Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus", issued 27 December 2016, assigned to Sendai Viralytics LLC

proteinatlas.org

"ASGR1 protein expression summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2020-01-14.
"ASGR2 protein expression summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2020-01-14.
"Asialoglycoprotein receptor 1 expression". The Human Protein Atlas. February 4, 2023. Retrieved February 4, 2023.
"Expression of TMPRSS2 in cancer - Summary - the Human Protein Atlas".
"Cell atlas - TMPRSS2 - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2019-08-20.
"Expression of TPSB2 in cancer - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2019-08-20.
"Cell atlas - TPSB2 - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2019-08-20.
"Expression of PLG in cancer - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2019-08-20.
"Expression of F10 in cancer - Summary - The Human Protein Atlas". www.proteinatlas.org. Retrieved 2019-08-30.

psu.edu

citeseerx.ist.psu.edu

Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A (March 2007). "Autophagy-dependent viral recognition by plasmacytoid dendritic cells". Science. 315 (5817): 1398–401. Bibcode:2007Sci...315.1398L. CiteSeerX 10.1.1.657.3208. doi:10.1126/science.1136880. PMID 17272685. S2CID 11549012.

ratguide.com

"Sendai Virus (SV)". Rat Guide.

sciencedirect.com

Suckow MA, Stevens KA, Wilson RP (23 January 2012). The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. Elsevier. ISBN 978-0-12-380920-9.

semanticscholar.org

api.semanticscholar.org

Samal SK (2008). "Paramyxoviruses of Animals". Encyclopedia of Virology. Elsevier. pp. 40–47. doi:10.1016/b978-012374410-4.00460-x. ISBN 9780123744104. S2CID 81060576.
Köhler G, Milstein C (August 1975). "Continuous cultures of fused cells secreting antibody of predefined specificity". Nature. 256 (5517): 495–497. Bibcode:1975Natur.256..495K. doi:10.1038/256495a0. PMID 1172191. S2CID 4161444.
Hu Z, Jiang W, Gu L, Qiao D, Shu T, Lowrie DB, et al. (December 2019). "Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines". Journal of Molecular Medicine. 97 (12): 1685–1694. doi:10.1007/s00109-019-01844-3. PMID 31786669. S2CID 208359634.
Seki S, Matano T (2016). "Development of a Sendai virus vector-based AIDS vaccine inducing T cell responses". Expert Review of Vaccines. 15 (1): 119–127. doi:10.1586/14760584.2016.1105747. PMID 26512881. S2CID 27197590.
Morimoto S, Saeki K, Takeshita M, Hirano K, Shirakawa M, Yamada Y, et al. (January 2023). "Intranasal Sendai virus-based SARS-CoV-2 vaccine using a mouse model". Genes to Cells. 28 (1): 29–41. doi:10.1111/gtc.12992. PMID 36401755. S2CID 253671438.
MacLachlan NJ, Dubovi EJ, eds. (2017). "Chapter 17 - Paramyxoviridae and Pneumoviridae". Fenner's Veterinary Virology (Fifth ed.). Academic Press. pp. 327–356. doi:10.1016/B978-0-12-800946-8.00017-9. ISBN 9780128009468. S2CID 214757272.
Flecknell PA, Parry R, Needham JR, Ridley RM, Baker HF, Bowes P (April 1983). "Respiratory disease associated with parainfluenza Type I (Sendai) virus in a colony of marmosets (Callithrix jacchus)". Laboratory Animals. 17 (2): 111–113. doi:10.1258/002367783780959448. PMID 6306336. S2CID 7413539.
Yamaguchi M, Kitagawa Y, Zhou M, Itoh M, Gotoh B (January 2014). "An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction". FEBS Letters. 588 (1): 28–34. Bibcode:2014FEBSL.588...28Y. doi:10.1016/j.febslet.2013.11.015. PMID 24269682. S2CID 24831300.
Kitagawa Y, Yamaguchi M, Kohno M, Sakai M, Itoh M, Gotoh B (2020). "Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling". FEBS Letters. 594 (5): 864–877. doi:10.1002/1873-3468.13670. PMID 31705658. S2CID 207944272.
Morita N, Tanaka Y, Odkhuu E, Naiki Y, Komatsu T, Koide N (February 2020). "Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages". Microbes and Infection. 22 (8): 322–330. doi:10.1016/j.micinf.2020.01.005. PMID 32032681. S2CID 211064429.
Qiao D, Janke BH, Elankumaran S (August 2009). "Molecular characterization of glycoprotein genes and phylogenetic analysis of two swine paramyxoviruses isolated from United States". Virus Genes. 39 (1): 53–65. doi:10.1007/s11262-009-0353-2. PMID 19337823. S2CID 7100230.
Hara H, Hara H, Hironaka T, Inoue M, Iida A, Shu T, et al. (June 2011). "Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectors". Human Vaccines. 7 (6): 639–45. doi:10.4161/hv.7.6.15408. PMID 21508675. S2CID 24481304.
Griesenbach U, McLachlan G, Owaki T, Somerton L, Shu T, Baker A, et al. (February 2011). "Validation of recombinant Sendai virus in a non-natural host model". Gene Therapy. 18 (2): 182–8. doi:10.1038/gt.2010.131. PMID 20962870. S2CID 23293412.
Miettinen M, Sareneva T, Julkunen I, Matikainen S (October 2001). "IFNs activate toll-like receptor gene expression in viral infections". Genes and Immunity. 2 (6): 349–55. doi:10.1038/sj.gene.6363791. PMID 11607792. S2CID 5819381.
Seth RB, Sun L, Ea CK, Chen ZJ (September 2005). "Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3". Cell. 122 (5): 669–682. doi:10.1016/j.cell.2005.08.012. PMID 16125763. S2CID 11104354.
Leib D (2010-03-08). "Evaluation for RIG-I detects viral genomic RNA during negative-strand RNA virus infection". Faculty of 1000. doi:10.3410/f.2412956.2047054. S2CID 90712939.
Servant MJ, Grandvaux N, tenOever BR, Duguay D, Lin R, Hiscott J (March 2003). "Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA". The Journal of Biological Chemistry. 278 (11): 9441–7. doi:10.1074/jbc.M209851200. PMID 12524442. S2CID 19096582.
Barnes BJ, Moore PA, Pitha PM (June 2001). "Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes". The Journal of Biological Chemistry. 276 (26): 23382–90. doi:10.1074/jbc.M101216200. PMID 11303025. S2CID 26896371.
Hua J, Liao MJ, Rashidbaigi A (July 1996). "Cytokines induced by Sendai virus in human peripheral blood leukocytes". Journal of Leukocyte Biology. 60 (1): 125–8. doi:10.1002/jlb.60.1.125. PMID 8699116. S2CID 28976518.
Milone MC, Fitzgerald-Bocarsly P (September 1998). "The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses". Journal of Immunology. 161 (5): 2391–9. doi:10.4049/jimmunol.161.5.2391. PMID 9725235. S2CID 30673547.
Eloranta ML, Sandberg K, Ricciardi-Castagnoli P, Lindahl M, Alm GV (September 1997). "Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria". Scandinavian Journal of Immunology. 46 (3): 235–41. doi:10.1046/j.1365-3083.1997.d01-120.x. PMID 9315110. S2CID 40570647.
Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A (March 2007). "Autophagy-dependent viral recognition by plasmacytoid dendritic cells". Science. 315 (5817): 1398–401. Bibcode:2007Sci...315.1398L. CiteSeerX 10.1.1.657.3208. doi:10.1126/science.1136880. PMID 17272685. S2CID 11549012.
Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, et al. (December 2003). "Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells". Journal of Leukocyte Biology. 74 (6): 1125–38. doi:10.1189/jlb.0603255. PMID 12960254. S2CID 12030752.
Vremec D, Pooley J, Hochrein H, Wu L, Shortman K (March 2000). "CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen". Journal of Immunology. 164 (6): 2978–86. doi:10.4049/jimmunol.164.6.2978. PMID 10706685. S2CID 20588521.
Suzuki H, Kurooka M, Hiroaki Y, Fujiyoshi Y, Kaneda Y (April 2008). "Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner". FEBS Letters. 582 (9): 1325–9. Bibcode:2008FEBSL.582.1325S. doi:10.1016/j.febslet.2008.03.011. PMID 18358837. S2CID 207607018.
Kawaguchi Y, Miyamoto Y, Inoue T, Kaneda Y (May 2009). "Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle". International Journal of Cancer. 124 (10): 2478–87. doi:10.1002/ijc.24234. PMID 19173282. S2CID 33289879.
Ittah M, Miceli-Richard C, Lebon P, Pallier C, Lepajolec C, Mariette X (2011). "Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type". Journal of Innate Immunity. 3 (2): 200–7. doi:10.1159/000321194. PMID 21051868. S2CID 6699971.
Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, et al. (December 2006). "Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA". The Journal of Biological Chemistry. 281 (48): 36560–8. doi:10.1074/jbc.M607594200. PMID 17008311. S2CID 23488241.
Öhman T, Söderholm S, Paidikondala M, Lietzén N, Matikainen S, Nyman TA (June 2015). "Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells". Proteomics. 15 (12): 2087–2097. doi:10.1002/pmic.201400586. PMID 25764225. S2CID 32610482.
Kinoh H, Inoue M, Washizawa K, Yamamoto T, Fujikawa S, Tokusumi Y, et al. (July 2004). "Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases". Gene Therapy. 11 (14): 1137–45. doi:10.1038/sj.gt.3302272. PMID 15085175. S2CID 10376042.
Kinoh H, Inoue M (January 2008). "New cancer therapy using genetically-engineered oncolytic Sendai virus vector". Frontiers in Bioscience. 13 (13): 2327–34. doi:10.2741/2847. PMID 17981715. S2CID 25851804.
Tatsuta K, Tanaka S, Tajiri T, Shibata S, Komaru A, Ueda Y, et al. (February 2009). "Complete elimination of established neuroblastoma by synergistic action of gamma-irradiation and DCs treated with rSeV expressing interferon-beta gene". Gene Therapy. 16 (2): 240–51. doi:10.1038/gt.2008.161. PMID 18987675. S2CID 27976395.
Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, et al. (June 2019). "Oncolytic Sendai virus-induced tumor-specific immunoresponses suppress "simulated metastasis" of squamous cell carcinoma in an immunocompetent mouse model". Head & Neck. 41 (6): 1676–1686. doi:10.1002/hed.25642. PMID 30620422. S2CID 58561289.
Tanaka Y, Araki K, Tanaka S, Miyagawa Y, Suzuki H, Kamide D, et al. (August 2019). "Sentinel Lymph Node-Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model". Molecular Cancer Therapeutics. 18 (8): 1430–1438. doi:10.1158/1535-7163.MCT-18-1372. PMID 31171582. S2CID 174812921.
Iwadate Y, Inoue M, Saegusa T, Tokusumi Y, Kinoh H, Hasegawa M, et al. (May 2005). "Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats". Clinical Cancer Research. 11 (10): 3821–7. doi:10.1158/1078-0432.CCR-04-1485. PMID 15897582. S2CID 37657020.
Tanaka M, Shimbo T, Kikuchi Y, Matsuda M, Kaneda Y (April 2010). "Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon". International Journal of Cancer. 126 (8): 1982–1991. doi:10.1002/ijc.24965. PMID 19830690. S2CID 3414189.
Fujihara A, Kurooka M, Miki T, Kaneda Y (January 2008). "Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation". Cancer Immunology, Immunotherapy. 57 (1): 73–84. doi:10.1007/s00262-007-0351-y. PMC 11030187. PMID 17602226. S2CID 8779015.
Saga K, Tamai K, Yamazaki T, Kaneda Y (February 2013). "Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production". Clinical Cancer Research. 19 (3): 668–79. doi:10.1158/1078-0432.CCR-12-1947. PMID 23251005. S2CID 14105282.
Kiyohara E, Tanemura A, Nishioka M, Yamada M, Tanaka A, Yokomi A, et al. (June 2020). "Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study". Cancer Immunology, Immunotherapy. 69 (6): 1131–1140. doi:10.1007/s00262-020-02509-8. PMC 11027698. PMID 32047956. S2CID 211074332.
Fuster MM, Esko JD (July 2005). "The sweet and sour of cancer: glycans as novel therapeutic targets". Nature Reviews. Cancer. 5 (7): 526–542. doi:10.1038/nrc1649. PMID 16069816. S2CID 10330140.
Hatano K, Miyamoto Y, Nonomura N, Kaneda Y (October 2011). "Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells". International Journal of Cancer. 129 (8): 1838–47. doi:10.1002/ijc.25860. PMID 21165949. S2CID 7765966.
Sterner E, Flanagan N, Gildersleeve JC (July 2016). "Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database". ACS Chemical Biology. 11 (7): 1773–1783. doi:10.1021/acschembio.6b00244. PMC 4949583. PMID 27220698. S2CID 17515010.
Ariga T, Bhat S, Kanda T, Yamawaki M, Tai T, Kushi Y, et al. (April 1996). "Expression and localization of Lewis(x) glycolipids and GD1a ganglioside in human glioma cells". Glycoconjugate Journal. 13 (2): 135–145. doi:10.1007/BF00731487. PMID 8737237. S2CID 11831860.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, et al. (April 1997). "Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis". Diseases of the Colon and Rectum. 40 (4): 420–431. doi:10.1007/bf02258386. PMID 9106690. S2CID 24770173.
Nakagoe T, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, et al. (March 2001). "Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels". Journal of Gastroenterology. 36 (3): 166–172. doi:10.1007/s005350170124. PMID 11291879. S2CID 25161348.
Nakagoe T, Fukushima K, Itoyanagi N, Ikuta Y, Oka T, Nagayasu T, et al. (May 2002). "Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer". Journal of Cancer Research and Clinical Oncology. 128 (5): 257–264. doi:10.1007/s00432-002-0334-5. PMID 12029441. S2CID 24553989.
Carrascal MA, Silva M, Ferreira JA, Azevedo R, Ferreira D, Silva AM, et al. (September 2018). "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer". Biochimica et Biophysica Acta (BBA) - General Subjects. 1862 (9): 2069–2080. doi:10.1016/j.bbagen.2018.05.013. PMID 29777742. S2CID 29167912.
Dimitroff CJ, Lechpammer M, Long-Woodward D, Kutok JL (August 2004). "Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin". Cancer Research. 64 (15): 5261–5269. doi:10.1158/0008-5472.CAN-04-0691. PMID 15289332. S2CID 11632075.
Idikio HA (November 1997). "Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer". Glycoconjugate Journal. 14 (7): 875–877. doi:10.1023/a:1018502424487. PMID 9511995. S2CID 28112794.
Fujii Y, Yoshida M, Chien LJ, Kihara K, Kageyama Y, Yasukochi Y, et al. (2000). "Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium". Urologia Internationalis. 64 (3): 129–133. doi:10.1159/000030512. PMID 10859542. S2CID 23332254.
Majdic O, Bettelheim P, Stockinger H, Aberer W, Liszka K, Lutz D, et al. (May 1984). "M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells". International Journal of Cancer. 33 (5): 617–623. doi:10.1002/ijc.2910330511. PMID 6724736. S2CID 20483491.
Hatano K, Miyamoto Y, Nonomura N, Kaneda Y (October 2011). "Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells". International Journal of Cancer. 129 (8): 1838–1847. doi:10.1002/ijc.25860. PMID 21165949. S2CID 7765966.
Shetterly S, Jost F, Watson SR, Knegtel R, Macher BA, Holmes EH (August 2007). "Site-specific fucosylation of sialylated polylactosamines by alpha1,3/4-fucosyltransferases-V and -VI Is defined by amino acids near the N terminus of the catalytic domain". The Journal of Biological Chemistry. 282 (34): 24882–92. doi:10.1074/jbc.m702395200. PMID 17604274. S2CID 27689343.
Ngamukote S, Yanagisawa M, Ariga T, Ando S, Yu RK (December 2007). "Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains". Journal of Neurochemistry. 103 (6): 2327–41. doi:10.1111/j.1471-4159.2007.04910.x. PMID 17883393. S2CID 21405747.
Nilsson G, Blom T, Kusche-Gullberg M, Kjellén L, Butterfield JH, Sundström C, et al. (May 1994). "Phenotypic characterization of the human mast-cell line HMC-1". Scandinavian Journal of Immunology. 39 (5): 489–98. doi:10.1111/j.1365-3083.1994.tb03404.x. PMID 8191224. S2CID 28014083.
Tai JA, Chang CY, Nishikawa T, Kaneda Y (August 2019). "Cancer immunotherapy using the Fusion gene of Sendai virus" (PDF). Cancer Gene Therapy. 27 (6): 498–508. doi:10.1038/s41417-019-0126-6. PMID 31383952. S2CID 199450913.
Lin EH, Salon C, Brambilla E, Lavillette D, Szecsi J, Cosset FL, et al. (April 2010). "Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer". Cancer Gene Therapy. 17 (4): 256–65. doi:10.1038/cgt.2009.74. PMID 19893593. S2CID 11203950.
Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, et al. (July 2005). "A critical function for type I interferons in cancer immunoediting". Nature Immunology. 6 (7): 722–9. doi:10.1038/ni1213. PMID 15951814. S2CID 20374688.
Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. (December 2007). "Interferons at age 50: past, current and future impact on biomedicine". Nature Reviews. Drug Discovery. 6 (12): 975–90. doi:10.1038/nrd2422. PMC 7097588. PMID 18049472. S2CID 583709.
Benedetto A, Elia G, Sala A, Belardelli F (January 1989). "Hyposialylation of high-molecular-weight membrane glycoproteins parallels the loss of metastatic potential in wheat-germ agglutinin-resistant Friend leukemia cells". International Journal of Cancer. 43 (1): 126–33. doi:10.1002/ijc.2910430124. PMID 2910824. S2CID 24704777.
Chiang CH, Wang CH, Chang HC, More SV, Li WS, Hung WC (May 2010). "A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling". Journal of Cellular Physiology. 223 (2): 492–9. doi:10.1002/jcp.22068. PMID 20112294. S2CID 24218458.
Cohen M, Elkabets M, Perlmutter M, Porgador A, Voronov E, Apte RN, et al. (November 2010). "Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting". Journal of Immunology. 185 (10): 5869–78. doi:10.4049/jimmunol.1001635. PMID 20956342. S2CID 45698975.
Powell LD, Whiteheart SW, Hart GW (July 1987). "Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction". Journal of Immunology. 139 (1): 262–70. doi:10.4049/jimmunol.139.1.262. PMID 2953814. S2CID 25762755.
Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O (September 2001). "Recognition of viral hemagglutinins by NKp44 but not by NKp30". European Journal of Immunology. 31 (9): 2680–9. doi:10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A. PMID 11536166. S2CID 22437769.
Harada Y, Yonemitsu Y (June 2011). "Dramatic improvement of DC-based immunotherapy against various malignancies". Frontiers in Bioscience. 16 (6): 2233–2242. doi:10.2741/3850. PMID 21622173. S2CID 30195748.
Shibata S, Okano S, Yonemitsu Y, Onimaru M, Sata S, Nagata-Takeshita H, et al. (September 2006). "Induction of efficient antitumor immunity using dendritic cells activated by recombinant Sendai virus and its modulation by exogenous IFN-beta gene". Journal of Immunology. 177 (6): 3564–3576. doi:10.4049/jimmunol.177.6.3564. PMID 16951315. S2CID 20134438.
Okano S, Yonemitsu Y, Shirabe K, Kakeji Y, Maehara Y, Harada M, et al. (February 2011). "Provision of continuous maturation signaling to dendritic cells by RIG-I-stimulating cytosolic RNA synthesis of Sendai virus". Journal of Immunology. 186 (3): 1828–1839. doi:10.4049/jimmunol.0901641. PMID 21187441. S2CID 36653582.
Sugiyama M, Kakeji Y, Tsujitani S, Harada Y, Onimaru M, Yoshida K, et al. (March 2011). "Antagonism of VEGF by genetically engineered dendritic cells is essential to induce antitumor immunity against malignant ascites". Molecular Cancer Therapeutics. 10 (3): 540–549. doi:10.1158/1535-7163.MCT-10-0479. hdl:2324/25486. PMID 21209070. S2CID 37616710.
Komaru A, Ueda Y, Furuya A, Tanaka S, Yoshida K, Kato T, et al. (October 2009). "Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus". Journal of Immunology. 183 (7): 4211–4219. doi:10.4049/jimmunol.0803845. PMID 19734206. S2CID 39194525.
Hosoya N, Miura T, Kawana-Tachikawa A, Koibuchi T, Shioda T, Odawara T, et al. (March 2008). "Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells". Journal of Medical Virology. 80 (3): 373–82. doi:10.1002/jmv.21052. PMID 18205221. S2CID 31337462.
Sakai Y, Kiyotani K, Fukumura M, Asakawa M, Kato A, Shioda T, et al. (August 1999). "Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication". FEBS Letters. 456 (2): 221–6. Bibcode:1999FEBSL.456..221S. doi:10.1016/s0014-5793(99)00960-6. PMID 10456313. S2CID 1285541.
Yoshizaki M, Hironaka T, Iwasaki H, Ban H, Tokusumi Y, Iida A, et al. (September 2006). "Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity". The Journal of Gene Medicine. 8 (9): 1151–1159. doi:10.1002/jgm.938. PMID 16841365. S2CID 39942120.
Miyazaki M, Segawa H, Yamashita T, Zhu Y, Takizawa K, Hasegawa M, et al. (2010-11-23). "Construction and characterization of a fluorescent sendai virus carrying the gene for envelope fusion protein fused with enhanced green fluorescent protein". Bioscience, Biotechnology, and Biochemistry. 74 (11): 2293–8. doi:10.1271/bbb.100511. PMID 21071846. S2CID 43669142.
Jin CH, Kusuhara K, Yonemitsu Y, Nomura A, Okano S, Takeshita H, et al. (February 2003). "Recombinant Sendai virus provides a highly efficient gene transfer into human cord blood-derived hematopoietic stem cells". Gene Therapy. 10 (3): 272–7. doi:10.1038/sj.gt.3301877. PMID 12571635. S2CID 22415369.
Seki T, Yuasa S, Fukuda K (March 2012). "Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus". Nature Protocols. 7 (4): 718–28. doi:10.1038/nprot.2012.015. PMID 22422317. S2CID 41397031.
Moreno-Fierros L, García-Silva I, Rosales-Mendoza S (August 2020). "Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?". Expert Opinion on Biological Therapy. 20 (8): 831–836. doi:10.1080/14712598.2020.1767062. PMID 32380868. S2CID 218556295.
Shi LY, Li M, Yuan LJ, Wang Q, Li XM (2008). "A new paramyxovirus, Tianjin strain, isolated from common cotton-eared marmoset: genome characterization and structural protein sequence analysis". Archives of Virology. 153 (9): 1715–23. doi:10.1007/s00705-008-0184-9. PMID 18696006. S2CID 6151471.
Yamada H, Hayata S, Omata-Yamada T, Taira H, Mizumoto K, Iwasaki K (1990). "Association of the Sendai virus C protein with nucleocapsids". Archives of Virology. 113 (3–4): 245–53. doi:10.1007/bf01316677. PMID 2171459. S2CID 24592567.
Payne V, Kam PC (July 2004). "Mast cell tryptase: a review of its physiology and clinical significance". Anaesthesia. 59 (7): 695–703. doi:10.1111/j.1365-2044.2004.03757.x. PMID 15200544. S2CID 7611291.
Le TQ, Kawachi M, Yamada H, Shiota M, Okumura Y, Kido H (April 2006). "Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain". Biological Chemistry. 387 (4): 467–75. doi:10.1515/BC.2006.062. PMID 16606346. S2CID 11969821.
Gotoh B, Yamauchi F, Ogasawara T, Nagai Y (January 1992). "Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation". FEBS Letters. 296 (3): 274–8. Bibcode:1992FEBSL.296..274G. doi:10.1016/0014-5793(92)80303-x. PMID 1537403. S2CID 33852517.
Lam A, Kirkland OO, Anderson PF, Seetharaman N, Vujovic D, Thibault PA, et al. (2021-11-23). "Single virus assay reveals membrane determinants and mechanistic features of Sendai virus binding". Biophysical Journal. 121 (6): 956–965. Bibcode:2022BpJ...121..956L. doi:10.1016/j.bpj.2022.02.011. PMC 8943810. PMID 35150620. S2CID 246715171.
Villar E, Barroso IM (February 2006). "Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview". Glycoconjugate Journal. 23 (1–2): 5–17. doi:10.1007/s10719-006-5433-0. PMID 16575518. S2CID 21083897.
Ogino T, Kobayashi M, Iwama M, Mizumoto K (February 2005). "Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA". The Journal of Biological Chemistry. 280 (6): 4429–35. doi:10.1074/jbc.M411167200. PMID 15574411. S2CID 27655763.
Ryu SW (2017). "Other Negative-Strand RNA Viruses". Molecular Virology of Human Pathogenic Viruses. Elsevier. pp. 213–224. doi:10.1016/b978-0-12-800838-6.00016-3. ISBN 978-0-12-800838-6. S2CID 88812845.
Lallemand C, Blanchard B, Palmieri M, Lebon P, May E, Tovey MG (January 2007). "Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB". Oncogene. 26 (3): 328–38. doi:10.1038/sj.onc.1209795. PMID 16832344. S2CID 25830890.
Zainutdinov SS, Grazhdantseva AA, Kochetkov DV, Chumakov PM, Netesov SV, Matveeva OV, et al. (2017-10-01). "Change in Oncolytic Activity of Sendai Virus during Adaptation to Cell Cultures". Molecular Genetics, Microbiology and Virology. 32 (4): 212–217. doi:10.3103/S0891416817040115. S2CID 46958676.
Belova AA, Sosnovtseva AO, Lipatova AV, Njushko KM, Volchenko NN, Belyakov MM, et al. (2017-01-01). "[Biomarkers of prostate cancer sensitivity to the Sendai virus]". Molekuliarnaia Biologiia. 51 (1): 94–103. doi:10.1134/S0026893317010046. PMID 28251971. S2CID 34514102.
Sakaguchi T, Kiyotani K, Sakaki M, Fujii Y, Yoshida T (March 1994). "A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains". Archives of Virology. 135 (1–2): 159–64. doi:10.1007/bf01309773. PMID 8198441. S2CID 12180965.
Kiyotani K, Sakaguchi T, Fujii Y, Yoshida T (2001). "Attenuation of a field Sendai virus isolate through egg-passages is associated with an impediment of viral genome replication in mouse respiratory cells". Archives of Virology. 146 (5): 893–908. doi:10.1007/s007050170123. PMID 11448028. S2CID 21947750.
Kolakofsky D (August 1976). "Isolation and characterization of Sendai virus DI-RNAs". Cell. 8 (4): 547–555. doi:10.1016/0092-8674(76)90223-3. PMID 182384. S2CID 32399729.

semanticscholar.org

Zainutdinov SS, Grazhdantseva AA, Kochetkov DV, Chumakov PM, Netesov SV, Matveeva OV, et al. (2017-10-01). "Change in Oncolytic Activity of Sendai Virus during Adaptation to Cell Cultures". Molecular Genetics, Microbiology and Virology. 32 (4): 212–217. doi:10.3103/S0891416817040115. S2CID 46958676.

springer.com

link.springer.com

Samal SK (2021), Vanniasinkam T, Tikoo SK, Samal SK (eds.), "Paramyxoviruses as Vaccine Vectors", Viral Vectors in Veterinary Vaccine Development, Cham: Springer International Publishing, pp. 113–139, doi:10.1007/978-3-030-51927-8_8, ISBN 978-3-030-51926-1, retrieved 2024-05-26